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Affective disorders and substance abuse disorders (SUDs) are highly prevalent within the US 
and result in substantial burdens on the affected individual, their loved ones, and society. 
Relatively few effective treatments exist however, due to a lack of understanding regarding the 
etiology of these complex disorders. Development of affective and SUDs are due to both 
environmental factors, (i.e. perinatal insults, childhood maltreatment, stressful life events), 
genetic background and the complex interplay of the two. Using inbred strains of mice can 
potentially disentangle the two (environment and genetic factors), and elucidate their interactions 
to aid in the identification of specific mechanisms. However, traditional inbred strains pose some 
limitations in the variation of genetic diversity present, which limits our ability to capture a full 
phenotypic range that may better model disease states seen in humans. In this thesis, we use a 
relatively new population of recombinant inbred strains, the Collaborative Cross (CC), that were 
designed to have increased genetic, and therefore phenotypic, diversity over traditional inbred 
strains.  
We used a panel of female F1 hybrids of CC strains (RIX) to investigate the effects of an 
environmental factor, nutritional deficiency in the perinatal period, genetic background, parent-
of-origin (PO) and any interactions on stress response, anxiety-, and depressive-like behaviors in
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adulthood. From this phenotypic screen, we identified two RIX lines (RIX 41/51 and 04/17) that 
were outliers for novelty-induced locomotion, a predictive trait for addiction-related behaviors. 
We characterized RIX 41/51 and 04/17 for cocaine (COC)-related behaviors and possible 
underlying mechanisms including COC metabolism, HPA axis dysregulation and dopamine 
dynamics in the striatum. We also performed QTL mapping for low initial locomotor response to 
COC using an F2 intercross of CC041/TauUnc and C57BL/6NJ and identified three significant 
QTLs on Chr 7, 11 and 14. These studies are the first to assess the CC or RIX of CC for 
addiction-related behaviors and provides evidence that RIX 41/51 and 04/17 are novel models 
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CHAPTER 1: GENERAL INTRODUCTION 
 
An individual’s phenotype is the result of their genetics, environment, and the interaction of 
the two. My research interests lie in understanding the role of genes and the environment in 
predisposition to develop psychiatric disorders. Psychiatric disorder is a term used to refer to a 
large number of disorders including: affective disorders (anxiety, depression, bipolar), eating 
disorders (bulimia, anorexia nervosa), dissociative disorders, schizophrenia, obsessive-
compulsive disorder, personality disorders, and substance use disorders (SUDs). Within the 
scope of my thesis, I focus on affective disorders (anxiety and depression) and SUDs – 
particularly for the psychostimulant, cocaine (COC).  
The lifetime prevalence of affective disorders such as anxiety and depression are 
approximately 29 and 21% respectively in the United States (Kessler et al, 2012). In 2015, 
approximately 20.8 million individuals met the diagnostic criteria for a SUD including 15.7 
million for alcohol and 7.1 million for illicit drugs (CBHSQ, 2016). Affective and substance use 
disorders are highly prevalent and result in significant burdens to the affected individual, their 
loved ones, and society. Treatments for depression and anxiety include selective serotonin 
reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and benzodiazepines but there 
remains a high rate of treatment cessation due to adverse side effects and a high incidence of 
individuals who are nonresponsive to treatment (Bull et al, 2002; Ferguson, 2001; Trivedi et al, 
2006). There are a few treatments for alcohol, opioid and nicotine SUDs, however there are 
currently no Food and Drug Administration-approved treatments for psychostimulants
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(SAMHSA, 2014). The complex nature of these disorders, including the interplay of genetics and 
environmental factors, makes it difficult to fully understand the various underlying mechanisms 
and prevents development of new effective treatments. Below I will briefly describe the 
environmental factors and genetic variants that play a role in predisposition to develop these 
disorders as well as the methods used to study these including genetic reference populations, 
genetic mapping, and behavioral assays. 
 
Role of Environmental Factors 
There are numerous environmental exposures that have been linked to increased 
predisposition to develop psychiatric disorders. These include exposures that happen in the 
perinatal period, early childhood, adolescence and adulthood. I thoroughly reviewed the 
environmental factors related to increased risk for affective disorders in Schoenrock and 
Tarantino (2014). Briefly, these include exposure to toxins or infection, maternal stress, and 
nutritional deficiencies during the perinatal period; maternal care/bonding and maltreatment in 
childhood; and stressful life events, social stress and periods of extreme hormonal change in 
adulthood. In this thesis, I focused on exposure to nutritional deficiencies during the perinatal 
period, defined as the time immediately preceding conception, through gestation, and in infancy. 
The perinatal period is a critical time for brain development, therefore exposures during this time 
could affect brain development and result in persistent changes throughout the lifespan. Studies 
linking nutritional deficiencies during this critical developmental period come from exposed 
groups such as the Dutch population during the Hunger Winter of 1944-1945 and the Chinese 
during the Great Famine of 1959-1961. Both populations represent unique case studies to 
examine the effects of perinatal insults throughout the lifespan based on the availability of 
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detailed medical and food ration records and numerous longitudinal follow-up studies of the 
affected individuals. Studies of these cohorts in adulthood found that, compared to non-exposed 
individuals, those exposed to nutritional deficiencies in the perinatal had an increased risk for 
developing psychiatric disorders including affective disorders (Brown et al, 1996; Brown et al, 
1995; Brown et al, 2000; Stein et al, 2009), addiction (Franzek et al, 2008), and schizophrenia 
(Brown and Susser, 2008; St Clair et al, 2005).  
In addition to affective disorders, environmental factors have also been shown to affect the 
development and maintenance of SUDs. The development of a SUD is a multistep process 
including initiation of drug use, repeated drug use and the transition to development of a SUD 
which is characterized by a repeating cycle of three steps: binge/intoxication, 
withdrawal/negative affect, preoccupation/anticipation (Koob and Volkow, 2010). In this thesis, 
I focused on the initiation and repeated use of drug phases of the progression towards 
development of an SUD. Several environmental factors have been identified to play a key role in 
the likelihood to initiate and repeat drug use, including childhood maltreatment, peer influence or 
social stress in adolescence, and stressful events in adulthood (Ducci and Goldman, 2012).  
 
Role of Genetics 
Familial and twin studies have found a high heritability (h2) for psychiatric disorders, 
indicating a significant role for genetics. The h2 of SUDs range from 0.4 to 0.7 with addiction to 
COC ranking among the highest (Ducci et al, 2012; Goldman et al, 2005) and the h2 for major 
depression is estimated at 0.37 (Sullivan et al, 2012). However, identification of genes that 
contribute to risk has been challenging due to the polygenic nature of the disorders with many 
causative variants including both common and rare polymorphisms with varying effect size 
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(Sullivan et al, 2012). Two common approaches for identifying genes involved in these disorders 
in humans are candidate gene analysis and genome-wide association studies (GWAS). Candidate 
gene studies are based on the known pathogenesis or pathways used in the treatment of the 
disorder while GWAS are hypothesis-free surveys of the entire genome. 
Candidate genes identified include those that mediate the monoamines, serotonin (5-HT), 
dopamine (DA), norepinephrine (NE) and play a role in the etiology of affective disorders and 
SUDs. Catechol-O-methyltransferase (COMT) plays a key role in the metabolism of DA and 
NE. A common variant of the COMT gene, Met158, results in less active COMT and higher DA 
levels. Individuals with the Met158 allele have decreased stress resilience and higher anxiety 
(Enoch et al, 2003). Another enzyme involved in monoamine metabolism is monoamine oxidase 
A (MAOA). A rare variant in the MAOA gene that results in an early stop codon and a non-
functional protein was reported in patients with mental retardation and impulsive behaviors 
(Brunner et al, 1993). 
Candidate genes have also been identified for drug metabolism, mainly genetic variants of 
enzymes involved in alcohol metabolism, alcohol dehydrogenase (ADH1B- His48Arg) and 
aldehyde dehydrogenase 2 (ALDH2- Glu487Lys), both of which have a protective effect on 
alcohol consumption and dependence (Wall, 2005; Wall et al, 2005). Presence of these variants 
are common in East Asian populations and act to increase buildup of acetaldehyde resulting in an 
adverse ‘flushing’ response to alcohol. Disulfiram is a treatment for alcohol use that blocks 
ALDH resulting in a build-up of acetaldehyde and the ‘flushing response’.  
GWAS are a powerful method to detect common alleles with large or moderate effects across 
the entire genome for a particular phenotype. GWAS requires a large sample size, but integration 
of samples is facilitated across testing sites by the use of the same microarrays. Additionally, the 
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cost of genotyping is declining making large scale GWAS much more feasible. The most notable 
GWAS finding for SUDs is the CHRNA5-CHRNA3-CHRNB4 cluster of chromosome 15q25, that 
encodes for the subunits of the nicotinic acetylcholine receptors and confers risk for addiction to 
nicotine (Bierut et al, 2007; Thorgeirsson et al, 2008).  
 
Role of Gene-by-Environment  
Not all individuals exposed to a specific environmental factor such as perinatal nutritional 
deficiency or a stressful life event go on to develop a psychiatric disorder. This indicates an 
interplay between genetic background and environmental exposure in development of these 
disorders and highlights the need to consider this interaction in experimental design. Very few 
genetic variants that interact with environmental factors have been identified. One that is heavily 
studied in the context of psychiatric disorders is a variant that results in differences in copy 
number and transcriptional efficiency in the promotor region (HTTLPR) of the serotonin 
transporter gene (SLC6A4). Genotype at HTTLPR has been associated with development of 
depression following a stressful live event (Caspi et al, 2003). A common variant in the 
regulatory region of the MAOA gene, MAOA-LPR leads to differences in copy number and 
therefore activity of the MAOA enzyme. An interaction between the MAOA-LPR low activity 
genotype and exposure to child adversity (i.e. maltreatment or abuse) has been shown to increase 
risk for developing conduct disorders, alcoholism and antisocial personality disorder (Caspi et al, 




Using Animal Models to Study Environmental Factors, Genetics and Gene by Environment 
Interactions  
The end goal of my research is identification of gene variants that interact with specific 
environmental factors to influence risk for development of psychiatric disorders. A major 
obstacle is disentangling these effects (gene, environment, gene-by-environment) for a given 
phenotype. Our ability to do this is humans is complicated due to the inability to accurately 
document all environmental exposures an individual has encountered throughout their lifespan 
(especially the perinatal period). Additionally, it is hard to properly control for the diversity of 
exposures in a given population.  
 
Inbred Strains of Mice 
Animal models, specifically inbred strains of mice, can be of substantial benefit in the 
research of psychiatric disorders. An inbred strain is generated through brother-sister mating 
pairs for at least 20 generations to reach homozygosity at loci in the genome. This allows for 
reproduction of the inbred genetic background at any time. Hundreds of inbred strains of mice 
currently exist, allowing for assessment of genetic background and environmental factors by 
comparison across or within strains, respectively. Additionally, gene-by-environment effects can 
be assessed using a panel of inbred strains exposed to the same environmental factor. 
 Advantages of using inbred strains include; 1) ability to control the environment to allow for 
manipulation and assessment of specific variables at certain time points, 2) access to relevant 
tissues (i.e. brain) needed for mechanistic studies both in vivo and postmortem, 3) availability of 
numerous stable and reproducible genetic backgrounds to assess phenotypic and genetic 
variation across strains, 4) access to fully sequenced genomes or dense genotyping and well-
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developed tools for manipulation of the genome (i.e. clustered regularly interspaced short 
palindromic repeats (CRISPR) and CRISPR-associated protein-9 nuclease (Cas9)), 5) short 
gestation periods (~21 days) and life spans with adulthood reached at ~60 days. These 
advantages will enable for the detection of the effects of genetics (comparison across strains), a 
specific environmental exposure (comparison within strain), and gene by environment 
interactions. Below we will discuss the methods used to assess behavioral phenotypes related to 
psychiatric disorders and identification of causative genes in mice. 
 
Behavioral assays that measure aspects of psychiatric disorders  
Our ability to study psychiatric disorders in mice is limited to assessment of specific aspects 
of these disorders. Numerous behavioral assays have been validated to have some degree of 
construct, face or predictive validity (reviewed in Nestler and Hyman (2010)). These assays were 
developed to assess one of the Diagnostic and Statistical Manual of Mental Disorders (DSM) 
criteria for diagnosis of that disorder, for example depression-related assays assess psychomotor 
agitation or retardation, anhedonia, and homeostatic symptoms (changes in sleep or eating 
behavior). However, there will always be certain aspects of the disorders that are impossible to 
assess in rodents, such as suicidal thoughts reported in patients with depression. Additional 
behavioral assays were developed as screens for antidepressant or anxiolytic agents, such as the 
forced swim test (FST), light/dark (LD) test and elevated plus maze (EPM) and, thus, show good 






To assess depressive-like behavior we used the FST in which a mouse is placed into a glass 
cylinder filled with water and the amount of time the animal exhibits escape behaviors 
(swimming, climbing) is monitored. This phenotype is thought to correlate with behavioral 
despair in humans and was developed based on the ability of antidepressants to increase the 
amount of time an animal exhibits escape behaviors (Porsolt et al, 1977a; Porsolt et al, 1977b).  
 
Anxiety-like behavior 
We assessed anxiety-like behavior using two common tests- the open field (OF) and LD. 
Both assays depend on the natural instinct of rodents to avoid open spaces and predators and the 
conflicting instinct to venture into riskier areas in search of possible rewards (Nestler et al, 
2010). Time spent or entries into the center of the OF arena or the lighted side of the LD arena 
are used to measure anxiety-like behavior with a greater amount of time spent or entries in these 
areas indicating lower anxiety (Crawley, 1981; Prut and Belzung, 2003). We also used stress-
induced hyperthermia (SIH) which is a physiological measure of anticipatory anxiety that is 
sensitive to anxiolytics (Borsini et al, 1989). 
 
Assessing stress response 
Exposure to stressful events and the ability to respond to a stressor are thought be 
precipitating factors for a variety of psychiatric disorders. Therefore, the functioning of the 
hypothalamic pituitary adrenal (HPA) axis is commonly assessed in rodents at baseline and after 
exposure to an acute or chronic stressor. Multiple stressors have been validated as a means to 
increase circulating corticosterone (CORT), the primary stress hormone in rodents that indicates 
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increased stress. These assays include restraint stress, exposure to a novel environment, chronic 
unpredictable mild stress, and social stress (Katz, 1981; Kudryavtseva et al, 1991; Piazza et al, 
1989; Willner et al, 1992). 
 
Addiction-related behaviors 
Behavioral assays that assess addiction-related phenotypes, specifically psychostimulant 
behaviors, include non-contingent (experimenter-administered) and contingent (self-
administered) drug administration. Psychomotor activation in an arena such as an OF is 
commonly used to assess non-contingent acute and repeated exposure to psychostimulants (van 
den Buuse et al, 2005). Behavioral sensitization, or an increase in psychomotor activation with 
repeated exposures to a drug, is a long-lasting phenomenon and is thought to reflect the presence 
of long-term neuronal changes that could underlie relapse behavior (Steketee and Kalivas, 2011). 
Conditioned place preference (CPP) is another test that involves repeated non-contingent drug 
exposure in which Pavlovian conditioning is used to train an animal to associate the subjective 
effects of a drug with a specific environment based on lighting, smell, and floor texture. After 
multiple training days, an animal’s preference-for the drug paired environment is thought to 
indicate whether they find the subjective effects of the drug rewarding or aversive (Bardo and 
Bevins, 2000). Intravenous self-administration (IVSA) is a commonly used paradigm that allows 
for the assessment of multiple phenotypes associated with addiction including acquisition and 
maintenance of drug-taking behavior, motivation to obtain drug (progressive-ratio breakpoint), 
extinction and reinstatement behaviors (Sanchis-Segura and Spanagel, 2006; Thomsen and 
Caine, 2007) and it is used to validate potential treatments for SUDs (Mello and Negus, 1996).  
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Gene identification in mice: QTL mapping  
As in humans, both candidate gene analysis and genome-wide analysis of genotype and 
phenotype are used in mice to identify genes that influence behavior. An approach called 
quantitative trait loci (QTL) mapping depends on phenotypic and genetic diversity within the 
mapping population. Genotyping is done using single nucleotide polymorphisms (SNPs) at 
places evenly distributed throughout the genome that differ between the mouse strains with 
millions of SNPs present among all strains. Interval mapping methods are used to infer 
genotypes between markers based on recombination frequency and distance between markers. A 
test is then performed at each locus to determine if the genotype is associated with the 
phenotype. Logarithm of odds (LOD) scores are used to determine genome-wide significance 
thresholds, corrected for multiple testing. There are programs available to aide in QTL mapping 
including R/qtl (Broman and Sen, 2009). Below we discuss the genetic reference populations 
used for genetic analysis with a focus on those using inbred strains and recombinant inbred (RI) 
populations.  
 
Genetic Reference Populations of Mice 
Intercross and backcross populations 
A common approach used in QTL mapping is generating a backcross or intercross population 
using two inbred strains. For an intercross, two inbred strains (for example, AA and BB) are 
crossed to generate F1s that are heterozygous at all loci for the two parental alleles (AB). F1s are 
then intercrossed to generate an F2 population. Due to recombination, animals will be 
homozygous for either parental strain (AA or BB) or heterozygous (AB) at any given locus. A 
backcross, begins the same way with a generation of heterozygous F1s (AB) but the F1 is 
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backcrossed to one of the parental strains (for example, AA) resulting in N2 offspring that are 
either AB or AA at a given loci. Within each of these mapping populations, each F2 or N2 
animal is genetically distinct resulting in a quantitatively distributed phenotypic range. Each 
animal in an intercross or backcross needs to be genotyped, although low density genotyping is 
sufficient due to the level of recombination present in these types of crosses. There are 
advantages and disadvantages to a F2 and N2 crossing approach which are discussed in 
Tarantino and Eisener-Dorman (2012b). 
 
Recombinant inbred strains with two parental strains 
Panels of RI strains are also used for QTL mapping. RIs are generated from crossing two 
inbred strains to generate an F2 and then intercrossing random pairs of F2 followed by 
successive brother-sister matings for at least 20 generations to reach inbred status (Bailey, 1971). 
Multiple RI strains derived from a cross between the same two inbred strains represent a RI 
panel. One of the most common RI panels is the BXD which resulted from a cross between 
C57BL/6J (B6J)and DBA/2J (DBA) (Peirce et al, 2004; Taylor et al, 1999) and currently has 
198 available strains (http://www.genenetwork.org/mouseCross.html). Advantages of the BXD 
population include a publicly available database GeneNetwork.org that has gene, protein and 
metabolite expression data, genotypes, and phenotypic data to facilitate systems genetics (Parker 
et al, 2017). BXD strains have been used to perform QTL mapping for behaviors related to 
several drugs of abuse including ethanol, COC and methamphetamine (METH) (Browman and 




Limitations of commonly used inbred strains 
While we have focused on the advantages and uses of traditional inbred strains thus far, there 
are limitations to these strains. One fundamental limitation is the lack of genetic diversity present 
across commonly used strains. A study by Yang et al (2011) found that there was limited and 
non-random genetic diversity present among classical inbred mouse strains with 
overrepresentation of genetic origin from the Mus musculus domesticus haplotype. Limited 
genetic diversity present across strains can limit the phenotypic range. Therefore, increasing 
genetic diversity can increase the phenotypic range and allow for identification of new 
phenotypic extremes that may represent disease states not seen in traditional inbred strains. 
 
Collaborative Cross 
The Collaborative Cross (CC) is a population of RI strains with eight parental strains that 
was designed by the Complex Trait Consortium to enable system genetic approaches for 
studying complex traits. The eight strains were carefully selected to represent three different 
subspecies of Mus musculus (domesticus, musculus, castaneus) and include both classical (A/J, 
B6J, 129S1Sv/ImJ, NOD/ShiLtJ, NZO/HlLtJ) and wild-derived (PWK/PhJ, CAST/EiJ, 
WSB/EiJ) strains (Churchill et al, 2004; Collaborative Cross, 2012; Threadgill and Churchill, 
2012).  
Early studies characterizing the genetic background of pre-CC strains (not fully inbred) via 
dense genotyping arrays have shown genome-wide distribution of the eight founder strains in 
relatively estimated ratios, although there are a few strains with missing contributions from one-
two strains due to breeding errors. Additionally, the genetic diversity present in the CC captures 
~90% of that present in the domesticated house mouse, and there is no evidence of long-range 
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linkage disequilibrium that can confound QTL detection (Collaborative Cross, 2012; Iraqi et al, 
2008; Roberts et al, 2007; Welsh et al, 2012). Recent analysis of the CC genomes via genotyping 
microarrays and DNA sequencing has refined earlier haplotype reconstructions and reports a 
reduction in overall contribution from two of the wild-derived strains (CAST/EiJ and PWK/PhJ) 
and new genetic variants on the order of tens of thousands due to mutations and genetic drift, 
including large deletions (>10kb) (Srivastava et al, 2017).  Studies using panels of pre-CC, CC 
or F1s have validated the increased phenotypic range present in this population over traditional 
experimental mouse populations for a variety of complex traits (Ferris et al, 2013; Graham et al, 
2015; Gralinski et al, 2015; Levy et al, 2015; Mosedale et al, 2017). Additionally, due to the 
increased diversity, new mouse models of disease states present in humans have also been 
identified (Rasmussen et al, 2014; Rogala et al, 2014). These studies highlight the usefulness of 
the CC to overcome limitations of traditional inbred strains for the study of complex traits, 
although the CC have not been used until now to assess behavioral phenotypes related to 
affective disorders and SUDs.  
 
Questions Addressed in This Thesis 
In Chapter 2, we assessed the role of genetics and an environmental factor, nutritional 
deficiency during the perinatal period, on behaviors that model anxiety- and depressive-like 
behavior and stress response. We used 18 different CC strains to generate nine sets of female F1 
hybrids, also known as recombinant inbred intercross (RIX) lines. We exposed dams from each 
of the CC strains to one of four experimental diets (protein deficient, vitamin D deficient, methyl 
enriched or standard) during the entire perinatal period. This experimental design allowed us to 
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assess genetic background, parent-of-origin (PO) effects, and perinatal diet exposure on 
behavior.  
In Chapter 3, two RIX lines (41/51 and 04/17) were identified in the experiment described in 
Chapter 2 as phenotypic outliers for novelty-induced locomotion. These lines were characterized 
for their utility as a model to assess high and low susceptibility for development of a COC SUD. 
Initial characterization of the lines included assessment of initial locomotor sensitivity, dose 
response, rewarding properties and behavioral sensitization to COC. Additionally, we assessed 
possible underlying mechanisms for the divergent behaviors observed in the two RIX lines 
including the HPA axis response to stress, tissue levels of monoamines (DA, 5-HT, NE), 
dopamine dynamics and pharmacokinetics (PK). These studies are the first to assess CC strains 
and RIX lines for addiction-related behaviors and provide evidence for the utility of RIX 04/17 
and 41/51 for the study of addiction. 
In Chapter 4, we assessed the genetics of initial cocaine sensitivity as measured by locomotor 
response to an acute dose of COC. We used an F2 intercross of CC041/TauUnc x C57BL/6NJ to 
perform QTL mapping for low locomotor response to COC to determine the mode of inheritance 
and QTL regions for identification of potential candidate genes controlling this response.  
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CHAPTER 2: PERINATAL NUTRITION INTERACTS WITH GENETIC 
BACKGROUND TO ALTER BEHAVIOR IN A PARENT-OF-ORIGIN DEPENDENT 
MANNER IN ADULT COLLABORATIVE CROSS MICE  1,2 
 
INTRODUCTION  
It is now well-established that the risk for developing a psychiatric disorder is influenced by 
a combination of genetics, the environment and gene-by-environment interactions (Lee and 
Avramopoulos, 2014). The complex etiology of psychiatric disease, whereby risk is likely due to 
the actions of hundreds or thousands of genes as well as numerous and largely undefined 
environmental factors, has made it difficult to pinpoint mechanisms and improve treatment and 
prevention strategies.  
One potentially modifiable environmental factor that has been linked to increased risk of 
psychiatric disorders is perinatal exposure to nutritional deficiencies. Longitudinal studies of the 
Dutch Hunger Winter and Chinese Famine cohorts have shown that perinatal nutritional 
deficiency increases risk for developing schizophrenia (Brown et al, 2008; Hoek et al, 1998; 
Hoek et al, 1996; St Clair et al, 2005; Susser et al, 1996; Xu et al, 2009), affective disorders  
______________________________ 
1This chapter previously appeared as an article in the Genes, Brains and Behavior journal. The 
original citation is as follows: Schoenrock SA, Oreper D, Farrington J, McMullan RC, Ervin R, 
Miller DR, Pardo-Manuel de Villena F, Valdar W and Tarantino LM (2017). Perinatal nutrition 
interacts with genetic background to alter behavior in a parent-of-origin dependent manner in 
adult Collaborative Cross mice. Genes Brain Behavior. 2017, 1-18. 
https://doi.org/10.1111/gbb.12438  Reprinted with premission from Wiley.  
 
 
2Supplemental material for this chapter is provided in Appendix A 
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(Brown et al, 1996; Brown et al, 1995; Brown et al, 2000; Stein et al, 2009), and addiction 
(Franzek et al, 2008) later in life. However, not all individuals exposed to perinatal nutritional 
deficiencies develop psychiatric disorders, suggesting potential interactions between the perinatal 
environment and genetic background. Published studies further suggest this interaction could be 
modulated by genomic imprinting, a phenomenon in which an allele is preferentially expressed 
depending on its parent-of-origin (PO)(Ishida and Moore, 2013); example, the expression of 
imprinted genes IGF2, GNASAS, and MEG3 were persistently altered in exposed vs unexposed 
siblings from the Dutch Hunger Winter cohort (Heijmans et al, 2008; Tobi et al, 2009). 
Approximately 150 imprinted genes have been identified, many of which are highly expressed in 
the brain (Davies et al, 2005; Williamson et al, 2013). Imprinted genes are known to be key 
regulators in prenatal development and postnatal growth (Cleaton et al, 2014), and dysregulation 
of imprinting has been shown to result in developmental disorders such as Prader-Willi, 
Angelman, Beckwith-Wiedmann and Silver-Russell syndromes, all of which result in growth and 
behavioral alterations (Ishida et al, 2013).  
Although the Dutch Hunger Winter and Chinese Famine allowed for observational studies of 
a perinatal nutrition challenge in human populations, obvious ethical issues preclude controlled 
studies during this key developmental period in humans. Fortunately, rodent models of 
psychiatric disorders have been developed and offer clear advantages for studying genetic and 
environmental risk factors. The advantages include: a short gestation and time to adulthood; the 
ability to control and manipulate the environment; access to relevant tissues (i.e., brain) for 
mechanistic studies; and access to well-characterized and replicable experimental populations 
along with advanced genetic tools. 
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A growing number of rodent studies demonstrate the persistent effect of perinatal nutritional 
deficiency on behavior in adulthood. Adult rodents exposed prenatally to vitamin D deficiency 
(VDD) show alterations in behaviors that model schizophrenia, including enhanced sensitivity to 
amphetamine (Kesby et al, 2010), spontaneous hyperactivity (Burne et al, 2004; Burne et al, 
2006; Eyles et al, 2006; Harms et al, 2008; Kesby et al, 2006) and decreased sustained 
attentional processing (Harms et al, 2012b; Turner et al, 2013). Rodents exposed to prenatal 
protein deficiency (PD) exhibit alterations in behavioral models of schizophrenia including 
enhanced sensitivity to amphetamine (Palmer et al, 2008) and decreased prepulse inhibition and 
startle response (Palmer et al, 2004); behaviors that model affective disorders including 
increased depressive-like (Belluscio et al, 2016; Belluscio et al, 2014; de Godoy et al, 2013; 
Vucetic et al, 2010) and anxiety-like behaviors (Belluscio et al, 2014; Reyes-Castro et al, 
2012a); and addiction-like behaviors including enhanced sensitivity to cocaine (Valdomero et al, 
2006; Vucetic et al, 2010). Rodents exposed to methyl donor deficiency (i.e. choline, folate) 
during some part of the perinatal period display increased anxiety-like behaviors (Ferguson et al, 
2005; Konycheva et al, 2011) and alterations in learning ability and memory (Berrocal-Zaragoza 
et al, 2014; Konycheva et al, 2011). A few studies in rodents have also reported strain 
differences in behavior after exposure to perinatal nutritional deficiencies (Harms et al, 2012a; 
Harms et al, 2008; Langley et al, 2015), although genetic-background dependent effects are 
largely unexplored in animal models. Rodent models also support the hypothesis that perinatal 
nutritional deficiencies lead to the dysregulation of imprinted genes and mediate behavior. Two 
studies using mice have reported alterations in the imprinted genes Cdkn1c and Igf2 following 
perinatal exposure to protein deficiency (Vucetic et al, 2010) or methyl donor deficiency 
(Waterland et al, 2006). 
	18 
In this study, we used a recently established mouse resource, the Collaborative Cross (CC) 
(Churchill et al, 2004; Srivastava et al, 2017). The CC is a panel of recombinant inbred strains 
with each strain derived from an independent cross of eight inbred founders. The eight founders, 
composed of five classical laboratory strains and three wild-derived strains, capture 90% of the 
common genetic variation present in the domesticated house mouse (Roberts et al, 2007). The 
CC was specifically designed for the study of complex phenotypes like behavior (Threadgill et 
al, 2012).  
In our study, we exposed females from 20 CC strains to one of four experimental diets prior 
to and during gestation and throughout the postnatal period until weaning. Strains were grouped 
into 10 pairs, and each strain within a pair was crossed with its CC strain partner, generating 10 
genetically distinct types of reciprocal F1 hybrid female offspring (also known as Recombinant 
Inbred Intercrosses, RIX). Based on this breeding strategy, all females within a reciprocal F1 pair 
were genetically identical except for the PO of the nuclear genome and, potentially, the 
mitochondria. These F1 females were subjected to a battery of commonly used behavioral 
models of psychiatric disorders (Fig 2.1c).  
Our experimental design takes advantage of this unique and powerful mouse population to 
detect the effects of exposure to nutritional deficiencies, genetic background, PO effects, and 
importantly, their interactions to alter behavior in adulthood.  
 
METHODS AND MATERIALS 
Collaborative Cross (CC) strain selection 
Generation of CC strains has previously been described in detail (Collaborative Cross, 2012; 
Srivastava et al, 2017). Briefly, CC are recombinant inbred strains created from eight inbred 
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lines from the three major Mus musculus subspecies, domesticus (A/J, C57BL/6J (B6J), 
129S1/SvImJ, NOD/ShiLtJ (NOD), NZO/H1LtJ, WSB/EiJ), castaneus (CAST/EiJ) and 
musculus (PWK/PhJ). CC mice were purchased from the Systems Genetics Core Facility 
(SGCF) at the University of North Carolina (UNC)(Welsh et al, 2012). 
The 20 CC strains used to generate the 10 RIX lines (S Table 1; Fig 2.1a) were selected 
using Rexplorer, a program developed at UNC for reciprocal cross strain selection (Oreper, 
Tarantino and Valdar, personal communication). Strain-pair selection aimed to maximize several 
criteria. 1) The number of known brain imprinted loci, as defined from (Crowley et al, 2015; 
Williamson et al, 2013), that are heterozygous between two categories of haplotypes: those that 
are identical by descent with NOD, and those that are identical by descent with B6J. This 
criterion was based on pilot data suggesting that offspring from a reciprocal cross between these 
two strains had different behavioral responses to perinatal nutritional deficiencies (Oreper, 
Valdar and Tarantino personal communication). Other criteria included: 2) maximum 
heterozygosity at all other haplotypes; 3) linkage disequilibrium between imprinted loci of 
interest in the ten-RIX population; and 4) predicted reproductive success (unpublished 
observations; http://csbio.unc.edu).  
 
Perinatal diet exposure and breeding RIX lines 
CC mice were purchased at approximately 4-5 weeks of age and acclimated for at least one 
week prior to diet exposure. After acclimation, dams were placed on one of four diets (S Table 2 
and see below) for five weeks. The average age at which dams were placed on the experimental 
diets was 41.4 ± 7.1 days. After five weeks on the experimental diet, dams were mated with a 
sire from a different CC strain to generate F1 offspring (S Table 1, Fig 2.1a). The average age of 
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dams at mating was 76.5 ± 7.3 days. CC dams remained on experimental diets throughout 
gestation and until litters were weaned, ensuring that the offspring were exposed throughout the 
entire perinatal period (Fig 2.1b). Sires were removed from the breeding cage once pregnancy 
was confirmed by visual inspection. We maximized the number of dams used in the study to 
ensure that behavioral observations in the F1 offspring were not attributable to a single dam. At 
least 3 dams per CC strain were used (S Table 3). We also used only the first litter per dam to 
avoid differences in reproductive parity and to minimize variation in timing of exposure to 
experimental diets. Due to the large scale of this study, we did not cross-foster the F1 offspring; 
consequently, any observed PO effects could be due to genomic imprinting and/or maternal 
effects. 
F1 offspring were weaned at postnatal day (PND) 23.1 ± 2.8 days onto standard laboratory 
chow (Harlan Teklad 2920; Envigo, Frederick, MD, USA). Female offspring were co-housed 
with reciprocals to control for cage effects. Male offspring were provided at weaning to a 
collaborator and used for unrelated studies (Xue et al, 2016).  
All mice were housed in a specific pathogen free vivarium and maintained on a 12-hour 
light/dark cycle with lights on at 7 A.M. All procedures and animal care were approved by the 
UNC Institutional Animal Care and Use Committee and followed the guidelines set forth by the 
National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. 
 
Nomenclature  
The official name of each CC strain used in this study is provided in S Table 1. For 
simplicity, we use only the last two digits of the name when referring to F1 hybrids in the text 
and figures. For each reciprocal F1 line the dam is listed first and the sire is listed second; for 
	21 
example CC(01x11)F1 refers to (CC001/Unc x CC011/Unc)F1. When referring to the collective 
group of F1 mice from a pair of reciprocal crosses, we simply list the two CC strains in 
numerical order separated by a forward slash; for example RIX 01/11 includes mice from both 
reciprocal crosses, (CC001/Unc x CC011/Unc)F1 and (CC011/Unc x CC001/Unc)F1. 
 
Experimental Diets 
Experimental diets were formulated by Dyets Inc. (Bethlehem, PA): vitamin D deficient 
(VDD; #119266), protein deficient (PD; 7.5% casein; #102787), methyl donor enriched (ME; 
#518893) or standard control (Std; #AIN-93G). S Table 2 shows the nutrient composition for all 
experimental diets. The PD and VDD diets were nutritionally matched to the Std diet. ME was 
matched to a methyl donor deficient diet that was used in pilot studies and eliminated from these 
experiments due to the inability of dams to produce viable offspring when exposed to the diet. 
All diets were administered in pelleted form and were available ad libitum to the dams during the 
perinatal period. The amount of diet consumed by each dam was not recorded.  
 
Behavior Assays 
Only female F1 offspring were tested to ensure an identical genetic background, including 
the sex chromosomes, between reciprocal hybrids. All behavioral testing was performed during 
the light part of the light/dark cycle between 8:00 A.M. and 12:00 P.M. Animals were assessed 
in adulthood (average age at initiation of testing was 68.2 ± 5.3 days). Mice were screened in a 
two-week behavioral pipeline that consisted of (in order of testing) open field (OF), light/dark 
(LD), stress-induced hyperthermia (SIH), forced swim (FST), and restraint stress tests (Fig 2.1c). 
Mice were free from testing for at least 1 day between behaviors. Behavioral tests were 
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administered in order of lowest to highest invasiveness/stress, in order to mitigate prior testing 
effects. We aimed to screen at least 20 females per RIX (10 of each reciprocal) for each of the 
four diet exposures. Actual sample sizes are provided in S Table 1. Due to the large number of 
animals screened (N=685), behavioral testing took place in 28 batches over a two-year period. In 
each batch, we tested a minimum of two diet exposure groups and two RIX. Each RIX and diet 
exposure was distributed across at least 3 test batches to mitigate seasonal and batch effects. All 
testing equipment was cleaned with a 0.25% bleach solution between test subjects unless 
otherwise stated.  
Body weight  
Female F1 offspring were weighed at weaning (referred to as PND 21) and again at the 
initiation of behavioral testing (referred to as PND 60). We did not weigh dams so as not to 
induce stress associated with manipulation during the perinatal period.  
Open field (OF)  
The OF apparatus (ENV-515-16, Med Associates, St. Albans, VT, USA) was a 43.2x43.2x33 
cm arena consisting of a white Plexiglas floor and clear Plexiglas walls with infrared detection 
beams at 2.54 cm intervals on the x, y, and z axes that tracked the animals’ position and activity 
automatically during the test session. The OF apparatus was enclosed in a sound-attenuating 
chamber (73.5x59x59 cm) fitted with two overhead light fixtures containing 28-V lamps. Mice 
were placed in the OF arena for 10 minutes and scored for total distance traveled (cm), number 
of vertical movements (rearing), and percent time spent in the center of the arena (defined as the 
22.86 cm2 central part of the arena). Percent time spent in the center of the OF arena is 
commonly used as a measure of anxiety-like behavior. Data were analyzed post-session in 2-
minute bins using commercially available software (Activity Monitor 5.1, Med Associates).  
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Light/dark (LD) 
 The LD apparatus consisted of a 42x42x30 cm open field arena (Versamax420 Animal 
Activity Monitoring System, AccuScan Instruments Inc., Columbus, OH, USA) with a white 
Plexiglas floor and clear Plexiglas walls. The arena was surrounded by 16 photobeams along 
each side that allowed for tracking of both horizontal and vertical activity. The black Plexiglas 
LD box (40x21x13 cm) occupied one-half of the arena and had a 10x3 cm opening to the light 
side and holes on all four sides that allowed detection of movement by the photobeams. Mice 
were placed in the lighted area immediately adjacent to and facing the entry to the dark enclosure 
and left to freely investigate the apparatus for 10 minutes. The amount of time (sec), number of 
transitions, distance moved (cm), and percent time in the dark and light zone was scored in 2-
minute bins in post-session analyses using commercially available software (VersaMap, 
AccuScan Instruments, Inc). Transitions into and percent time spent in the light side of the arena 
are used as measures of anxiety-like behavior. 
Stress-induced hyperthermia (SIH)  
Mice were individually removed from the home cage and the initial temperature (SIH-T1) 
was measured by insertion of a lubricated digital thermometer probe (TH-5 Thermalert 
Monitoring Thermometer with RET-3 rectal probe, Physitemp Instruments, Clifton, NJ) 1-1.5 
cm into the rectum for approximately 10 seconds. The animal was immediately returned to the 
home cage and 10 minutes later, the temperature measurement was repeated (SIH-T2). The 
difference in body temperature between T2 and T1 was calculated as the change in temperature 
(SIH-∆T). This physiological response to a stressor is commonly used as a measure of anxiety-
like behavior and is responsive to anxiolytic drugs (Adriaan Bouwknecht et al, 2007).  
Forced swim test (FST) 
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The FST was conducted in a glass-polycarbonate cylinder (46cm tall x 21cm in diameter) 
filled with water to a depth of 15 cm and maintained at a temperature of 25-28°C. Mice were 
tested for six minutes. Percent immobility during the last four minutes of the test period was 
recorded by video and scored using Ethovision 7.0 automated tracking software (Noldus, 
Leesburg, VA). Immobility was defined as the mouse making no movements other than those 
needed to stay afloat; this phenotype is thought to capture behavioral despair or depressive-like 
behavior. Mice were monitored continuously and removed from the apparatus if they were 
unable to keep their nose or heads above water for more than 30 seconds.  
Restraint stress  
Restraint was used to elicit a stress response that was quantified by measurement of 
corticosterone (CORT) levels in the serum. A retro-orbital blood sample was taken from 
unanesthetized mice to assess basal CORT levels, and then mice were immediately placed into a 
Broome-Style restraint tube (Plas Labs, Inc., Lansing, MI, USA) for 10 minutes. Immediately 
upon removal from the restrainer, a second unanesthetized retro-orbital eye bleed was performed 
to assess stress-induced CORT levels (Stress CORT). Whole blood was centrifuged to isolate 
plasma and CORT levels (in ng/ml) were measured with a competitive radioimmunoassay (RIA) 
using the manufacturer’s protocol (MP Biomedicals, Santa Ana, CA, USA). Stress CORT minus 
basal CORT levels (change in CORT or ∆CORT) was calculated to assess stress reactivity. 
CORT RIAs were only performed on RIX lines that had an N>4 for both sets of reciprocal 
females within a diet exposure group. Therefore, RIX 04/17 ME, RIX 23/47 Std, RIX 03/14 ME 




Missing data from the behavior pipeline 
Equipment failure led to the loss of data from 14 females in the OF (three RIX 01/11 PD, 
four RIX 01/11 ME, three RIX 41/51 Std and four RIX 23/47 PD) and five animals in the LD 
(one RIX 01/11 ME and four RIX 04/17 VDD). Ten females died during restraint stress and 15 
females did not have enough serum for CORT RIA analysis. 
The entire dataset from this study will be deposited and made available in the Mouse 
Phenome Database (MPD; RRID:SCR_003212) for use in follow-up studies. 
 
Statistical Analysis 
All statistical analyses were performed using R Studio 1.0.136 or SPSS v24 for Mac OS X 
10.6+. Graphs were generated using Graphpad Prism 7.0c for Mac OS X.  
Analysis of breeding performance 
Percent productive matings = ((# litters born/# dams mated) x 100), average litter size at 
birth, % survival to weaning = ((# pups at weaning/# pups born) x 100), and sex ratio = (# F pups 
weaning/total pups at weaning) were calculated for each CC reciprocal cross/diet combination. 
For each of these four measures, an ANOVA was performed to assess effects of PO, diet and 
diet-by-PO effects within each RIX. Overall effects of genetic background (RIX), diet and diet-
by-RIX across all 20 CC reciprocal crosses was also analyzed by ANOVA. 
Correlation of behavioral phenotypes 
The Hmisc 4.0-2 package in R Studio was used to generate coefficient and p values using 
Spearman correlation (Harrell et al, 2017). The p value threshold for significance was adjusted to 
p<0.00026 to correct for 190 correlations. Correlation plots were generated using Corrplot 0.77 
package (Wei and Simko, 2016).  
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Analysis of effects of RIX, diet and diet-by-RIX 
To assess the overall effect of genetic background (also referred to as RIX effect or RIX in 
the text), perinatal diet and perinatal diet-by-RIX interactions, we fit linear mixed models to the 
behavior of all mice. Model fitting was performed using the lmer function from the lme4 1.1-12 
R package (Bates et al, 2015). Our ‘base’ model had fixed effects of RIX, Diet, and Diet-by-
RIX, and random effects of Dam, Sire, and Behavior Batch (Eq 1; lmer notation, where 
“(1|term)” indicates a random effect). 
(Eq 1) phenotype ~ RIX + Diet + Diet:RIX + (1|Dam) + (1|Sire) + 
(1|BehaviorBatch) 
(Eq 2) phenotype ~ RIX + Diet + Diet:RIX + (1|Dam) + (1|Sire) + 
(1|Testing Chamber) + (1|BehaviorBatch) 
(Eq 3) phenotype ~ RIX + Diet + Diet:RIX + (1|Dam) + (1|Sire) + 
(1|BehaviorBatch) + (1|TestOrder) 
(Eq 4) phenotype ~ RIX + Diet + Diet:RIX + (1|Dam) + (1|Sire) + 
(1|BehaviorBatch) + (1|TestOrder) + (1|Experimenter) 
 
For behavioral tests, additional random effects were added to the base model (Eq 1) as 
needed. For the OF, LD and FST phenotypes, test chamber was also included (Eq 2). For the 
SIH phenotypes, test order was added (Eq 3) whereas for restraint test phenotypes both test order 
and experimenter were added (Eq 4), as two people were required to conduct that test. The same 
experimenter conducted all other behavioral assays across all batches.  
P-values for fixed effects were calculated by Type I ANOVA (sequential) tests, using the 
lmerTest 2.0-33 package (Kuznetsova et al, 2016) (see Table 2.1 for a list of all phenotypes). To 
account for multiple testing, p values within each type of test (eg, tests of diet) were subject to 
false discovery rate correction, with q values generated using the Shiny implementation of the 
qvalue R package (Bass et al, 2015; Storey, 2002). When a significant diet effect was observed 
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(p<0.05), between-diet differences were examined by a Tukey’s HSD post-hoc tests, with p 
values reported.  
Analysis of PO, diet and diet-by-PO effects within strain 
 PO, diet and diet-by-PO effects were assessed within each RIX, using linear mixed models 
based on Eq 5:  
(Eq 5) phenotype ~ Reciprocal + Diet + Diet:Reciprocal + (1|Dam) + (1|Sire) 
+ (1|BehaviorBatch) 
(Eq 6) phenotype ~ Reciprocal + Diet + Diet:Reciprocal + (1|Dam) + (1|Sire) 
+ (1|Testing Chamber) + (1|BehaviorBatch) 
(Eq 7) phenotype ~ Reciprocal + Diet + Diet:Reciprocal + (1|Dam) + (1|Sire) 
+ (1|BehaviorBatch) + (1|TestOrder) 
(Eq 8) phenotype ~ Reciprocal + Diet + Diet:Reciprocal + (1|Dam) + (1|Sire) 
+ (1|BehaviorBatch) + (1|TestOrder) + (1|Experimenter) 
 
where a ‘Reciprocal’ fixed effect term models PO effects and a ‘Diet:Reciprocal’ fixed 
interaction effect models diet-by-PO. Eq 6 was used for OF, LD and FST phenotypes, Eq 7 was 
used for SIH phenotypes and Eq 8 was used for restraint stress phenotypes. P and q values as 
well as Tukey’s HSD post-hocs for significant diet effects were generated in the same manner 
described above. 
Analysis of variance explained by PO, diet and diet-by-PO effects within strain  
The models from Eq 5-8 include random effects, complicating a typical percent variance 
explained computation. To overcome this difficulty, the random effects in Eq 5-8 were regressed 
out and a new simple linear model with only the effects of interest was fit, namely PO, diet and 
diet-by-PO effects. The percent variance explained was then calculated for each effect using the 
ratios of fitted sums-of-squares to total sums-of-squares from a sequential (ie, type 1 sums-of-




Effects of perinatal diet exposure on reproductive fitness 
Number of dams, percent productive matings and survival of pups to weaning, number of 
pups born, average litter size and sex ratio for each of the 20 reciprocal crosses are provided in S 
Table 3. CC014/Unc and CC062/Unc became unavailable during the study (CC014/Unc is now 
extinct; SGCF personal communication) (Shorter et al, 2017) and we were unable to produce a 
sufficient number of RIX 03/14 and RIX 35/62 F1 females exposed to PD and ME diets. 
Therefore, RIX 05/40 was added to the study and perinatal exposure was limited to PD and ME 
diets. 
Genetic background affected success of matings, average litter size and survival to weaning 
but not sex ratio (S Table 4). Exposure to ME lead to decreased mating productivity in 
comparison with the Std diet (p=0.05). We also assessed the effects of diet exposure and PO on 
breeding productivity between reciprocal crosses of each RIX line (p values are provided in S 
Table 4). There was a PO effect on % productive matings and average litter size for six of the 
RIX lines. PO differences for % survival to weaning were observed for four of the RIX lines. 
Only one RIX differed by PO for sex ratio (RIX 01/11).  
In five of the reciprocal crosses PO affected multiple measures of breeding success (S Table 
3 & 4) but many of these effects seem to be diet-dependent. In RIX 01/11, CC001/Unc dams had 
more productive matings but fewer pups survived until weaning than CC011/Unc dams. 
Additionally, CC001/Unc dams had litters with a skewed sex ratio in favor of females compared 
to litters from CC011/Unc dams, although this finding appears to be specific to dams on the ME 
diet. In RIX 04/17, CC004/TauUnc dams had larger litter size and more pups that survived to 
weaning compared to CC017/Unc dams. However, reduced survival of pups from CC017/Unc 
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dams was primarily observed in dams given a ME diet. In RIX 32/42, CC032/GeniUnc dams had 
more productive matings, larger litters and more pups that survived to weaning compared to 
CC042/GeniUnc dams. However, decreased survival of pups from CC042/GeniUnc dams was 
primarily observed in dams exposed to PD diet. There was also a significant difference of sex 
ratio, dependent on diet exposure in RIX 32/42. CC042/GeniUnc dams exposed to ME diet had 
litters with more males and dams on VDD diet had litters with increased numbers of females 
compared to CC032/GeniUnc dams.  
 
Correlation of behavioral phenotypes 
 Spearman correlations between the 20 phenotypes measured in this study are shown in S Fig 
1. We observed the highest correlations among phenotypes measured in a single behavioral 
assay. However, we also observed significant correlations across behavioral assays. Locomotor 
phenotypes were positively correlated in the OF and LD assays (r(188)=0.47-0.75; p<1x10-14). 
Percent center time in the OF was significantly and positively correlated with percent time in the 
light (r(188)=0.19; p=1.2x10-6) and transitions (r(188)=0.60; p<1x10-14) in the LD test. 
Phenotypes from the two stress-based behavioral assays, SIH and restraint stress, were also 
significantly correlated. SIH basal temperature was negatively correlated with stress-induced 
CORT (r(188)=-0.17; p=2.8x10-5) and change in CORT (r(188)=-0.21; p=1.5x10-7) while change 






Overall effects of genetic background, perinatal diet and diet-by-RIX 
A linear mixed effects model was used to assess the overall effects of genetic background 
(RIX), perinatal diet, and diet-by-RIX interactions. Table 2.1 presents the p and q values for 
each of the 20 phenotypes assessed in the five behavioral tests.  
 
Genetic background affects all phenotypes  
We assessed effects of genetic background across the nine RIX lines, collapsed across diets, 
and found significant effects of RIX on all behavioral phenotypes (Table 2.1).  
 
Perinatal exposure to protein deficiency and methyl enrichment alters body weight, body 
temperature and behavior in adulthood  
Body weight. Overall effects of perinatal diet exposure were assessed across the four diet 
groups, collapsed across the nine RIX lines. Females exposed to PD and ME weighed 
significantly less than either VDD or Std exposed females at weaning (p=2.2x10-16, q=2.2x10-15; 
S Fig 2b; S Table 5) and at the onset of behavioral testing (p=2.2x10-16, q=2.2x10-15; S Fig 2d; 
S Table 5). These data indicate that the effects of perinatal diet on body weight persisted into 
adulthood, well after exposure to PD and ME had ceased.  
Body temperature. ME exposed females had a lower basal temperature relative to all other 
groups (p=0.0002, q=0.001; Fig 2.2b; S Table 5). Basal temperature in PD exposed females did 
not differ from the other three groups, suggesting that basal temperature is not necessarily 
associated with the body weight changes described above (i.e. lower body weight = normal basal 
temperature for PD and decreased basal temperature for ME).   
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Anxiety-like behavior. Perinatal diet affected two measures of anxiety-like behavior: percent 
time in the light compartment in the LD test (p=0.048, q=0.096) and stress-induced temperature 
in the SIH test (SIH-T2; p=0.0002, q=0.001). ME exposed females spent less time in the lighted 
compartment compared to all other groups although this difference was only significant in 
comparison with VDD exposed females (S Table 5). ME exposed females also had a lower SIH-
T2 temperature compared to all other groups, although this difference was only significant in 
comparison with females exposed to PD (S Table 5). However, ME exposed females were not 
significantly different from other diet groups for SIH change in temperature (Fig 2.2e). 
Therefore, the significant difference in SIH-T2 in the ME exposed group may simply reflect 
differences in body temperature rather than response to the stressor.  
Basal stress and stress reactivity. Perinatal diet altered basal CORT (p=0.038, q=0.085; Fig 
2.3b), stress-induced CORT (p=0.003, q=0.010) and change in CORT (p=2.1x10-5, q=1.4x10-4; 
Fig 2.3e). PD exposed females show significantly greater stress-induced CORT and change in 
CORT (Fig 2.3e) in comparison with both ME and VDD exposed females (S Table 5). Post hoc 
comparisons did not identify any significant differences in basal CORT among the experimental 
diet groups.  
 
Genetic background interacts with perinatal diet to alter body weight, stress response and 
anxiety-like behavior  
Fourteen of the 20 phenotypes exhibited significant diet-by-RIX effects based on p value, 
whereas 13 had a significant q value. Body weight, basal temperature, anxiety-like behavior and 
stress response all show a diet-by-RIX effect (see Table 2.1). In order to investigate these 
interactions, we analyzed each RIX independently to examine which genetic backgrounds were 
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altered by perinatal diet and to determine if the diet-induced changes in a RIX matched the 
overall diet effects reported above. P and q values along with Tukey’s post hoc analyses of diet 
effects within a RIX are reported in S Table 6.   
Body weight. There was a significant diet-by-RIX effect on body weight at weaning 
(p=1.5x10-7, q=7.4x10-7; S Fig 2a) and in adulthood (p=0.002, q=0.004; S Fig 2c). For six of the 
RIX lines (RIXs 01/11, 41/51, 04/17, 23/47, 06/26 and 03/14), diet-specific differences in body 
weight at weaning persisted into adulthood. RIX lines 35/62 and 32/42 both exhibited diet-
specific differences in body weight at only one of the time points – RIX 35/62 in adulthood and 
RIX 32/42 at weaning. RIX 05/40 was the only line for which perinatal diet did not differentially 
affect body weight, although only two diets were examined in this line.  
Stress-induced hyperthermia. All three measures from the SIH assay showed a diet-by-RIX 
effect; basal temperature (p=3.6x10-7, q=1.4x10-6; Fig 2.2a), stress-induced temperature 
(p=0.008, q=0.018) and change in temperature (p=2.6x10-4, q=0.001; Fig 2.2d). Five of the RIX 
lines showed no effect of diet on basal temperature (RIXs 41/51, 04/17, 23/47, 35/62, 05/40) and 
six showed no effect of diet exposure on change in temperature following a stressor (RIXs 41/51, 
04/17, 23/47, 03/14, 35/62, 32/42). To highlight a diet-by-RIX effect, the opposing effects of the 
PD compared to Std diet observed in RIX 01/11 and RIX 06/26 females is shown in Figs 2.2c 
and 2.2f. RIX 01/11 females exposed to PD showed increased basal temperature and a decreased 
change in temperature in response to stress while RIX 06/26 females exposed to a PD diet had a 
lower basal temperature and an increased change in temperature in response to stress. These data 
show that the effects of perinatal diet on basal temperature and stress-induced temperature 
change, a physiological measure of anxiety, are dependent on genetic background.  
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Basal stress and stress reactivity. Basal CORT (p=1.5x10-10, q=1.5x10-9; Fig 2.3a), stress-
induced CORT (p=2.7x10-13, q=5.4x10-12) and change in CORT (p=1.1x10-8, q=7.6x10-8; Fig 
2.3d) all showed significant diet-by-RIX effects. Diet had no effect on change in CORT in four 
lines (RIXs 01/11, 06/26, 03/14, 35/62). Interestingly, RIX 32/42 and RIX 04/17 females 
exposed to VDD showed diametrically opposed change in CORT levels. RIX 32/42 VDD 
exposed females showed increased change in CORT while VDD exposed RIX 04/17 females 
showed decreased change in CORT (Fig 2.3f). A similar opposing effect of exposure to VDD 
compared to Std is seen in basal CORT levels for RIX 06/26 and RIX 03/14, although this effect 
did not reach significance. VDD exposure in RIX 06/26 resulted in decreased basal CORT while 
the same dietary exposure in RIX 03/14 resulted in increased CORT (Fig 2.3c). Collectively, 
these data show that the effects of perinatal diet on basal stress and response to a stressor are also 
dependent on genetic background.  
 
Parent-of-origin effects on behavior 
A linear mixed effects model was used to assess the effects of PO, by comparing reciprocal 
females within each RIX line. We report p and q values for PO in Table 2.2. RIX 32/42 was the 
only line that showed no effect of PO on behavioral phenotypes.  
PO effects for body weight were observed in six of the nine RIX (RIXs 01/11, 41/51, 04/17, 
23/47, 06/26, 05/40). Five of these six lines (RIXs 01/11, 41/51, 04/17, 23/47, 06/26) also had a 
PO effect for vertical counts, or rearing, in the OF. In each case, the reciprocal group that 
weighed more was also the one that made more vertical movements in the OF. This might 
indicate that body weight influenced detection of vertical movements by the infrared sensors in 
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the OF arena. However, we observed no significant correlation between weight at testing and OF 
vertical counts (r(188)=0.06, p>0.05; S Fig 1).  
Several RIX displayed multiple PO effects across behavioral tests and are highlighted below. 
For example CC(03x14)F1 females showed increased locomotion in the OF (Fig 2.4a), increased 
time spent in the center of the OF (Fig 2.4b), decreased immobility in the FST (Fig 2.4c) and 
increased transitions (Fig 2.4d), distance moved (Fig 2.4e), and time spent in the light side of the 
LD arena (Fig 2.4f) in comparison to CC(14x03)F1 females. These data indicate that female 
offspring from CC003/Unc dams have decreased anxiety- and depressive-like behavior 
compared to female offspring from CC014/Unc dams.  
CC(62x35)F1 females showed increased locomotion (Fig 2.5a), transitions (Fig 2.5b), 
distance moved (Fig 2.5c), and time spent in the light side (Fig 2.5d) of the LD test compared to 
CC(35x62)F1 females. CC(62x35)F1 females also showed decreased CORT in response to a 
restraint stress (Fig 2.5f). These results indicate that female offspring from CC062/Unc dams 
have decreased anxiety-like behavior and are more resilient to stress compared to female 
offspring from CC035/Unc dams.  
CC(06x26)F1 females showed increased locomotion (S Fig 3a) and vertical counts in the OF 
(S Fig 3b) and increased basal (S Fig 3c) and stress-induced CORT levels (S Fig 3d & S Fig 6a) 
in comparison with CC(26x06)F1 females, but no reciprocal difference in change in CORT (S 
Fig 3e). Collectively, these data indicate that female offspring from CC006/TauUnc dams have 
increased locomotion and exploratory behavior and a dysregulated hypothalamic-pituitary-
adrenal (HPA) axis as reflected by increased basal CORT levels. 
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Female offspring from CC005/TauUnc mothers exhibited increased locomotor activity as 
measured in both the OF and LD tests (S Figs 4a-e) in comparison with female offspring from 
CC040/TauUnc mothers. 
 
Perinatal diet interacts with parent-of-origin in certain genetic backgrounds to alter body weight 
and behavior 
We were particularly interested in assessing whether perinatal diet would induce behavioral 
differences between reciprocal females within a RIX. We found 18 significant diet-by-PO effects 
based on p value, although none were significant after multiple testing corrections (based on the 
q value; Table 2.3).  
A significant PO effect for stress-induced CORT was observed in RIX 06/26 (Fig 2.6a). The 
PO effect is driven by a significant difference between CC(06x26)F1 females exposed to ME 
relative to other diets (posthoc p≤0.001; Fig 2.6b); by contrast, stress induced CORT in 
CC(26x06)F1 females was unaffected by diet.  
Eight of the significant diet-by-PO effects involved body weight at weaning or in adulthood. 
For five of the RIX (RIXs 41/51, 04/17, 03/14, 32/42, 05/40), there was a significant diet-by-PO 
effect on body weight at weaning. For example, the PO effect on weaning weight in RIX 04/17 
(Fig 2.7a) was due to increased weight in VDD and Std exposed CC(04x17)F1 females 
compared to ME and Std (posthoc p≤0.01), a diet effect not observed in CC(17x04)F1 females 
(Fig 2.7b). Only one RIX showed a significant diet-by-PO effect on adult body weight (Fig 2.7c-
d) only. VDD and Std exposed CC(11x01)F1 females weighed more than CC(01x11)F1 females 
(posthoc p≤0.02; Fig 2.7d). Only one RIX showed a significant diet-by-PO effect on body 
weight at both weaning and in adulthood. CC(06x26)F1 females weighed more than 
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CC(26x06)F1 females at weaning (Fig 2.7e). This effect was due to a difference in the ME 
exposed groups across reciprocals (posthoc p≤0.01; Fig 2.7f). In adulthood, CC(06x26)F1 
females still weighed more than CC(26x06)F1 females although this effect was no longer 
significant (Fig 2.7g). However, there is still a significant diet-by-PO effect, and the distribution 
of diet effects on adult weight is similar to the distribution at weaning (Fig 2.7h). Collectively, 
these data demonstrate that body weight is strongly influenced by perinatal diet in a PO-specific 
manner across different genetic backgrounds.  
 
Variance explained by PO, diet and diet-by-PO effects 
Within each RIX line and for all 20 phenotypes measured, we assessed the percent variance 
explained by the effect of PO, diet and diet-by-PO (S Table 7). Of particular interest in this 
study was the variance due to PO effects as PO effects on behavioral phenotypes are seldom 
reported. For phenotypes that exhibited a significant PO effect, variance explained ranged from 
4-59%. Body weight at weaning in RIX 23/47 had the highest variance explained by PO while 
basal CORT in RIX 04/17 had the lowest percent variance explained by PO. For any given 




We used reciprocal F1 females derived from ten pairs of CC strains to investigate the effects 
of perinatal diet exposure, genetic background, PO and their interactions on 20 phenotypes. 
Genetic background significantly affected all phenotypes, whereas perinatal diet exposure 
affected fewer phenotypes – namely, body weight, basal body temperature, anxiety-like behavior 
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and stress response – but all in a manner dependent on genetic background. We also found 
significant PO effects in eight of the nine RIX lines and for a variety of behavioral phenotypes. 
To further investigate PO effects, we examined the interaction of PO with diet, identifying a 
small number of diet-by-PO effects; notably, body weight showed consistent diet-by-PO effects 
across seven of the nine RIX lines. Our data shows that rodent behaviors that model psychiatric 
disorders are affected by genetic background, parent-of-origin, and perinatal diet, as well as by 
interactions among these factors. Below we compare our main findings with the current literature 
and highlight several interesting results that we believe warrant further investigation.  
 
Genetic background effects 
Significant effects of RIX were observed on all 20 phenotypes. This result was not surprising 
given that these phenotypes have a genetic component and the genetic backgrounds we tested 
covered a broad range of genetic diversity. The CC was designed to maximize genetic diversity 
and our choice of CC strain pairs in the 10 RIX lines was intended to maximize genetic 
heterozygosity so as to include novel combinations of alleles from the three-major subspecies of 
Mus musculus. The genetic diversity of the CC population resulted in an expanded phenotypic 
range relative to that observed in standard inbred strains (i.e. Mouse Diversity Panel) (Gralinski 
et al, 2015; Levy et al, 2015; Mosedale et al, 2017; Venkatratnam et al, 2017; Vered et al, 2014). 
The wide range of phenotypes in the CC has also led to the development of stable models of 
human disease not previously observed in traditional inbred strains (Rogala et al, 2014). Our 
RIX lines also included clear phenotypic outliers. For example, RIX 41/51 and RIX 04/17 F1 
mice were outliers for novelty-induced locomotion as measured in the OF and LD tests (S Fig 5). 
	38 
Based on the literature linking novelty-induced locomotion with addiction-related behaviors 
(Piazza et al, 1989), we are currently investigating these two lines in rodent models of addiction.  
 
Diet effects 
 Although we chose perinatal diet as our environmental challenge based on existing literature 
in humans from the Dutch Hunger Winter and Chinese Famine (Brown et al, 2008; Brown et al, 
2000; St Clair et al, 2005) we acknowledge that we are not modeling human perinatal nutritional 
exposures per se. Rather, we are using these experimental diets as tools to induce behavioral 
changes based on evidence from published data in animal models (Burne et al, 2004; Glenn et al, 
2012; Harms et al, 2008; Plyusnina et al, 2007; Vucetic et al, 2010), as well as data from our 
laboratory (Oreper, Valdar and Tarantino personal communication). Our study was designed to 
compare phenotypes across diets and across genetic background rather than comparing each diet 
to a standard or treated animals to controls.  
Effects of methyl enrichment  
DNA methylation is an important mechanism for regulation of gene expression and is 
dependent on the availability of methyl donors mainly from diet (Niculescu and Zeisel, 2002). 
Disruption in DNA methylation has been implicated as a mechanism for increased risk for 
complex diseases, including psychiatric disorders (Grayson and Guidotti, 2013). In our study, we 
exposed animals to methyl donor (choline) enrichment (S Table 2). Perinatal exposure to ME 
resulted in lower body weight at weaning and adulthood, decreased basal body temperature and 
increased anxiety-like behavior in the LD test.  
Choline supplementation during development is thought to be neuroprotective (Bekdash, 
2016) and is commonly used in animal models to ‘rescue’ the adverse effects of perinatal 
	39 
challenges such as iron deficiency (Kennedy et al, 2014), stress (Schulz et al, 2014) and alcohol 
exposure (Thomas et al, 2010). Prenatal choline supplementation has also been shown to 
improve negative behavioral phenotypes in mouse models of neurodevelopmental disorders such 
as Rett Syndrome (Mecp2; (Nag and Berger-Sweeney, 2007)), autism (BTBR T+ltpr3tf/J; 
(Langley et al, 2015)) and Down Syndrome (Ts65Dn; (Moon et al, 2010)).  
We found that exposure to perinatal ME increased anxiety-like behavior in the LD test. Our 
findings are in contrast to studies in rats in which choline supplementation decreased anxiety in 
the LD (Plyusnina et al, 2007) and OF tests (Glenn et al, 2012).  However, the increased anxiety-
like behavior we observed in ME exposed females was specific to certain RIX lines, or genetic 
backgrounds (S Table 5). Very few studies have examined the effect of methyl supplementation 
in different genetic backgrounds. Notably, one study comparing BTBR T+ltpr3tf/J (a mouse 
model of autism) to B6J mice did report differences in these two strains in response to perinatal 
choline supplementation on anxiety-like behavior in the EPM (Langley et al, 2015).  
Effects of protein deficiency  
Proteins play a key role in brain development as they serve as key neurotransmitters and 
hormones. Protein deficiency during the perinatal period has been used to induce intrauterine 
growth restriction and alter behaviors that model psychiatric disorders (Tarantino et al, 2012a). 
In our study, perinatal PD led to decreased body weight at weaning and in adulthood. The 
findings of decreased weight at weaning are consistent with previous reports in rats (Palmer et al, 
2008) and mice (Belluscio et al, 2016; Belluscio et al, 2014; Vucetic et al, 2010). However, the 
persistence of weight deficits into adulthood has not been consistent across studies (Palmer et al, 
2008; Vucetic et al, 2010). 
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We also observed increased stress reactivity in response to perinatal PD – a finding that is 
consistent with previous studies in rats exposed to PD in utero (Reyes-Castro et al, 2012a; 
Reyes-Castro et al, 2012b). Previous studies have also reported increased depressive-like 
behaviors in response to perinatal PD (Belluscio et al, 2016; Belluscio et al, 2014; de Godoy et 
al, 2013; Vucetic et al, 2010). We did not observe any changes in depressive-like behavior in the 
FST in response to PD exposure. Nor did PD exposure alter anxiety-like behavior in the OF, LD 
and SIH assays. This finding is not particularly surprising given that the effects of exposure to 
PD on anxiety-like behavior have been equivocal across published studies (Almeida et al, 1996; 
Belluscio et al, 2014; Francolin-Silva et al, 2006; Furuse et al, 2017; Reyes-Castro et al, 2012a; 
Reyes-Castro et al, 2012b). We did observe a significant diet-by-RIX effect on all three 
measures of anxiety-like behavior and stress response (Table 2.1). These data in combination 
with conflicting results in the literature support a hypothesis that the effects of exposure to PD on 
anxiety and stress response are dependent on genetic background. 
Effects of vitamin D deficiency 
Vitamin D is well known for its role in calcium homeostasis and bone formation, but it is 
also a neuroactive steroid involved in brain development and function (Garcion et al, 2002). 
Exposure to VDD during development is hypothesized to increase risk for schizophrenia 
(McGrath, 2001). As such, the effects of VDD during the perinatal period have been studied in 
rodents using behavioral models of schizophrenia.  
In the present study, we observed very few overall effects of exposure to perinatal VDD. We 
considered the possibility that VDD diet exposure was not reducing endogenous vitamin D by 
the amount expected. It has been shown that exposure to unfiltered fluorescent lighting can 
induce production of endogenous Vitamin D3 in laboratory animals (McDowell, 1989) and we 
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did not filter the lighting in our vivarium. However, we did observe significant decreases in 
serum vitamin D levels in VDD exposed dams from several of the CC strains used in this study 
(Xue et al, 2016).  
Previous studies have assessed the role of VDD exposure on the stress axis in rodents and 
have reported either no effects (Eyles et al, 2006) or increased CORT levels (Tesic et al, 2015). 
In our study, exposure to VDD induced RIX-specific alterations in basal and stress-induced 
CORT (Fig 2.3c & 2.3f) supporting a role for vitamin D in moderating the stress system.  
We also considered the possibility that the behaviors examined in this study are not 
particularly sensitive to perinatal VDD exposure. However, the literature does report 
hyperlocomotion in rats exposed to VDD (Burne et al, 2004; Burne et al, 2006; Eyles et al, 
2006; Kesby et al, 2006) and we did not observe an overall or RIX-specific effect of VDD 
exposure on locomotion in either the OF or LD test.  
Perinatal diet effects depend on genetic background  
Our data highlight the importance of genetic background on the expression of body weight, 
basal temperature, anxiety-like behavior, and stress response following exposure to perinatal 
dietary manipulations. We acknowledge that our assessment was limited to a small number of 
behaviors and did not include several that have been previously reported to be altered by 
perinatal diet (i.e. learning and memory tests, response to psychostimulants, sensorimotor 
gating). Regardless of the limitations in behavioral assays employed, our data highlight the need 





Parent-of-origin effects on behavior and physiology 
We found PO effects in eight of the nine RIX lines for a number of behavioral phenotypes, 
body weight, and basal body temperature. Although there are many studies that utilize F1 mice, 
few have used reciprocal F1 hybrids and even fewer have assessed the effects of PO on 
behavioral phenotypes. There is, however, a vast literature assessing the role of known imprinted 
genes on growth, physiology and behavior via reverse genetic approaches such as overexpression 
or gene knockouts (KO) (for a thorough review see (Cleaton et al, 2014)). Relevant findings 
from these studies will be discussed in relation to PO effects we observed.  
Body weight 
PO effects were observed for body weight in six RIX lines and in four of these lines, body 
weight differences persisted from weaning into adulthood. This result is not surprising, given the 
vast amount of literature implicating imprinted genes on growth (Cleaton et al, 2014). Additional 
studies are necessary to determine whether the specific genes responsible for body weight PO 
effects in our study are known imprinted genes or new genes. Of note, in this study we assessed 
body weight but no other measures of growth (i.e. body length). Follow-up studies using both 
body mass and body size measurements are necessary to determine whether strain, diet, or PO 
effects on body weight were due to the changes in the actual size of the mice (i.e. length) or 
reflect only weight differences (i.e. overweight or underweight).  
Locomotor behavior  
 We found PO effects on locomotor behavior in four of the RIX lines. In two of these RIXs, 
we also observed PO effects on body weight, although the relationship between body weight and 
locomotion is opposite in the two RIX lines (RIX 06/26 vs RIX 05/40, Table 2.2). Hyperactivity, 
body weight and metabolism have been linked previously in studies manipulating the imprinted 
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genes Asb4 (Li et al, 2010) and Kcnq1 (Boini et al, 2009; Casimiro et al, 2001). These RIX lines 
can be examined in follow up studies to determine whether locomotor activity and body weight 
PO effects share a common genetic basis.  
Anxiety- and depressive-like behaviors and stress response  
We found a consistent PO effect among RIX 03/14 reciprocal females on anxiety-like and 
depressive-like behavior (Fig 2.4). Interestingly, these behavioral phenotypes are very similar to 
that observed in KO mice for the imprinted gene, Sgce. Sgce KO mice display increased anxiety-
like and exploratory behavior in the OF and increased depressive-like behavior in the FST 
(Yokoi et al, 2006). There is also an abundance of evidence from the literature that establishes a 
role for imprinted genes such as Sgce, Nesp55, Htr2a, Peg3, and Snord116 in mediating anxiety-
like behavior (Champagne et al, 2009; Ding et al, 2008; Plagge et al, 2005; Weisstaub et al, 
2006). Studies also show a role of Nesp55 in mediating addiction-related behaviors (Dent et al, 
2016; Plagge et al, 2005). It would be interesting to assess PO effects on addiction-related 
behaviors in RIX 03/14 females. 
RIX 35/62 reciprocal females displayed PO effects on anxiety-like behavior and stress 
response. Two other RIX also displayed PO effects on measures of stress response. A previous 
study using F1 reciprocals of spontaneously hypertensive rat and Wistar-Kyoto rats reported a 
PO effect on the cardiovascular activity in response to an acute stressor (Woodworth et al, 1990). 
A recent study also reported PO effects on stress reactivity using reciprocal F1 of B6J and 
129S1/SvlmJ mice (Chan et al, 2017). These studies, together with our findings, indicate that 
further work is needed to examine the HPA axis in regards to imprinted gene functions and other 
effects due to PO. 
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Perinatal diet interaction with PO  
We identified perinatal diet-by-PO effects on body weight, exploratory behavior, basal 
temperature, anxiety- and depressive-like behavior, and stress response. PO effects on body 
weight were the most severely affected by perinatal diet, as evidenced by our observation of diet-
by-PO effects in seven of the RIX lines (Table 2.2, Fig 2.7).  
Although we cannot directly compare our diet-by-PO findings on behavior with previously 
published studies due to methodological differences, there are a few studies that have reported 
changes in imprinted gene expression due to perinatal diet alterations, which might indicate a 
mechanism for these effects (Vucetic et al, 2010; Waterland et al, 2006). Vucetic et al (2010) 
found that perinatal PD caused a reduction in the methylation at the promotor of the imprinted 
gene Cdkn1c, along with a correlated increase in its expression in the prefrontal cortex, nucleus 
accumbens, and hypothalamus. Cdkn1c is involved in differentiation and specification of 
dopamine neurons and the authors also reported an alteration in dopamine-mediated behaviors in 
these mice. The link between exposure to PD, imprinted gene expression differences and 
dopamine-mediated behaviors provides a potential avenue for future mechanistic studies in our 
RIX lines.  
Collectively, our findings support the role of PO on body weight and behavioral phenotypes 
that model psychiatric disorders. It is interesting that RIX 32/42 was the only RIX that showed 
no PO effects on any behavioral phenotype measured. One possible explanation for this result is 
lower genetic diversity at imprinted loci in the CC strains used to generate RIX 32/42 mice. 
Importantly, the PO effects we observed are dependent on genetic background. Of note, our use 
of the term PO effect, by definition, assumes an interaction with genetic background. We 
assessed the variance explained due to PO to get a sense of the importance of these effects on the 
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phenotypes measured. On average, variance explained by PO was less than that explained by 
strain. In fact, variance explained by PO effects depended on both strain and the specific 
behavioral assay, ranging from 4 to 59 percent (with the highest value for body weight). 
Nonetheless, it is important to note that within RIX comparisons describe differences between 
two experimental groups that are genetically identical and differ only in the parental origin of the 
genome and the maternal environment; therefore, even small effects can be biologically relevant 
and useful for developing interventions and treatments. 
Although we focused our discussion on imprinted genes, we acknowledge that they are likely 
not the sole source of the observed PO effects. Future studies examining gene expression in these 
RIX lines will likely help identify specific genes responsible. We expect that some of these genes 
will be at known imprinted loci, while others will be novel in the context of behavioral effects. 
Additionally, PO effects can be due to maternal effects independent of imprinting (Weaver et al, 
2004), and further studies will be necessary to disentangle their respective contributions to the 
PO effects observed in this study. Lastly, our study illustrates how the CC and RIX lines derived 
from the CC can provide an ideal experimental model for jointly examining genetic background 
and PO, being reproducible, genetically diverse and uniquely designed to support systems 
genetics studies.  
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Table 2.1. Effect of genetic background (RIX), perinatal diet and diet-by-RIX on behavioral 
phenotypes 
Behavior Test 
Phenotype RIX Diet Diet-by-RIX 
p-value q-value p-value q-value p-value q-value 
Body Weight Weaning (PND 21) 1.4E-05 1.5E-05 2.2E-16 2.2E-15 1.5E-07 7.4E-07 
Adulthood (PND 60) 2.3E-15 2.9E-15 2.2E-16 2.2E-15 0.002 0.004 
Open Field (OF) Total Distance Moved 2.0E-16 3.4E-16 0.772 0.881 0.209 0.209 
% Center Time 2.0E-16 3.4E-16 0.807 0.881 0.041 0.058 
Vertical Counts 2.0E-16 3.4E-16 0.998 0.998 0.072 0.089 
OF Boli 6.3E-14 7.4E-14 0.192 0.350 0.010 0.021 
Light/Dark (LD) Total Distance Moved 2.0E-16 3.4E-16 0.228 0.381 0.061 0.082 
Distance Dark 2.0E-16 3.4E-16 0.023 0.058 0.021 0.034 
Distance Light 2.0E-16 3.4E-16 0.805 0.881 0.097 0.114 
Total Transitions 2.0E-16 3.4E-16 0.837 0.881 0.130 0.136 
% Time Light 1.3E-04 1.4E-04 0.048 0.096 0.025 0.039 




SIH-T1 4.4E-16 6.3E-16 2.0E-04 0.001 3.6E-07 1.4E-06 
SIH-T2 2.2E-16 3.4E-16 1.9E-04 0.001 0.008 0.018 
deltaSIH 0.006 0.006 0.342 0.502 2.6E-04 0.001 
Forced Swim 
(FST) 
% Immobile 2.0E-16 3.4E-16 0.377 0.502 0.122 0.135 
FST Boli 6.7E-16 8.9E-16 0.023 0.058 0.013 0.023 
Restraint Stress Basal CORT 2.2E-16 3.4E-16 0.038 0.085 1.5E-10 1.5E-09 
Stress CORT 2.2E-16 3.4E-16 0.003 0.010 2.7E-13 5.4E-12 
deltaCORT 2.2E-16 3.4E-16 2.1E-05 1.4E-04 1.1E-08 7.6E-08 
Significant values are shaded and bolded. CORT = corticosterone; PND = postnatal day; SIH-T1 
= basal temperature; SIH-T2 = post-stress temperature; deltaSIH = (T2-T1); deltaCORT = 















Table 2.2. Parent-of-origin effects on behavior 
  RIX 01/11 RIX 41/51 RIX 04/17 RIX 23/47 RIX 06/26 RIX 03/14 RIX 35/62 RIX 32/42 RIX 05/40 
Phenotype p q p q p q p q p q p q p q p q p q 
WeightPND21 0.80 0.94 0.01 0.10 2E-05 3E-04 6E-08 1E-06 0.03 0.12 0.55 0.78 0.47 0.56 0.20 0.83 0.05 0.14 
WeightPND60 1E-02 0.14 0.01 0.10 1E-03 7E-03 2E-06 2E-05 0.11 0.27 0.86 0.89 0.47 0.56 0.32 0.83 2E-03 0.01 
OF TotalDist 0.34 0.62 0.76 0.94 0.34 0.45 0.80 0.84 1E-03 0.01 0.03 0.12 0.08 0.20 0.63 0.83 0.04 0.14 
OF %Center 0.71 0.91 0.43 0.78 0.21 0.35 0.26 0.64 0.070 0.20 0.05 0.15 0.12 0.28 0.40 0.83 0.14 0.27 
OF VertCount 0.02 0.15 0.02 0.10 5E-03 0.02 0.04 0.18 2E-04 4E-03 0.15 0.38 0.59 0.65 0.78 0.83 0.36 0.48 
OF Boli 0.61 0.91 0.27 0.68 0.03 0.07 0.65 0.81 0.38 0.55 0.49 0.75 0.47 0.56 0.85 0.85 0.15 0.28 
LD TotalDist 0.10 0.29 0.27 0.68 0.62 0.68 0.71 0.83 0.20 0.37 0.08 0.24 0.04 0.16 0.54 0.83 2E-04 3E-03 
LD DistDark 0.15 0.34 0.56 0.79 0.41 0.51 0.37 0.65 0.39 0.55 0.63 0.79 0.39 0.56 0.16 0.83 2E-03 0.01 
LD DistLight 0.12 0.31 0.14 0.57 0.88 0.88 0.65 0.81 0.13 0.29 5E-03 0.10 0.03 0.15 0.79 0.83 0.05 0.14 
LD Transition 0.32 0.62 0.59 0.79 0.26 0.40 0.39 0.65 0.44 0.59 0.03 0.12 0.03 0.15 0.35 0.83 6E-03 0.03 
LD %Light 0.98 0.98 0.41 0.78 0.32 0.45 0.30 0.65 0.18 0.36 0.01 0.12 0.03 0.15 0.73 0.83 0.79 0.84 
LD Boli 0.66 0.91 0.95 0.95 0.55 0.65 0.61 0.81 0.52 0.65 0.31 0.69 0.87 0.87 0.66 0.83 0.12 0.26 
SIH-T1 0.73 0.91 0.25 0.68 0.02 0.06 0.90 0.90 0.84 0.84 0.89 0.89 0.26 0.44 0.24 0.83 0.65 0.82 
SIH-T2 0.72 0.91 0.07 0.34 0.04 0.09 0.20 0.64 0.79 0.83 0.64 0.79 0.30 0.47 0.68 0.83 0.80 0.84 
deltaSIH 0.86 0.96 0.91 0.95 3E-03 0.01 0.44 0.68 0.66 0.73 0.73 0.86 0.22 0.41 0.52 0.83 0.23 0.33 
FST %Imb 0.05 0.29 0.83 0.94 0.19 0.35 4E-03 0.03 0.36 0.55 0.02 0.12 0.18 0.36 0.56 0.83 0.10 0.26 
FST Boli 0.10 0.29 0.36 0.78 0.69 0.73 0.33 0.65 0.04 0.12 0.35 0.69 0.08 0.20 0.12 0.83 0.22 0.33 
BasalCORT 0.95 0.98 0.84 0.94 0.04 0.09 0.78 0.84 4E-03 0.02 0.86 0.89 0.82 0.86 0.68 0.83 0.17 0.29 
StressCORT 0.08 0.29 0.47 0.79 4E-05 4E-04 0.09 0.38 3E-03 0.02 0.45 0.75 0.02 0.15 0.17 0.83 0.90 0.90 
deltaCORT 0.08 0.29 0.59 0.79 1E-03 5E-03 0.25 0.64 0.66 0.73 0.49 0.75 0.07 0.20 0.36 0.83 0.77 0.84 
Significant values are shaded and bolded. CORT = corticosterone; deltaCORT = (Stress CORT – Basal CORT); deltaSIH = (T2-T1); Dist 
= distance; FST = forced swim test; Imb = immobile; LD = light/dark; OF= open field; PND = postnatal day; SIH = stress-induced 





Table 2.3. Diet-by-PO effects on behavior 
  RIX 01/11 RIX 41/51 RIX 04/17 RIX 23/47 RIX 06/26 RIX 03/14 RIX 35/62 RIX 32/42 RIX 05/40 
Phenotype p q p q p q p q p q p q p q p q p q 
WeightPND21 0.51 0.76 0.03 0.19 0.01 0.19 0.47 0.85 0.04 0.15 0.03 0.57 0.94 0.99 0.04 0.68 0.02 0.47 
WeightPND60 0.03 0.32 0.24 0.46 0.65 0.76 0.18 0.85 0.04 0.15 0.34 0.77 0.37 0.70 0.56 0.71 0.92 0.97 
OF TotalDist 0.56 0.76 0.09 0.26 0.07 0.26 0.44 0.85 0.77 0.82 0.99 0.99 0.81 0.99 0.17 0.68 0.79 0.97 
OF %Center 0.85 0.89 0.06 0.23 0.06 0.26 0.73 0.85 0.14 0.35 0.83 0.93 0.06 0.50 0.40 0.68 0.92 0.97 
OF VertCount 0.71 0.78 0.72 0.85 0.04 0.26 0.61 0.85 0.58 0.68 0.13 0.57 0.35 0.70 0.21 0.68 0.37 0.93 
OF Boli 0.19 0.54 0.81 0.85 0.41 0.64 0.01 0.17 0.35 0.68 0.18 0.57 0.06 0.50 0.64 0.73 0.92 0.97 
LD TotalDist 0.09 0.48 0.46 0.71 0.48 0.64 0.74 0.85 0.46 0.68 0.78 0.93 0.18 0.70 0.43 0.68 0.99 0.99 
LD DistDark 0.10 0.48 0.78 0.85 0.91 0.96 0.73 0.85 0.61 0.68 0.82 0.93 0.08 0.50 0.54 0.71 0.65 0.97 
LD DistLight 0.12 0.49 0.28 0.46 0.10 0.28 0.49 0.85 0.18 0.40 0.87 0.93 0.22 0.70 0.51 0.71 0.67 0.97 
LD Transition 0.17 0.54 0.07 0.23 0.36 0.64 0.60 0.85 0.45 0.68 0.85 0.93 0.90 0.99 0.31 0.68 0.73 0.97 
LD %Light 0.61 0.76 0.62 0.85 0.26 0.64 0.23 0.85 0.51 0.68 0.18 0.57 0.14 0.70 0.69 0.73 0.42 0.93 
LD Boli 0.03 0.32 0.94 0.94 0.08 0.26 0.04 0.36 0.58 0.68 0.11 0.57 1.00 1.00 0.12 0.68 0.47 0.93 
SIH-T1 0.63 0.76 0.19 0.46 0.90 0.96 0.56 0.85 0.02 0.14 0.75 0.93 0.48 0.74 0.44 0.68 0.21 0.85 
SIH-T2 0.47 0.76 0.02 0.19 0.59 0.73 0.82 0.87 0.54 0.68 0.88 0.93 0.38 0.70 0.67 0.73 0.72 0.97 
deltaSIH 0.65 0.76 0.25 0.46 0.46 0.64 0.60 0.85 0.01 0.14 0.88 0.93 0.75 0.99 0.88 0.88 0.31 0.93 
FST %Imb 0.35 0.71 0.74 0.85 0.05 0.26 0.91 0.91 0.53 0.68 0.25 0.63 0.88 0.99 0.15 0.68 0.07 0.70 
FST Boli 0.51 0.76 0.24 0.46 0.96 0.96 0.20 0.85 0.07 0.23 0.82 0.93 0.31 0.70 0.44 0.68 0.12 0.78 
BasalCORT 0.90 0.90 0.65 0.85 0.48 0.64 0.56 0.85 0.94 0.94 0.58 0.93 0.70 0.99 0.41 0.68 0.53 0.96 
StressCORT 0.29 0.71 0.02 0.19 0.36 0.64 0.68 0.85 0.02 0.14 0.20 0.57 0.27 0.70 0.28 0.68 0.19 0.85 
deltaCORT 0.35 0.71 0.06 0.23 0.39 0.64 0.77 0.85 0.10 0.27 0.18 0.57 0.45 0.74 0.25 0.68 0.43 0.93 
Significant values are shaded and bolded. CORT = corticosterone; deltaCORT = (Stress CORT – Basal CORT); deltaSIH = (T2-T1); 
Dist = distance; FST = forced swim test; Imb = immobile; LD = light/dark; OF= open field; PND = postnatal day; SIH = stress-




Figure 2.1. Experimental design 
	
(a) Twenty different Collaborative Cross (CC) strains were used to generate ten recombinant 
inbred intercross (RIX) lines. Each RIX is a set of F1 reciprocal females that differ only in the 
parental origin of alleles. The CC alleles come from the 8 inbred strains (represented by 8 colors) 
that were used to generate the CC. Comparison of F1 reciprocal females within a RIX allows for 
detection of parent-of-origin effects. Comparison across RIX lines allows for detection of genetic 
background effects. (b) Multiple dams from each CC strain were put on one of four diets (PD, 
ME, VDD, Std) for 5 weeks prior to mating, throughout gestation and the postnatal period. F1 
females were weaned onto a regular diet and remained on that diet until the completion of 
behavioral testing. (c) F1 females underwent a 2-week behavioral pipeline to assess anxiety- 
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Figure 2.2. Basal and stress-induced temperature are affected by the interaction of perinatal diet 
exposure and genetic background. 
 
Data points are means of diet exposure groups. Error bars are SEM. There was a significant diet-
by-RIX effect on (a) basal body temperature (p=3.6x10-7, q=1.4x10-6) and (d) change in 
temperature following a stressor (p=2.6x10-4, q=0.001). There was an overall effect of perinatal 
diet on (b) basal temperature (p=0.0002, q=0.001) with ME exposed females showing decreased 
basal temperature compared to PD exposed females (posthoc ***p<0.001; N =157, 177, 170, 
180 for PD, ME, Std & VDD, respectively). (e) No significant overall effect of diet was observed 
for change in temperature (p>0.05). An example of a diet-by-RIX interaction is shown for (c) 
basal and (f) change in temperature. (c) RIX 01/11 PD exposed females (N=31) show increased 
basal temperature (post hoc p≤0.02) and (f) decreased change in temperature in response to stress 
(post hoc p≤0.03) compared to Std exposed females. (N=28). (c) An opposing effect is seen in 
RIX 06/26 wherein PD exposed females (N=12) have decreased basal temperature (post hoc 
p<0.01) and (f) increased change in temperature in response to stress (post hoc p≤0.009) 
compared to Std exposed females (N=21).  
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Figure 2.3. Perinatal diet interacts with genetic background to alter measures of stress response.  
 
Data are means of diet exposure groups. Error bars are SEM. There was a significant diet-by-
RIX effect on (a) basal CORT (p=1.5x10-10, q=1.5x10-9) and (d) change in CORT following a 
restraint stress (p=1.1x10-8, q=7.6x10-8). There was an overall effect of perinatal diet on (b) basal 
CORT (p=0.038, q=0.085) although post hoc tests revealed no significant effects. (e) There was 
a significant diet effect on change in CORT (p=2.1x10-5, q=1.4x10-4) with PD exposed females 
showing increased change in CORT (posthoc ***p<0.001; Ns=141, 150, 157, 171 for PD, ME, 
Std & VDD). Example of a diet-by-RIX interaction is shown for (c) basal CORT and (f) change 
in CORT. (c) In RIX 06/26, VDD exposure (N=23) resulted in decreased basal CORT compared 
to Std exposure (N=21) while in RIX 03/14, VDD exposed females (N=15) showed increased 
CORT compared to Std exposed females (N=21). (f) RIX 32/42 VDD exposed females (N=25) 
showed increased change in CORT compared to Std exposed females (N=30; post hoc p≤0.001) 
while RIX 04/17 VDD exposed females (N=27) showed decreased change in CORT compared to 
Std exposed females (N=27; post hoc p≤0.001).  
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Figure 2.4. Parent-of-origin affects anxiety- and depressive-like behaviors in RIX 03/14 females 
 
Data points are individual animals with bars indicating means. Error bars are SEM. 
CC(03x14)F1 females (N=29) showed (a) increased distance moved (*p=0.031, q=0.12), (b) 
increased time spent in the center of the OF (*p=0.045, q=0.15), (c) decreased % immobility in 
the FST (*p=0.02, q=0.12), (d) increased transitions (*p=0.026, q=0.12), (e) increased distance 
moved on the light side (**p=0.005, q=0.10), and (f) increased % time spent in the light side of 





Figure 2.5. Parent-of-origin affects locomotion, anxiety-like behavior and stress response in RIX 
35/62 females 
 
Data points are individual animals with bars indicating means. Error bars are SEM. 
CC(62x35)F1 females (N=21) showed (a) increased total distance (*p=0.041, q=0.16), (b) 
increased transitions (*p=0.03, q=0.15), (c) increased distance on the light side (*p=0.025, 
q=0.15) and (d) increased % time spent in the light side of the LD test (*p=0.028, q=0.15) 
compared to CC(35x62)F1 females (N=13). (e) RIX 35/62 reciprocal females did not differ in 
basal CORT levels (p>0.05). (f) CC(62x35)F1 females (N=10) showed decreased CORT levels 
following a restraint stress (*p=0.02, q=0.15) which resulted in (g) decreased change in CORT 
compared to CC(35x62)F1 females (N=10), although this effect did not reach statistical 
significance (p=0.07). Stress response is only reported for females exposed to VDD and Std due 





Figure 2.6. Parent-of-origin and diet-by-PO effects on stress-induced CORT in RIX 06/26 
females  
 
(a) Data points are individual animals with bars indicating means. Error bars are SEM. There 
was a significant PO effect on stress-induced CORT levels in RIX 06/26 (**p=0.003, q=0.02) 
with CC(06x26)F1 females (N=29) showing increased CORT compared to CC(26x06)F1 
females (N=35). (b) Data points shown are individual animals with mean (black bar). Error bars 
are SEM. There was a significant diet-by-PO effect on stress-induced CORT for RIX 06/26 
(p=0.018, q=0.14). Posthoc analysis revealed that within CC(06x26)F1, ME exposed females 
(N=5; ***p≤0.001) had increased CORT compared to PD (N=6), Std (N=9) and VDD (N=9) 
exposed females. No diet effects were observed within CC(26x06)F1 females (N=5,5,11,14). 





Figure 2.7. Perinatal diet interacts with parent-of-origin to affect body weight in multiple RIX 
lines 
 
Data points are individual animals with bars indicating means. Error bars are SEM. There was a 
(a) PO effect (***p=2.0x10-5, q=3.0x10-4; N=44,39) and (b) diet-by-PO effect (p=0.01, q=0.19) 
on weight at weaning in RIX 04/17. Posthoc revealed that CC(04x17)F1 PD (***p≤0.001) and 
ME (**p≤0.01) exposed females weighed less than Std and VDD groups (N=12,6,12,14) and 
within CC(17x04)F1, only PD exposed females weighed less  (**p≤0.004; N=9, 2,15,13). 
Reciprocal females in the Std and VDD exposure groups also differed (###p≤0.001). For weight 
in adulthood in RIX 01/11, there was a (c) PO effect (**p=0.01, q=0.14; N=54,63) and (d) diet-
by-PO effect (p=0.03, q=0.32). Posthoc showed that CC(11x01)F1 females exposed to PD 
(**p≤0.002) and ME (*p≤0.03) weighed less than Std and VDD groups (N=12,14,17,11) while 
within CC(01x11)F1 there was no effect of diet (N=19,13,11,20). Std (#p=0.03) and VDD 
(#=0.02) exposure also differed across reciprocal females. In RIX 06/26, there was a PO effect 
on (e) weight at weaning (*p=0.03, q=0.12; N=36,30) and a similar pattern in (g) adulthood 
(p>0.05) and a diet-by-PO effect on (f) weight at weaning (p=0.04, q=0.15) and (h) in adulthood 
(p=0.04, q=0.15). (f) Posthoc revealed that CC(26x06)F1 females exposed to PD (***p≤0.001) 
and ME (**p≤0.003) weighed less than Std and VDD groups (N=6,5,11,14) while in 
CC(06x26)F1, only PD exposed females weighed less (**p≤0.006; N=6,5,10,9). Across 
reciprocal females, ME exposed groups differed (##p=0.01). (h) Posthoc tests showed that 
CC(26x06)F1 females exposed to PD (*p≤0.04) weighed less than Std and VDD groups but 
within CC(06x26)F1, PD exposed females only weigh less than VDD (**p=0.003). 




CHAPTER 3: CHARACTERIZATION OF TWO F1 HYBRID LINES OF 




Substance use disorders (SUDs) are highly prevalent and result in significant health and 
financial burdens on affected individuals and society. Heritability estimates from twin studies 
range from 40 to 70% (Goldman et al, 2005) indicating that genetics play a significant role in the 
development of SUDs. Genetic differences are likely involved in multiple parts of the addiction 
cycle: the likelihood of initiating drug use (i.e. risk-taking personality or response to stressors), 
subjective effects caused by initial drug response or the transition to drug dependence after use is 
initiated (Kendler et al, 1999; Kendler et al, 2000). Identifying genetic differences in individuals 
that are susceptible to initiate drug use and those that are resilience to development of a SUD 
after drug use is initiated is crucial for the development of effective treatments.  
Human studies are challenging due to the complex etiology of SUDs, the contribution of 
largely unknown environmental factors and previous or chronic drug exposures that make it 
difficult to parse the effects of the drug from potential predisposing factors. Moreover, genetic  
________________________ 
1This chapter has been prepared for submission to the Neuropsychopharmacology journal. The 
authors will be: Sarah A Schoenrock, Padam Kumar, Alex Gomez-A, Joseph Farrington, Sofia 
Neira, Kyle Riker, Christiann H Gaines, Saad Khan, William Valdar, Fernando Pardo-Manuel de 
Villena, Donita L Robinson, and Lisa M Tarantino. 
 
 
2Supplemental material for this chapter is provided in Appendix  B
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heterogeneity in human populations creates the need for extremely large sample sizes to identify 
genetic loci that increase risk. 
Animal models have been developed and offer several advantages including control over the 
environment, baseline assessment before drug exposure and the ability to manipulate and access 
brain tissue for mechanistic studies. While animal models are limited in ability to recapitulate the 
full spectrum of diagnostic criteria observed in human SUDs, they do allow for evaluation of 
discrete phenotypes that model specific aspects of the addiction process (i.e. initial drug 
sensitivity, rewarding effects, etc). Commonly used models include selecting individual animals 
within an outbred population based on various predictive traits (i.e. novelty response, 
impulsivity) or initial drug response or screens of numerous inbred strains and selection of 
phenotypic outliers for a given phenotype (reviewed in Yamamoto et al (2013)). In these models, 
the individuals or inbred strain outliers are then used to investigate the relationship among 
addiction-related behaviors and probe for underlying mechanisms driving their divergent 
phenotypes. 
In this study, we utilize a relatively new inbred mouse resource known as the Collaborative 
Cross (CC) (Churchill et al, 2004; Threadgill et al, 2012). The CC is a panel of recombinant 
inbred strains with genetic contributions from eight inbred strains; five classical strains (A/J, 
C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ, NZO/HlLtJ) and three-wild derived (WSB/EiJ, 
CAST/EiJ, PWK/PhJ). The eight founder strains represent three subspecies of Mus musculus, 
resulting in novel combinations of alleles, and capture 90% of the genetic diversity present in the 
domesticated house mouse (Roberts et al, 2007; Srivastava et al, 2017). The increased genetic 
diversity of the CC results in a greater phenotypic range than observed in commonly used 
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models and could provide novel insight into the relationship among predictive and addiction-
related behaviors and the underlying mechanisms. 
In a previously published study, we assessed a panel of CC F1 hybrid female mice (referred 
to as Recombinant Inbred Intercrosses (RIX)) for locomotor behavior (Schoenrock et al, 2017). 
We identified two RIX lines that were outliers for novelty-induced locomotion in both a novel 
open field (OF) and light/dark (LD) arena (see S Fig 5 in Appendix A). Locomotor response to a 
novel environment is one commonly used animal model for studying addiction-related behaviors 
(Piazza et al, 1989), and is thought to reflect sensation-seeking in humans, a personality trait 
linked to increased drug initiation (Howard et al, 1997). Locomotor response to a novel arena 
has been shown to predict initial locomotor response (Hooks et al, 1991b), behavioral 
sensitization (Hooks et al, 1992; Hooks et al, 1991a) and intravenous self-administration (IVSA) 
behaviors (Marinelli and White, 2000; Piazza et al, 1989; Piazza et al, 1990; Pierre and Vezina, 
1997) to psychostimulants in animal models. 
We conducted a set of experiments to assess these two RIX lines for addiction-related 
behaviors including those modeling early (i.e. initial locomotor sensitivity) and subsequent (i.e. 
behavioral sensitization, reward and reinforcement) phases of the addiction process. We also 
explored mechanisms that might explain their divergent behavioral phenotypes including the 
hypothalamic-pituitary-adrenal (HPA) axis and dopaminergic system, both well-established in 
their role in addiction (Koob, 2008; Volkow et al, 2011). We believe these studies establish a 
framework for using the genetically diverse CC to identify phenotypic outliers that can aid in the 




METHODS AND MATERIALS  
Animals 
CC mice were purchased from the UNC Systems Genetics Core Facility. CC mice were bred 
to generate F1 hybrids. In this paper, F1 mice from each cross are collectively referred to as a 
RIX line. CC004/TauUnc and CC017/Unc were crossed to create RIX 04/17; CC041/TauUnc 
and CC051/TauUnc were crossed to create RIX 41/51; CC005/TauUnc and CC040/TauUnc were 
crossed to create RIX 05/40. All crosses were performed reciprocally such that maternal and 
paternal contribution was balanced in the F1 offspring. 
Mice were housed in a specific pathogen-free animal facility on a 12-hour light/dark cycle 
with lights on at 7:00 A.M. All procedures and animal care were approved by the UNC 
Institutional Animal Care and Use Committee and followed guidelines set forth by the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals. Food and water were 
provided ad libitum throughout the experiment. Breeder diet was AIN-93G (Dyets Inc, 
Bethlehem, PA) and offspring were weaned and maintained on Harlan Teklad 2920 (Envigo, 
Frederick, MD, USA).  
 
Drugs 
Cocaine HCl (COC; Sigma-Aldrich, St. Louis, MO) and methamphetamine (METH; Sigma-
Aldrich, St. Louis, MO) were dissolved in 0.9% saline. COC was administered intraperitoneally 
(IP) at a dose of 20 mg/kg of body weight for all experiments except behavioral sensitization (10 
mg/kg) and dose response (10, 20, 30, 40, 45, and 50 mg/kg). METH was administered IP at a 
dose of 2 mg/kg. Both drugs and saline controls were injected administered in a volume of 




All behavioral testing was performed during the light portion of the light/dark cycle between 
8:00 A.M. and 12:00 P.M. except for the 6-hr OF test and behavioral sensitization experiments 
which ran until 4:00 P.M. All experimental animals were naive to any previous testing at the start 
of each experiment. All animals were tested at a mean age of 65 ± 6.6 days.  
Open field (OF) arena  
The eight OF apparatuses (ENV-515-16, Med Associates, St. Albans, VT, USA) were 
43.2x43.2x33 cm with white Plexiglas floors and clear Plexiglas walls. Infrared detection beams 
at 2.54 cm intervals on the x, y, and z-axes tracked the animals’ position and activity 
automatically during testing. Each OF was enclosed in a sound-attenuating chamber (73.5x59x59 
cm) illuminated by two overhead light fixtures containing 28-V lamps. Data were analyzed post-
session using commercially available software (Activity Monitor 5.1, Med Associates). The OF 
was used to assess acute locomotor response to COC and METH, behavioral sensitization to 
COC and stress response in a novel environment. Eight identical OF arenas were used. For tests 
requiring repeated exposure to the OF, mice were tested in the same arena for all sessions.  
Acute locomotor response to COC 
For the initial test of COC-induced locomotion, we used a 6-hr OF test. Mice were weighed 
and placed into the OF arena for 1 hr, then removed and injected with saline and returned to the 
OF for 2 hrs. After 2 hrs, mice were injected with COC and returned to the OF for an additional 
3 hrs. Distance moved was scored in 5-min bins. Distance moved in the first 10 mins of the test 
was used to assess novelty-induced locomotion and the sum of the distance moved post-COC 
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injection (180-360 min), referred to as area under the curve (AUC) was used to assess COC-
induced locomotion. 
COC dose response and methamphetamine response  
Animals were tested on 3 consecutive days in the OF and all test sessions were 30-mins in 
length. On Day 1 (habituation) and Day 2 (baseline) animals were injected with saline and on 
Day 3, animals were injected with either saline, COC, or METH before being immediately 
placed into the OF arena. Distanced moved was recorded in 2-min bins. A difference score of 
total distance moved on Day 3 - Day 2 was used to assess COC- or METH-induced locomotion.  
Behavioral sensitization to COC 
Each day of the 19-day sensitization protocol consisted of a 90-min test session. On each test 
day, animals were placed into the OF for 30 min, then removed and injected with either saline or 
COC and returned to the arena for 60 min. Animals received saline injections on Days 1, 2, and 
12 and COC injections on Days 3, 5, 7, 9, 11, and 19. Total distanced moved in the 60-min post 
injection was used to assess initiation of behavioral sensitization (Days 3,5,7,9,11), expression of 
sensitization (Day 19) and conditioned activation (comparison of Day 12 to Day 2).  
Stress response to a novel environment  
Corticosterone (CORT) was assessed at three time points immediately prior to and 30- and 
120-min after a 10-min exposure to a novel OF arena. Blood was collected by retro-orbital bleed 
for the first two time points and trunk blood was collected for the third-time point. Whole blood 
was centrifuged at 11,700 rpm for 13 min to isolate serum, and CORT levels (measured in 
ng/mL) were analyzed by competitive radioimmunoassay following the manufacturer’s protocol 
(MP Biomedicals, Santa Ana, CA, USA).  
 
	62 
Conditioned Place Preference (CPP)  
CPP was assessed using a 10-day protocol in a three-chambered arena (46.5×12.7×12.7 cm; 
MED-CPP-MSAT, Med Associates) that consisted of a grey middle chamber (7.2×12.7 cm; 21-
24 lux lighting) with a smooth PVC floor flanked by white and black chambers (each 16.8×12.7 
cm) on either side. The black chamber had a stainless-steel grid rod floor (3.2 mm rods, 7.9 mm 
centers; 25-27 lux lighting) and the white chamber had a stainless-steel mesh floor (6.35×6.35 
mm; 13-15 lux lighting). The chambers were separated by guillotine doors that were open on 
habituation Day 1 and the preference test on Day 10 and closed on conditioning Days 2-9. Each 
CPP arena was enclosed in a sound-attenuating box (ENV-016MD, Med Associates). Two 
identical CPP arenas were used; each mouse was tested in the same arena throughout testing. 
The 10-day CPP protocol is described in more detail elsewhere (Eisener-Dorman et al, 
2011). On Day 1, mice were injected with saline before being placed in the middle compartment 
of the CPP apparatus with access to all 3 chambers for 30 min. On days 2, 4, 6, and 8, animals 
were given an injection of saline before being confined to the saline-paired compartment. On 
days 3, 5, 7, and 9, mice were given an injection of COC before being confined to the COC-
paired chamber. The CPP apparatus was unbiased and mice were randomly assigned to receive 
COC in either the black or white chamber. Assignment to a training chamber was balanced 
within RIX line and sex. Day 10 served as the test day during which mice were given an 
injection of saline before being placed into the middle compartment with access to the entire 
apparatus for 30-minutes. Time spent in each chamber on Day 10 was recorded and compared to 
Day 1. A control group that received saline on all days was included to allow for comparison of 
drug effects within a RIX line.  
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Brain concentration of COC 
Animals were injected with COC and returned to their home cage. At 10-min whole brain 
was collected, rinsed with ddH2O, hemisected and snap-frozen in liquid nitrogen.  This time 
point was chosen to correlate with the peak behavioral response. Brain concentrations of COC, 
and its metabolites (norcocaine (NOR); benzoylecgonine (BZE)) were quantified using liquid 
chromatography tandem mass spectrometry as previously described (Slawson et al, 2002).  
 
Monoamine brain tissue content 
Monoamine levels in the dorsal striatum (dST) and nucleus accumbens (NAc) were measured 
in both drug naïve and COC-exposed animals. For COC exposure, animals were given an 
injection of COC and returned to the home cage for 10 min prior to brain collection. Brain tissue 
was collected and immediately sectioned using a 1mm brain block that was kept cold on ice. One 
mm tissue punches were taken from dST and NAc, pooled across hemispheres for each animal 
and flash frozen in liquid nitrogen. Tissue content of norepinephrine (NE), dopamine (DA), 
serotonin (5-HT) and select metabolites (DOPAC, HVA, 3-MT, 5-HIAA) was measured by high 
performance liquid chromatography at the Vanderbilt Neurochemistry Core 
(medschool.vanderbilt.edu/vbi-core-labs/neurochemistry-core). 
 
In vivo Fast Scan Cyclic Voltammetry (FSCV)3  
Endogenous DA release was measured in anesthetized mice before and after COC 
administration according to published (Shnitko et al, 2016) and supplemental methods. Briefly,  
________________________ 
3In vivo FSCV was performed through a Collaboration with the Robinson Lab at UNC (Fig 4.4, 
S Fig 1 & 2 in Appendix B): A. Gomez, S. Neira, K. Riker, D. Robinson  
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mice were anesthetized with urethane (50% w/w in saline, 1.8g/kg IP) and placed in a stereotaxic  
frame. A bipolar stimulating electrode was lowered -4.0mm from the skull surface into the 
ventral tegmental area (VTA; AP -3.8, ML -0.2). A carbon-fiber microelectrode was lowered  
into the NAc -4.0mm from dura (AP +1.2, ML -1.2). An Ag/AgCl reference electrode was  
inserted into contralateral cortex. A triangle waveform potential ramping from -0.4V to +1.3V to 
0.4V at 400 V/s was applied to the carbon-fiber electrode at 10Hz and DA signals were obtained 
upon stimulation of the VTA. Evoked DA signals were collected five minutes apart. First, saline 
(vehicle) was administered IP and three evoked DA recordings were collected; this constituted 
the baseline measurement. Next, mice received either 20mg/kg COC or saline IP and evoked DA 
recordings were collected for 60 min. Evoked DA was background subtracted and confirmed via 
the cyclic voltammogram as previously described (Shnitko et al, 2016). 
 
Statistical analysis 
All statistical analyses were performed using SPSS v24 (IBM, Armonk NY, USA) and 
GraphPad Prism (GraphPad, La Jolla CA, USA). Within an experiment, analysis of variance 
(ANOVA) tests were performed to analyze the effects of RIX (referred to as strain), sex, time 
points and dose (as relevant) on the dependent variable. Dependent variables included distance 
moved, AUC, locomotor difference score, CORT levels, time in CPP chambers, monoamine 
tissue content, concentrations of COC and metabolites and electrically-evoked DA release. 
Significant main effects were followed up with Tukey’s or Bonferroni’s posthoc analyses. Mean 
differences were significant at p < 0.05. Pearson 2-tailed correlation was used for novelty- and 




RIX 04/17 and 41/51 show phenotypically divergent initial locomotor sensitivity to COC  
We tested the relationship between novelty-induced locomotion and COC-induced 
locomotion using a 6-hr OF test (Fig 3.1a). RIX 05/40 was included for comparison as it 
displayed normal novelty-induced locomotion among a panel of 9 RIX lines (Schoenrock et al, 
2017). ANOVA of strain x sex revealed a significant effect of strain on novelty-induced 
locomotion as measured by the distance moved in the first 10 min (F2,141=119.8, p=10.0x10-31) 
and COC-induced locomotion as measured by the total distance moved post COC (F2,141=72.3, 
p=4.2x10-22). RIX 41/51 moved significantly less than RIX 04/17 and RIX 05/40 and RIX 04/17 
moved significantly more than RIX 41/51 and 05/40 for both novelty- (p<0.001; Fig 3.1b) and 
COC-induced locomotion (p<0.001; Fig 3.1c).  
 
Strain difference in initial COC locomotion is not dose-dependent 
We tested whether the difference between RIX 04/17 and 41/51 for initial sensitivity to COC 
was dose-dependent. We assessed dose dependency of initial locomotor sensitivity between RIX 
04/17 and 41/51 using the three-day OF test and six doses of COC (Fig 3.1e). An ANOVA of 
strain x sex x dose on locomotor response to COC revealed a significant effect of strain 
(F1,258=484.3, p=1.3x10-58) and dose (F6,258=37.4, p=1.5x10-31) and a strain x dose interaction 
(F6,258=20.7, p=2.1x10-19). RIX 41/51 mice were significantly more activated at 30, 40, 45, and 
50 mg/kg compared to saline (p£4.1x10-5). RIX 04/17 mice were significantly more activated at 
all COC doses compared to saline (p£1.6x10-5). RIX 04/17 showed significantly higher 
locomotor response at every COC dose tested (p£1.63x10-4) compared to RIX 41/51. Peak 
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locomotor response for RIX 41/51 was at 40 mg/kg while RIX 04/17 showed peak activation at 
20 mg/kg.   
 
RIX 04/17 and 41/51 differ in initial locomotor response to METH 
To assess whether the difference in initial locomotor sensitivity was specific to COC or 
extended to other psychostimulants, we measured locomotor response to METH using our 3-day 
protocol (Fig 3.1f). An ANOVA of strain x sex x dose on locomotor response revealed a 
significant effect of strain (F1,75=30.0; p=6.7x10-7), dose (F1,75=39.3; p=2.9x10-8) and a strain x 
dose interaction (F1,75=28.3; p=1.0x10-6), but no effect of sex (p>0.05). Follow-up analyses 
revealed that METH-treated animals of both strains moved significantly more than saline-treated 
animals (p£0.007) but RIX 04/17 had greater METH-induced response compared to RIX 41/51 
(p=2.2x10-7).  
 
Strain difference in initial locomotor response to COC is not due to brain concentrations of COC 
or metabolites 
We tested for differences in brain concentrations of COC and its metabolites at 10-mins post 
drug exposure; the time point of peak behavioral activation (see Fig 1a). RIX 04/17 and 41/51 
did not differ for COC, NOR or BZE concentrations in the brain. Nor were there any sex 
differences or sex by strain interaction effects (all p>0.05; S Table 1).  
 
RIX 04/17 and 41/51 show behavioral sensitization to repeated exposures to COC 
Behavioral sensitization was assessed by repeated measures ANOVA of distance moved post 
COC dosing for each exposure day (Fig 3.2a). There was a significant effect of day 
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(F2.5,64.2=13.1; p=4.0x10-6) and a day x strain interaction effect (F2.5,64.2=3.9; p=0.018). RIX 04/17 
shows a significant increase in COC-induced locomotor activity from Day 3 to 5 (p=0.0002) and 
Day 7 to 9 (p=0.025) and appears to reach a plateau after the third exposure to COC. RIX 41/51 
showed a significant increase in distance from Day 5 to 7 (p=0.01). These data indicate that both 
strains show behavioral sensitization, however, RIX 41/51 animals require more exposures to 
COC before showing a significant increase in locomotor behavior. 
We also assessed conditioned activation by comparison of saline treatment on Day 2 
(baseline) to Day 12 within each strain. Both RIX 41/51 (F1,14=33.6; p=4.7x10-5) and RIX 04/17 
(F1,14=12.5; p=0.003) showed a significant increase in locomotion on Day 12, indicating some 
level of conditioned activation. Although Day 12 locomotion is much lower than on the last 
exposure to COC on Day 11 in both RIX. 
 
RIX 04/17 and 41/51 show conditioned place preference to COC 
We measured CPP to a single dose of COC to determine if differences in initial locomotor 
sensitivity in these two RIX lines predicted differences in sensitivity to the rewarding effects of 
the drug (Fig 3.2b). An ANOVA assessing the effects of strain, chamber, test day (pre- vs post-
training), dose (COC vs saline) and sex on the time spent in the drug-paired chamber revealed a 
significant effect of chamber (F2,436=12.2; p=7.0x10-6), strain x chamber (F2,436=31.8; p=1.6x10-
13), and dose x chamber (F2,436=13.2; p=3.0x10-6). RIX 41/51 spent significantly more time in the 
middle chamber during the habituation session on Day 1 (p£3.2x10-7). However, both RIX 41/51 
and 04/17 COC-trained mice spent significantly more time in the COC-paired chamber than the 
saline-paired chamber on Day 10, after eight conditioning days (all p£3.2x10-4) and also spent 
significantly more time in the COC-paired chamber than saline control animals (p£0.015). We 
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observed no strain difference in time spent in the COC-paired chamber post conditioning 
(p>0.05) indicating that both strains show CPP for the COC-paired chamber.  
 
RIX 41/51 males have alterations in stress reactivity and recovery to a novel environment  
The HPA axis is involved in initiation of drug use, transition to drug dependence and the 
negative affective state that drives drug-seeking (Koob, 2008). We assessed the HPA axis at 
baseline and in response to a stressor in both RIX lines. A repeated measures ANOVA of serum 
CORT levels before (0 min) and after (30 and 120 min) exposure to novel OF stress yielded a 
significant effect of time (F2,78=171.1; p=3.0x10-29), time x strain (F2,78=5.5; p=0.006), time x 
sex (F2,78=6.3; p=0.03). Due to the significant sex difference, we analyzed females and males 
separately and observed a significant effect of time in both males (p=7.7x10-13) and females 
(p=4.3x10-18; Fig 3.3b) and a male-specific time x strain interaction (p=1.1x10-4; Fig 3.3a). 
CORT was significantly increased at 30 min post stressor in males from both RIX lines 
(p£0.001) but the level at 30 min was significantly lower in RIX 41/51 compared to RIX 04/17 
(p=0.001). Additionally, only RIX 04/17 shows a significant decrease in CORT at 120 compared 
to 30 (p<0.001). Collectively, these data indicate that RIX 41/51 males have a blunted and 
prolonged elevation in CORT in comparison with RIX 04/17.  
 
Specific strain differences in NE and 5-HT, but not DA striatal tissue content  
Since DA has a known role in mediating both movement and addiction-related phenotypes, 
we assessed the dopaminergic system as a possible mechanism for the observed RIX differences. 
We assessed tissue content of monoamines and their metabolites basally and after exposure to 
COC in two key areas with DA neuronal projections, the dST and NAc, (S Table 2). There were 
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no strain differences in DA tissue content in either brain region, but there were select differences 
in 5-HT and NE. RIX 41/51 has increased levels of 5-HT in the dST at basal conditions 
compared to RIX 04/17 (F1,13=7.4, p=0.022) and in the NAc after acute exposure to COC 
(F1,14=11.0, p=0.07). RIX 04/17 has increased basal levels of NE in the NAc compared to RIX 
41/51 (F1,11=16.8, p=0.003).  
 
COC effects on DA dynamics is not different across strains 
We used in vivo FSCV to assess potential strain differences in DA release and clearance at 
baseline and after COC exposure. We collapsed samples after the initial saline injection (i.e., 
baseline), plotting them as concentration versus time in Fig 3.4a. The peak DA concentration, or 
[DA]max, at baseline was higher in RIX 41/51 than 04/17 mice, but this did not reach significance 
(inset; t=1.91, p=0.073). We compared the effect of saline versus COC on [DA]max by strain and 
found that COC increased evoked DA release similarly in each strain. Illustrating this, Fig 3.4b 
displays [DA]max as percent change from baseline (non-transformed data displayed in S Fig 1). A 
3-way repeated measures ANOVA of strain x drug x time (calculated on non-transformed data), 
revealed a significant drug x time interaction (F1,19=5.40, p<0.004) with significant main effects 
of time (F1,19=4.12, p=0.014) and drug (F1,19=10.43, p=0.004). Post-hoc analysis (collapsed 
across strain) indicated that DA release was three times higher after COC compared with saline 
(all t’s>3.44, p<0.01), Fig 3.4b, S Fig 1). To further assess pharmacological effects of COC, we 
determined the sample containing the peak effect of COC on DA release for each mouse and 
calculated several parameters (S Fig 2). We found no strain differences on the peak [DA]max 
(t=1.82, p=0.093), the time of that peak (Tmax, t=0.20, p=0.843), the latency from the end of the 
stimulation to the [DA]max (t=1.63, p=0.129), the full width of the DA signal at half height 
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(t=0.39, p=0.699), and the slope of the clearance curve (t=0.922, p=0.376). Together, these data 
indicate that the RIX lines show a similar pattern of DA dynamics after COC.  
 
DISCUSSION 
RIX 04/17 and 41/51 as models to study addiction-related behaviors 
In this study, we selected two CC-RIX lines that were outliers for locomotor activity in a 
novel environment; a phenotype previously shown to predict addiction-related behaviors (Piazza 
et al, 1989). We characterized these lines for several addiction-related behaviors to establish 
their utility as mouse models for assessing the underlying genetic and mechanistic factors that 
drive these behaviors. We first assessed initial locomotor sensitivity to COC and found a 
significantly divergent response that was consistent across multiple doses. Comparison of their 
COC-induced locomotion at 20 mg/kg in the 3-day OF test (see Fig 3.1e) to a previously 
published survey of 45 traditional inbred mouse strains confirms that RIX 41/51 and 04/17 are at 
the phenotypic extremes. Only one strain (LG/J) showed a lower locomotor response to COC 
than RIX 41/51 and only one strain (C57BR/cdJ) was more responsive to COC than RIX 04/17, 
Furthermore, both RIX lines fell outside the range of the seven founders of the CC population 
that were tested in this study (Wiltshire et al, 2015).  
Our ability to identify phenotypic outliers for locomotor sensitivity to COC highlights the 
genetic diversity present in the CC resulting from novel allele combinations of the three-major 
subspecies of Mus musculus. Expanded phenotypic range in the CC, relative to that observed in 
standard inbred strains, has also been observed for phenotypes related to immunology and 
toxicology (Gralinski et al, 2015; Mosedale et al, 2017; Venkatratnam et al, 2017; Vered et al, 
2014). Ours is the first study to examine addiction-related behaviors in the CC.  
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Human studies have shown that individuals who experienced a positive or pleasurable first 
experience with COC have a higher lifetime use and increased risk for dependence (Davidson et 
al, 1993; Haertzen et al, 1983; Lambert et al, 2006). In animal models, however, locomotor 
sensitivity to COC does not always predict other addiction-related behaviors (Yamamoto et al, 
2013). For this reason, we examined behaviors thought to reflect the rewarding and neuro-
modulating properties of psychostimulants, CPP and behavioral sensitization, in the CC-RIX. 
We hypothesized that RIX 04/17 would show greater COC CPP compared to RIX 41/51. To the 
contrary, we found that both RIX lines showed a preference for COC after multiple training 
exposure days. These data would indicate that initial locomotor response to COC does not 
predict the rewarding effects in these lines. One consideration in the interpretation of CPP data is 
that our RIX 04/17 do exhibit much higher locomotor activity on COC training days compared to 
RIX 41/51, which may inhibit their ability to associate the compartment with the drug’s effects 
(Cunningham et al, 2006). Another significant caveat was the use of only one dose of COC for 
CPP experiments. Additional experiments using lower, less activating doses of COC are needed 
to more fully explore the relationship between initial sensitivity and the rewarding effects of 
COC in these lines. 
Behavioral sensitization is the phenomenon of increased locomotor response across repeated 
exposures to a drug and is thought to reflect underlying long-term neuroadaptations in response 
to the drug, although the mechanisms are a subject of debate in the literature (Rothenfluh and 
Cowan, 2013). We observed behavioral sensitization in both RIX lines but sensitization emerged 
earlier in RIX 04/17 compared to RIX 41/51. One caveat that must be considered when 
interpreting the behavioral sensitization data is that RIX 04/17 could have reached a ceiling in 
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locomotor activation as there appears to be a plateau after the third COC exposure. Additional 
sensitization studies with lower doses would be necessary to test this further. 
The experiments described in this paper are in response to experimenter-administered drug. 
Additional studies are needed to assess the effects of drug in a contingent or self-administrated 
paradigm. Use of a paradigm such as IVSA will allow for the assessment of additional addiction-
related behaviors such as acquisition of drug intake, maintenance, motivation to administer, 
extinction resistance and reinstatement behavior, all of which cannot be assessed in a non-
contingent paradigm.  
 
Investigation of possible underlying mechanisms for divergent behavioral phenotypes 
Role of the HPA axis 
The HPA axis thought to be involved in initiation of drug use, transition to drug dependence 
and the negative affective state that drives drug-seeking (Koob, 2008). We assessed the HPA 
axis at baseline and in response to a stressor and found differences in HPA axis reactivity and 
recovery in RIX 41/51 males compared with RIX 04/17. The sex-specific nature of this effect is 
difficult to interpret as we did not observe sex-specific differences in other behaviors. It is 
possible that if we had assessed behaviors that more directly model the negative reinforcement of 
withdrawal and reinstatement of drug use, sex-specific differences in RIX 41/51 might have been 
observed. One caveat in the interpretation of these data is that the initial blood sample collection 
is very stressful itself. Therefore, the increase in CORT seen following the novel OF exposure is 
likely due to a combination of the basal blood collection and the novel environment. A follow-up 
study using separate animals for the different time points would allow for assessment of HPA 
axis activity due solely to the novel environment.  
	73 
Role of the dopaminergic system 
COC affects DA dynamics in subregions of the brain associated with motor behavior and 
rewarding properties of drugs, including NAc, dST and prefrontal cortex, (Hedou et al, 1999; 
Volkow et al, 2011). We found that COC-induced increases in evoked DA signals in the NAc 
were similar between the RIX lines, suggesting that DA release and clearance dynamics did not 
underlie RIX differences in COC-induced behavior. However, it should be noted that we chose 
to target the NAc core, whereas some published studies indicate that DA in the NAc shell more 
closely aligns with behavioral effects of stimulants (Hedou et al, 1999; Parkinson et al, 1999). 
We did identify differences in other monoamines. Basal NE levels in the NAc were higher in 
RIX 04/17 than RIX 41/51. The NA shell receives NE projections mainly from the nucleus of the 
tractus solitarius and locus coeruleus (Delfs et al, 1998) and recent evidence has shown that 
noradrenergic neurotransmission might be implicated in COC sensitization. Jimenez-Rivera et al 
(2006) found that the alpha-2 receptor agonist clonidine attenuated the acute locomotor response 
to COC. We also observed a significant decrease in 5-HT in the dST at baseline and in the NAc 
after acute COC in RIX 04/17 mice. Low serotonergic activity has been observed in humans with 
a sensation-seeker personality (Netter et al, 1996), which would fit with the high novelty-
induced phenotype observed in RIX 04/17, which is thought to model sensation-seeking 
behavior. It should be noted that we made all of our comparisons between RIX 41/51 and 
RIX04/17, and it is possible that divergent initial locomotor sensitivity to COC may not be due 





Conclusion and future directions 
We have shown that RIX 41/51 and 04/17 are phenotypically divergent for initial locomotor 
response to COC and can be used as genetically diverse, yet stable models to study addiction-
related behaviors and the underlying mechanisms. Their divergent behavior does not appear to be 
due to differences in the dopaminergic system, but could involve the noradrenergic or 
serotonergic systems which would be interesting as these circuits have a strong role in other 
phenotypes related to psychiatric disorders (i.e. mood, stress) but are less characterized as a 
mechanism in development of COC SUDs. Future studies utilizing these RIX lines to assess 
other addiction-related phenotypes such as impulsivity and IVSA should be performed to further 
establish the relationship among behaviors. Additionally, the genetic diversity present in the CC 
lines can be used to perform genetic analysis of initial locomotor sensitivity to COC using these 
RIX lines to identify genetic loci contributing to this phenotype. 
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Figure 3.1. RIX 04/17 and 41/51 show divergent initial locomotor sensitivity to cocaine 
 
Data are either strain means or individual animals with think black bars representing strain mean. 
All error bars are SEM. (a) Distance moved in 5 min bins across a 6-hr OF test for RIX 41/51 
(N=56), RIX 04/17 (N=42) and RIX 05/40 (N=44). From this test, there was a significant strain 
difference on (b) novelty-induced locomotion (distance moved in the first 10 mins) and (c) 
cocaine (COC) induced-locomotion (Area Under Curve (AUC) in the last 3-hrs post COC 
injection) (***strain effect, p<0.001). (d) Novelty- and COC-induced locomotion are positively 
correlated (p<0.001). (e) Day 3-Day 2 distance for RIX 41/51 (Ns=22,21,21,22,21,21,21) and 
RIX 04/17 (Ns=15,16,16,15,16,16,16) in a 3-day OF test. RIX 04/17 had COC-induced increase 
in locomotion at all doses while RIX 41/51 only had COC-induced increase at the four highest 
doses (#COC effect within strain compared to saline, p<0.001). There was a significant effect of 
strain at all doses of COC (*strain effect, p<0.001). (f) Day 3-Day 2 distance for RIX 41/51 
(N=21, 23) and RIX 04/17 (N=13, 19). There was a significant effect of METH in both strains 
(##p<0.01, ###p<0.001) and a significant effect of strain on METH response (***p<0.001).  
 
  




























































































































































Figure 3.2. Strain differences in behavioral sensitization but not conditioned place preference to 
cocaine 
 
Data are either strain means with SEM error bars. (a) Distance post injection of saline (S) or 10 
mg/kg cocaine (C) for RIX 41/51 (N=15) and 04/17 (N=16) animals. There was a significant 
effect of COC exposure day (p=4.0x10-6) and COC exposure day x strain (p=0.018). Comparing 
consecutive exposures days, RIX 41/51 had a significant increase from Day 5-7 and RIX 04/17 
from Day 3-5 and Day 7-9 (within RIX effect, +p<0.05, p<0.01, p<0.001). (b) Time spent for 
RIX 41/51 and 04/17 mice in each of the three chambers (cocaine (COC)-paired, saline (SAL)-
paired and middle) before (Pre) or after (Post) training to COC (N=19, 20) or for saline-saline 
controls (N=17, 18). RIX 41/51 spent significantly more time in the middle chamber during the 
pre-test session on Day 1 (***p£3.2x10-7). Both RIX 41/51 and 04/17 mice that were trained 
with COC spent significantly more time in the COC-paired chamber than the SAL-paired 
chamber on the post-test session (***p£3.2x10-4). Within RIX, COC trained animals spent more 








































































Figure 3.3. Dysregulation of stress response in RIX 41/51 males 
 
Data are strain means with SEM error bars for RIX 41/51 and RIX 04/17 (a) males (N=11,12) 
and (b) females (N=11,12) before and after a 10-min open field (OF) exposure. (a) There was a 
significant time x strain in males (p=1.1x10-4). Post hoc analysis in males showed increased 
CORT at 30 min compared to 0 in both strains (p£0.001) but increased CORT at 30 min was 
lower in RIX 41/51 (***p=0.001, strain effect). Only RIX 04/17 shows a significant decrease in 
CORT at 120 compared to 30 (p<0.001). (b) There was a significant effect of time (p=7.7x10-13) 
























































Figure 3.4. Cocaine enhanced electrically evoked dopamine release in the NAc of RIX 41/51 
and RIX 04/17 anesthetized mice  
 
(a) Concentration-versus-time traces of evoked dopamine (DA) release in RIX 41/51 (n=14) and 
RIX 04/17 (n=12) mice during saline/pre-drug recordings; the stimulation is indicated by the 
gray line. Inset: [DA]max did not significantly differ between strains, p=0.073. (b) Cocaine 
(COC) increased evoked DA release compared to saline (Sal) administration in both strains. Data 
are expressed as percent of the baseline, mean ± SEM (n=6-8/group). Collapsed across strain, 
significantly different from Sal groups, ** p<0.01, *** p<0.001. 
	

























































CHAPTER 4- GENETIC ANALYSIS OF INITIAL LOCOMOTOR RESPONSE TO 
COCAINE USING THE COLLABORATIVE CROSS 
 
INTRODUCTION 
Approximately two million individuals report current cocaine (COC) use in the United States 
despite the drug being illegal. Among addictive substances, COC has the highest risk of 
addiction (Goldstein and Kalant, 1990). In the most recent survey, one million individuals in the 
United States met the diagnosis criteria for a COC Substance Use Disorder (SUD) (CBHSQ, 
2016). Despite the significant personal, societal and financial burden of COC use disorders, there 
are currently no FDA-approved treatments. Increased knowledge of the underlying mechanisms 
that lead to COC use disorders are needed to develop effective treatments.  
Twin studies indicate that the heritability (h2) of COC addiction ranges from 0.4 - 0.7 
indicating that genetics plays a significant role (Ducci et al, 2012; Goldman et al, 2005). 
Approaches to identify genes involved in SUDs include candidate gene and genome-wide 
association studies (GWAS). Candidate genes studies are hypothesis-driven, based on what is 
known about a drug (i.e. target system, kinetics, etc) while GWAS are hypothesis-free. A GWAS 
study for COC dependence found a genome-wide significant association with a single nucleotide 
polymorphism (SNP) in FAM53B (family with sequence similarity 53, member B) on Chr 10 
(Gelernter et al, 2014). The Chr 10 region was previously identified by linkage analysis in a 
COC dependence study (Gelernter et al, 2005). Despite these few successful genetic associations 
with SUD, GWAS studies have been limited by insufficient sample sizes that reduce power to
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detect the likely numerous genetic variants as that drive COC use and abuse (Goldman et al, 
2005).  
Genome-wide mapping approaches have been employed in rodents and overcome some of 
the obstacles present in humans. Such studies include mapping of quantitative trait loci (QTL) – 
genetic loci that contribute to phenotypic variation. In mouse QTL studies, acute psychomotor 
response to COC is commonly used as a measure of initial sensitivity to a drug. Human studies 
have shown that initial response to a drug predicts future use and abuse (de Wit and Phillips, 
2012). Numerous QTL studies have been conducted using standard recombinant inbred (RI) 
strains (Boyle and Gill, 2001; Boyle and Gill, 2009; Gill and Boyle, 2003, 2008; Jones et al, 
1999; Miner and Marley, 1995; Phillips et al, 1998; Tolliver et al, 1994) or C57BL/6 substrains 
(Kumar et al, 2013) and have identified genomic regions that are associated with initial 
locomotor response to COC. While these studies identified some overlapping QTL regions, only 
one genetic variant in the Cyfip2 gene has been identified and validated for this phenotype 
(Kumar et al, 2013). Identification of genes that influence initial response to COC in QTL 
studies will further our understanding of its mechanisms and provide candidate genes for 
analysis in human studies. 
In the present study, we utilized a new resource, the Collaborative Cross (CC). The CC was 
created by intercrossing eight inbred mouse strains including five classical – A/J, C57BL/6J 
(B6J), 129S1/SvImJ (129), NOD/ShiLtJ (NOD), NZO/HlLt (NZO) and three wild-derived – 
WSB/EiJ (WSB), CAST/EiJ (CAST), PWK/PhJ (PWK). This set of inbred strains represents the 
three subspecies of Mus musculus (Churchill et al, 2004; Srivastava et al, 2017) and the diversity 
allows for novel combinations of alleles and the observation of expanded phenotypic diversity 
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across the population in comparison to traditional inbred and RI strains (Graham et al, 2015; 
Gralinski et al, 2015; Mosedale et al, 2017; Rasmussen et al, 2014).  
In a previous study, we identified two CC F1 hybrid lines (referred to as Recombinant Inbred 
Intercrosses or RIX), RIX 41/51 and 04/17 that showed very low or high initial locomotor 
response to COC, respectively (see Fig 3.1). Therefore, we wanted to use these two RIX lines to 
conduct QTL mapping to identify candidate genes that contribute to either low or high initial 
locomotor response to COC. Since each RIX is an F1 hybrid of two CC strains, we investigated 
whether the phenotype was due to one or both of the CC parental strains in order to develop an 
effective mapping strategy. For both RIX 41/51 and 04/17, we identified a single CC parent that 
displayed a similar COC locomotor phenotype, CC041/TauUnc and CC004/TauUnc 
respectively. We crossed each of these CC strains to C57BL/6NJ (B6N) to generate two separate 
F2 populations. QTL mapping using the CC041 X B6N F2 and identified genome-wide 
significant QTLs on Chrs 7, 11 and 14 for low COC locomotor response. This study is the first to 
use the CC to perform QTL mapping for an addiction-related phenotype, validates previously 
identified QTLs and proposes several candidate genes for follow-up analysis. 
 
METHODS AND MATERIALS  
Animals 
CC004/TauUnc (CC004), CC017/Unc (CC017), CC041/TauUnc (CC041) and 
CC051/TauUnc (CC051) were purchased from the Systems Genetics Core Facility at the 
University of North Carolina (UNC; http://csbio.unc.edu/CCstatus/index.py). C57BL/6NJ (B6N) 
mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Animals were housed in a 
specific pathogen-free facility on a 12-hour light/dark cycle with lights on at 7:00 A.M. All 
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procedures were approved by the UNC Institutional Animal Care and Use Committee and 
followed guidelines set forth by the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals. Food and water were available ad libitum throughout the experiment. 
Breeder diet was Harlan Teklad 2919 and post-weaning diet was Harlan Teklad 2920 (Envigo, 
Frederick, MD, USA).  
 
Drugs 
Cocaine HCl (COC; Sigma-Aldrich, St. Louis, MO) was dissolved in 0.9% saline and a dose 
of 20 mg/kg of body weight was used to test initial locomotor response in the 6-hr and 3-day 
open field (OF) test. 
 
Phenotyping RIX parental strains for initial locomotor sensitivity to COC 
RIX 41/51 and 04/17 show divergent initial locomotor response to COC. Each RIX is an F1 
hybrid of two CC strains: CC041 and CC051 were crossed to make RIX 41/51 (Fig 4.1a) and 
CC004 and CC017 were crossed to make RIX 04/17 (Fig 4.2a). We phenotyped these four CC 
strains for initial locomotor sensitivity using a 6-hr OF test to determine if one, or both CC 
parental strains contribute to the phenotype of the RIX. Mice were weighed and placed into a 
43.2x43.2x33 cm OF arena (ENV-515-16, Med Associates, St. Albans, VT, USA) and tracked 
by infrared detectors that surrounded the arena at 2.54 cm intervals on the x, y, and z axes. After 
1hr, mice were removed, injected with saline and returned to the OF for 2 hrs and then injected 
with 20 mg/kg COC and returned to the OF for the remaining 3 hrs. Distance moved (in 
centimeters) was analyzed in 5-min bins and the sum of the distance moved post-COC injection 
(180-360 min), referred to as area under the curve (AUC), was used to assess COC-induced 
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locomotion. Data from the CC strains was compared to data previously collected in RIX 04/17 
(N=42) and 41/51 (N=56) (see Fig 3.1a).  
 
Statistical analysis 
An ANOVA of the effects of strain and sex on AUC was performed using SPSS v24 for Mac 
OS X 10.6+. Tukey’s post hoc was used to follow-up on any significant main effects of strain. 
Graphs were generated using Graphpad Prism 7.0c for Mac OS X.  
 
F2 mapping population 
Two separate F2 populations were created. Low responding CC041 animals were 
reciprocally bred to B6N to generate CC041xB6N and B6NxCC041 F1s. These F1s were crossed 
in all combinations (CC041xB6NXCC041xB6N, CC041xB6NXB6NxCC041, B6NxCC041X 
CC041xB6N, B6NxCC041XB6NxCC041) to generate an F2 population (Fig 4.1c). High COC 
responding CC004 animals were bred to B6N animals in the same fashion to generate a 
CC004xB6N F2 population (Fig 4.2c).  
 
Phenotyping F2 populations for initial locomotor sensitivity to COC 
Table 4.1 provides the number of mice tested in each mapping population. F2 animals were 
tested using a high-throughput 3-day test in the OF arena. On Day 1 (habituation) and Day 2 
(baseline) animals were injected with saline before being placed into the OF arena for 30 mins. 
On Day 3, animals were injected with 20 mg/kg COC before being placed into the OF for 30 
mins. Distanced moved was recorded in 2-min bins for the entire test. Total distance moved on 
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Day 3-Day 2 was used to assess COC-induced locomotion. All data was transformed using a 
two-step inverse rank transformation to normality in SPSS. 
 
Genotyping 
Genotyping was performed for the CC041 X B6N F2 population. Mice were euthanized 
immediately following testing on Day 3 and DNA was extracted from tail tissue from CC041, 
B6N, F1 breeders and the F2 population using the DNeasy Blood & Tissue kit (Qiagen). 
Genotypes were determined using the Mouse Universal Genotyping Array (MUGA) that consists 
of 7851 SNP markers on an Illumina Infinium platform that are distributed throughout the 
genome (average spacing of 325 kb) and were chosen to be maximally informative and for the 
eight founder strains of the CC (Morgan et al, 2015). Nucleotide genotypes were processed and 
converted to haplotype calls (i.e. B6N, CC, or HET) for use in QTL mapping using the argyle 
package (version 0.2.0) in R Studio (Morgan, 2015). A series of genotype checks were 
performed and markers were eliminated for any of the following reasons: they were not 
informative between B6N and CC041, did not meet the Chi-square distribution of expected 
genotypes for an intercross population (showed segregation distortion) or had a large number of 
missing calls (>40). This left 2701 markers with an average spacing of 0.5 cM and maximum gap 
of 8.8 cM, ample coverage for an F2 population.  
  
QTL mapping 
QTL mapping was performed using the qtl package (version 1.40-8; (Broman, 2014; Broman 
et al, 2003) in R Studio (version 1.0.136). Single scan QTL analyses using the scanone function 
were performed for transformed total distance data for Day 1, Day 2 and Day 3 and D3-D2 
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distance. Only the autosomes were assessed as there was no difference in response between 
males with either B6N or CC041 mothers. Sex and F2 breeding cross direction were included as 
covariates. A Haley-knot regression approximation model of interval mapping was used based 
on the density of the genotyping array and the amount of recombination present in the F2 
intercross. Genome-wide significant thresholds for logarithm of the odds (LOD) scores (measure 
of genotype to phenotype association) were determined using 1000 permutations. For each QTL 
peak identified, the 1.5 LOD support interval was used and it thought to reflect the 95% 
confidence interval, or that the true QTL lies within this region 95% of the time (Dupuis and 
Siegmund, 1999). The MUGA markers closest to the outer limits of the 1.5 LOD interval was 
identified and used as the megabase (Mb) locations flanking the region (mm10, GRCm38). 
Genotype data provided by Srivastava et al (2017) was used to determine the CC parental strain 
haplotype in the 1.5 LOD intervals for each QTL. Using the fitqtl function and an equation 
assuming an additive model, y = QTL 1 + QTL 2 + QTL 3, the amount of variance explained for 
the QTL peaks of a given phenotype was estimated. 
Two scan QTL analysis using the scantwo function in R/qtl was performed for the significant 
QTLs identified for each of the measures with sex and cross direction as covariates. Both full 
(LODfv1) and additive models (LODav1), allowing for the possibility of epistasis or not, 
respectively, were fit by comparing pairs of loci on the two chromosomes to the single-QTL 
model. LODi indicates evidence for an interaction of the two loci by comparing the fit of the two 
models (LODfv1 - LODav1). LOD thresholds of 6, 4, 3 for LODfv1, LODi, LODav1 were used to 
determine a significant pair of QTLs (Gary Churchill, personal communication). Effect plots at 




Prioritizing candidate genes in QTL regions 
To prioritize genes in the QTL intervals as potential candidates we used the process outlined 
in Fig 4.6. Using the BioMart tool in Ensemble (http://www.ensembl.org/biomart/) we identified 
protein-coding, micro RNAs (miRNA) and long non-coding RNAs (lncRNA). We then used the 
Mouse Phylogeny Viewer tool (http://msub.csbio.unc.edu/, Wang et al (2012)) to identify 
regions that were identical-by-descent (IBD) between B6J and the haplotype of CC041 and 
eliminated any genes in those regions. Using multiple resources 
(https://tissues.jensenlab.org/Search; http://www.informatics.jax.org/; 
http://biogps.org/#goto=welcome; http://amp.pharm.mssm.edu/Enrichr/#find; 
https://www.ebi.ac.uk/gxa/home) we eliminated any genes not expressed in the brain. From this 
list, we prioritized any genes that contained non-synonymous SNPs or insertions/deletions 
(indels) between B6J and the CC parent haplotype in the QTL region (i.e. NOD). We used the 
Sanger Institute SNP Viewer tool (http://www.sanger.ac.uk/sanger/Mouse_SnpViewer/rel-1505) 
and limited the types of SNPs to those that were introduced or inserted a stop or were present in 
coding regions, regulatory regions, splice regions or induced missense and frameshift variants. 
From this list, we prioritized genes that met all three of the following criteria: 1) genes with 
previously-identified phenotypes that affect brain morphology or function (i.e. axon 
development, brain size, dendrite morphology, etc.), were identified as a GWAS hit for a 
psychiatric disorder or were linked with relevant behavioral phenotypes (i.e. abnormal 
locomotion, psychostimulant response, etc.); 2) genes that overlap with previously-identified 
QTL regions for initial COC locomotor response; 3) genes that show differential gene expression 
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Initial locomotor sensitivity to COC is driven by one CC parental strain for both RIX lines 
We assessed initial locomotor sensitivity to COC using the 6-hr OF test in all four CC strains 
that were used to produce the RIX lines. For RIX41/51, the low COC response line, there was a 
significant effect of strain (F(2,96)=24.8; p=2.5x10-9) with post hoc tests showing CC041 < 
RIX41/51 < CC051 (p£0.016; Fig 4.1b). For RIX04/17, the high COC response line, there was a 
significant effect of strain (F(2,78)=8.0; p=0.001) with post hoc tests showing RIX 04/17 = CC004 
> CC017 (p£0.002; Fig 4.2b). There were no effects of sex (p>0.05). The data for RIX41/51 and 
RIX04/17 were previously shown in Fig 3.1a. These data indicate that only one of the CC 
parental strains showed a similar phenotype for initial locomotor sensitivity to COC for both RIX 
41/51 and 04/17.  
 
Low locomotor response to COC in CC041 is dominant  
CC041, CC004, B6N, F1s and F2s were phenotyped in a 3-day OF test. For the low COC 
response population, the F1s showed similar response to CC041, indicating that this phenotype is 
dominant. The F2 population showed a wider range of responses, although there was a large 
proportion at the lower end of the phenotypic distribution (Fig 4.1d). For the high COC response 
population, there was a range of response in the F2 population, although very few mice showed 
the extreme response seen in CC004 (Fig 4.2d). Due to the dominant nature of the low COC 
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response, we chose to conduct QTL analysis in this population as we believed we would have 
greater power to detect causative loci than in the high responding population.  
 
QTL on Chr 7, 11 and 14 for low initial locomotor response to COC 
QTLs that passed the p<0.1 genome-wide LOD threshold based on 1000 permutations are 
shown in Table 4.2. We identified 3 significant QTL for locomotor response to COC (Day3-
Day2 distance) on Chr 7, 11 and 14 (Fig 4.3a). The QTL on Chr 7 had a peak at 17.2cM or 
29.74Mb (LOD=4.21, p=0.023) that accounted for 4.3% of the variance. The effect plot at this 
peak showed that both the CC041/CC041 and HET genotypes were driving the low COC 
response (Fig 4.3b), indicating a dominant phenotypic effect at this locus similar to that observed 
in the parental and F1 populations (see Fig 4.1d). The LOD interval (27.5-40.3 Mb) of the Chr 7 
peak is 12.8 Mb and contains 203 protein-coding genes. CC041 has a NOD haplotype that 
transitions to NZO at approximately 36.05Mb in this interval. The QTL on Chr 11 had a peak at 
14.3cM or 20.98Mb (LOD=6.54, p=0.001) and accounted for 6.1% of the variance. The effect 
plot at this peak showed that the B6N/B6N genotype was driving the low COC response (Fig 
4.3c) indicating that this is a transgressive QTL (see Fig 4.1d). The LOD interval (12.6-37.7Mb) 
of the Chr 11 peak is 25.1 Mb and contains 106 protein-coding genes. CC041 has a NOD 
haplotype that transitions to a WSB haplotype at approximately 36.8 Mb. The Chr 14 QTL had a 
peak at 42.7cM or 79.67Mb (LOD=3.88, p=0.051) that accounted for 4% of the variance. The 
effect plot at this peak showed that the CC041/CC041 genotype was driving the low COC 
response (Fig 4.3d). The LOD interval (9.1-97.4) on Chr 14 was very large spanning most of the 
chromosome (88.3 Mb) due to the appearance of multiple peaks towards the proximal end (see 
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Fig 4.3a), therefore we did not perform follow-up analysis of potential candidate genes in this 
region.  
Single QTL analysis of Day 1, Day 2 and Day 3 distance revealed several overlapping 
regions (Table 4.1, Fig 4.4). Interestingly, a peak on Chr 11 was identified for all days in similar 
locations to the peak identified for COC locomotor response (peaks at 30.88 or 35.7 Mb 
compared to 20.9 Mb) and in every case, the B6N/B6N genotype was associated with the low 
response. A QTL peak on Chr 7 was identified for Day 2 and Day 3 distance with the Day 3 peak 
being the same as the one identified for Day 3-Day 2 and in every case, the CC041/CC041 and 
CC041/B6N genotypes was associated with low response. A QTL peak on Chr 14 was identified 
for Day 1 and Day 3 with the Day 3 peak being the same as the one identified for Day 3-Day 2 
and in all cases only the CC041/CC041 genotype showed the low response. Two separate QTLs 
on Chr 6 were specific to non-COC exposures on Day 1 (peak at 97.0 Mb) and Day 2 (peak at 
37.0 Mb). For both Chr 6 QTL, the CC041/CC041 genotype was associated with low locomotor 
response. A QTL on Chr 2 (peak at 152.7 Mb) was unique for the Day 3 distance phenotype with 
the CC041/CC041 genotype driving the low response.  
Collectively, the single scan QTL analysis in the low responding population indicates that 
QTL identified are associated with locomotor phenotypes on multiple days in the 3-day OF test, 
a finding that could be due to the significant correlation among the phenotypes (Table 4.3). 
Pearson correlation showed that Day 1, Day 2, Day 3 and Day 3-Day 2 distance were all 
significantly correlated (r(6)=0.31-0.99; p£1x10-15). The strongest correlation was observed 




Two-locus analysis shows additive effect of QTLs for low COC response   
Most complex traits, such as initial drug sensitivity, are thought to be due to the action of 
multiple genetic loci, some of which may act in concert to affect the phenotype. Therefore, we 
performed a two-locus analysis to determine if the QTLs identified in the single scan are linked 
and if so, in what manner (i.e. additive or epistasis). For each phenotype, only the chromosomes 
with significant QTLs in the single scan were analyzed. Table 4.4 shows all loci that met the 
threshold in either a full model (allows for possibility of epistasis; LODfv1 ≥ 6.0) or additive 
model (assumed no epistasis; LODav1 ≥ 3.0).  
For Day3-Day2, we found strong evidence for an interaction among a pair of QTL at the 
same location identified in the single scan analyses on Chrs 7 and 11 at 29.74 and 20.98 Mb, 
respectively. The presence of a homozygous B6N genotype on Chr 11 results in low response to 
COC independent of their genotype on Chr 7 (Fig 4.5a). There was also evidence for an 
interaction between QTL on Chrs 7 and 14 at 29.74 and 79.67 Mb, respectively (Fig 4.5b). There 
was also evidence for interaction between a pair of QTL on Chrs 11 and 14 at 20.98 and 79.67 
Mb, respectively (Fig 4.5c). Collectively, the findings presented here and in Table 4 support the 
idea that the QTLs identified in the single scan analysis are linked and act in a predominantly 
additive manner to contribute to the low locomotor response to COC seen in CC041.  
 
Prioritization of interesting candidate genes at Chr 7 and 11 QTL regions 
The strategy outlined in Fig 4.6 was used to identify potential candidate genes for COC 
locomotor response at the QTL regions on Chr 7 and 11. The 12.8 Mb QTL region on Chr 7 
contained 203 protein-coding genes. 63 of these genes were in regions of IBD between B6N and 
the CC parental strain (NOD or NZO) and were eliminated from our priority list of candidates. 
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124 genes in the interval are expressed in the brain. From those 124, we prioritized the 54 that 
had a deleterious SNP or indel present. From this list, we then identified genes that met all three 
of the criteria described above. Five genes met all criteria: Chst8, Pepd, Slc7a10, Ankrd27, and 
Dpy19l3 are discussed below as potential candidates.  
The Chr 11 QTL interval contained 106 protein-coding genes, all of which were 
expressed in the brain. 45 genes contained either a nonsynonymous SNP or indel. Using the 
same criteria described above, we identified six genes that met our three criteria for inclusion as 
candidates: Xpo1, Ccdc88a, Rtn4, Hba-a1, Slit3, and Rars.  
 
DISCUSSION 
In this study, we used an F2 intercross of a traditional inbred mouse strain (B6N) and a CC 
strain (CC041) to map three QTLs on Chr 7, 11 and 14 that are involved in locomotor response 
to COC. The association between genotype and phenotype on Chr 7 best matches the mode of 
inheritance observed in the analyses of the parental lines, F1 and F2 populations. Interestingly, at 
the Chr 11 region, we made the observation that the B6N genotype was responsible for low COC 
response. All three QTL are acting in an additive manner, although there is also evidence for an 
epistatic interaction of allelic status at Chr11 with both the Chr 7 and 14 loci. Using a 
bioinformatics approach, we identified potential candidate genes in the Chr 7 and Chr 11 regions 
that could be mediating low COC locomotor response. Below we compare our QTL regions to 





Previous QTL studies for initial COC locomotor response 
Several previous studies have performed QTL mapping for initial locomotor response to 
COC, mostly using a panel of RI strains (Boyle et al, 2001; Boyle et al, 2009; Gill et al, 2003, 
2008; Jones et al, 1999; Miner et al, 1995; Phillips et al, 1998; Tolliver et al, 1994). Three 
studies assessing initial COC locomotor response identified regions that overlap with our QTL 
regions on Chr 7 and 11. A study by Gill et al (2003) used males and females from 36 strains of 
AcB/BcA which are congenic strains with small regions of B6J (B) introgressed on an A/J (A) 
background or small regions of A/J introgressed on a B6J background. This study identified 
several QTLs associated with initial COC locomotor response including one on Chr 7 (peak at 
26.5 cM or 51.7 Mb) for which increased COC response was driven by the B6J donor allele. This 
study did not include a QTL interval since associations of genotype and phenotype were done by 
correlation rather than interval mapping. However, using a 25 Mb region around the peak at 51.7 
Mb gives us a QTL region of 33.2-76.9 Mb which overlaps with the proximal end of our Chr 7 
region. Tolliver et al (1994) used males from 16 BXD strains and identified multiple significant 
loci including one on Chr 11 (peak at 5 cM or 12.3 Mb) where the B6J genotype was associated 
with higher COC response than DBA genotype. QTL intervals were not used at this time either, 
but using the 25 Mb region around the peak gives us a QTL region of 0-33.4 Mb which overlaps 
with our Chr 11 region. Another study by Jones et al (1999) used males and females from 26 
BXD strains to assess initial COC locomotor response, COC-related behaviors (center time, 
nosepokes, repeated movements) and D1R, D2R and DAT densities in the brain. They identified 
several QTL for COC-related behaviors where the B6J genotype was associated with increased 
COC response on Chr 11 (peaks 2-11 cM or 12.3-19.7 Mb), which overlaps with our Chr 11 
region and the region observed by Tolliver et al (1994). 
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Two additional studies identified significant QTL in close proximity to ours. A study by 
Kumar et al (2013) used an F2 intercross of two B6 substrains, B6N and B6J, and identified a 
QTL peak on Chr 11 (1.5 LOD interval 35-57 Mb). Within this region, they identified a variant 
in the Cyfip2 gene as the causative SNP for the low locomotor response to COC in B6N mice. 
While Cyfip2 does not fall within the 1.5 or 2.0 LOD interval of our Chr 11 QTL, we cannot rule 
out the possibility that the Cyfip2 gene is causing the B6N-driven low COC response we 
observed. The B6N variant of Cyfip2 has also been identified as a causative gene in a QTL 
mapping study of binge-eating behavior in mice (Kirkpatrick et al, 2017) indicating that Cyfip2 
may be modulating a phenotype associated with multiple psychiatric disorders (i.e., behavioral 
disinhibition).  
A study by Dickson et al (2016) performed QTL mapping for intravenous self-administration 
(IVSA) of COC using males and females from 44 BXD strains. While IVSA behaviors are not 
the same as initial locomotor response, it was interesting that the two QTL regions they 
identified for IVSA dose response curves were on Chr 7 (30.4-30.6 Mb) which is within our 
region and Chr 11 (46.18-50.57 Mb) which is slightly outside our region but does contain Cyfip2 
as candidate gene. For both QTL, the B6J genotype showing higher and more consistent COC 
infusions at lower doses of COC compared to animals with the DBA genotype. They also 
performed a eQTL using gene expression from midbrain tissue and found that Fam53b (located 
on Chr 7 at 139.9 Mb) had a trans-eQTL that overlapped with the Chr 11 QTL region. FAM53B 
was previously identified as a candidate in a human GWAS for COC dependence (Gelernter et 
al, 2014). Furthermore, they showed a correlation between the expression of Fam53b and 




Potential candidate genes controlling locomotor response to COC 
We wanted to prioritize potential candidate genes within each of the QTL regions. Previous 
studies have used a variety of techniques to prioritize candidate genes including pre-existing 
knowledge about the function of genes in relation to the drug’s effects (i.e. genes involved in the 
dopaminergic system), genes with SNPs between the two parental strains of the mapping cross, 
and correlation with gene expression changes. We employed a variety of these and additional 
tools to propose five potential candidate genes in the Chr 7 region (Chst8, Pepd, Slc7a10, 
Ankrd27, Dpy19l3) and six potential candidate genes in the Chr 11 region (Xpo1, Ccdc88a, Rtn4, 
Hba-a1, Slit3, and Rars). We briefly discuss why we believe each gene is a potential candidate 
and might warrant further investigation. 
Chst8 (carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8) has been shown to be 
differentially expressed in the hippocampus (Hipp) and prefrontal cortex (PFC) of mice exposed 
to chronic COC and in postmortem tissue from COC addicts (Farris et al, 2015; Krasnova et al, 
2008). A SNP in Chst8 was also identified in a human GWAS for antipsychotic regulation of 
working memory in schizophrenia patients (McClay et al, 2011). Additionally, Chst8 knockout 
(KO) mice show overall hypoactivity, possibly indicating an alteration in the underlying circuity 
for activity which includes dopamine (MGI:1916197). Collectively, Chst8 is a good potential 
candidate due to its differential expression after COC exposure in brain tissue from mice and 
humans, its association with the mechanisms of antipsychotic drugs and its effect on overall 
activity in mice. 
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Pepd (peptidase D) plays a key role in recycling of the amino acid proline. Pepd is a potential 
candidate gene as chronic COC exposure can alter its gene expression in the brain (Krasnova et 
al, 2008) and mice lacking Pepd show abnormal brain morphology (MGI:2683289).  
Slc7a10 (solute carrier family 7, cationic amino acid transporter, y+ system member 10) is a 
transmembrane transporter for small neutral amino acids. Slc7a10 has been shown to be 
differentially expressed in the brain after chronic exposure to COC (Krasnova et al, 2008) and 
Slc7a10 KO mice show multiple neuro-related abnormalities including overall hypoactivity, 
seizures, ataxia, spontaneous tremors, and abnormal synaptic transmission (Xie et al, 2005). 
Collectively, this indicates that Slc7a10 has an effect on multiple movement-related phenotypes 
and therefore is a potential candidate for follow-up analysis.  
Ankrd27 (ankyrin repeat domain 27) serves as a guanine-exchange factor (GEF) that acts on 
the GTPase, Rab21, to influence neurite outgrowth (Burgo et al, 2009). Ankrd27 has been shown 
to be epigenetically dysregulated in Hipp tissue from COC addicts (Farris et al, 2015). Ankrd27 
KO mice display abnormal motor capabilities, coordination, and movements (MGI:211773). Due 
to the widespread action of GEFs within the brain, previous connections to movement-related 
phenotypes and evidence from human studies of COC addicts, Ankrd27 is a potential candidate 
gene for follow-up studies. 
Dpy1913 (dpy-19-like 3) was selected as a potential candidate gene due to previous 
identification in a human GWAS for a psychiatric disorder, Bipolar Disorder, and as a gene that 
is epigenetically dysregulated in the NAc after exposure to chronic COC in mice (Renthal et al, 
2007; Smith et al, 2009). Additionally, there is evidence that Dpy1913 is involved in 
development of glutamatergic neurons and glutamate has been shown to play a role in addiction 
(Koob et al, 2010; Watanabe et al, 2011). 
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Xpo1 (exportin 1) is a nuclear export protein that is a popular target for cancer treatments as 
it has wide-spread actions within the body. In humans, it is known to be involved in the 
2p15p16.1 microdeletion syndrome that presents with many autistic features. The XPO1 protein 
was identified by meta-analysis to be associated with psychiatric disorders (Bagheri et al, 2016; 
Zhao et al, 2016). Xpo1 has also been identified as differentially regulated by chronic exposure 
to COC in the PFC, Hipp and NAc of mice (Krasnova et al, 2008; Renthal et al, 2009).  
Ccdc88a (coiled coil domain containing 88A) was identified as a potential candidate gene for 
multiple reasons. KO mice display multiple neuro-related phenotypes including hypoactivity, 
impaired learning and memory, impaired sensorimotor gating and abnormal dendritic spine 
morphology and synaptic transmission (Nakai et al, 2014). In humans, Ccdc88a is involved in 
PEHO syndrome in which patients present with severe mental retardation and epileptic seizures 
(Nahorski et al, 2016). Ccdc88a has also been shown to be downregulated by CREB, a key 
transcription factor in the rewarding effects of repeated drug exposure (McClung and Nestler, 
2003).  
Rtn4 (reticulon 4) was selected as a potential candidate gene due to its known involvement in 
axonal outgrowth, cell migration and synaptic plasticity (Su et al, 2008; Sui et al, 2015). 
Additionally, Rtn4 was shown to be differentially expressed in mice exposed to chronic COC 
(Krasnova et al, 2008; Renthal et al, 2007) and epigenetically dysregulated in the Hipp of COC 
addicts (Farris et al, 2015).  
Hba-a1 (hemoglobin alpha, adult chain 1) is a potential candidate gene due to studies that 
shown that its gene expression can be regulated by exposure to stress (Stankiewicz et al, 2015; 
Stankiewicz et al, 2014), which is thought to play a key role in the development and maintenance 
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of SUDs (Koob, 2008). Additionally, Hba-a1 expression is dysregulated in the NAc of mice 
exposed to chronic COC (Feng et al, 2014).  
Slit3 (slit homolog 3) was selected as a candidate gene due to its known role in axon 
guidance during brain development. A SNP in Slit3 was also identified in GWA studies for 
psychiatric disorders, including MDD and Schizophrenia, further supporting its role in the brain 
(Glessner et al, 2010; Shi et al, 2004). Slit3 was also identified as epigenetically dysregulated in 
the NAc of mice exposed to chronic COC (Renthal et al, 2007).  
Rars (arginyl-tRNA synthetase) is a key player in myelination and is known to be involved in 
human disorders of hypomyelination (Wolf et al, 2014). Rars has been shown to be differentially 
regulated in the Hipp and PFC of mice exposed to chronic COC and in the Hipp of COC addicts 
and alcoholics (Farris et al, 2015; Krasnova et al, 2008). Due to the critical role of myelination in 
synaptic transmission and it differential expression by COC, we prioritized Rars as a candidate 
gene for follow-up studies. 
 
Reflections on the generation of the QTL mapping population 
One unexpected finding was the large QTL on Chr 11 in which the low response to COC was 
driven by the B6N allele and not the CC041 allele. This is surprising given the data the CC041 
mice show lower COC response than B6N (see Fig 4.1d). We chose to cross CC041 to B6N as it 
is closely related genetically to B6J, which is one of the eight founder strains of the CC and 
therefore, would not introduce an entirely new genetic background in with the already 
genetically diverse background of the CC strain. However, investigation of the founder 
contribution in CC041 revealed that there was only 0.05% B6J present. Consequently, we did 
introduce an entirely new genetic background including allelic combinations that would not have 
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been present in this particular CC strain, making the transgressive nature of the Chr 11 QTL less 
surprising. Identification of causative variants in the Chr 11 region are clearly contributing to 
low response to COC, however this variant is likely not responsible for the phenotypic effect 
observed in CC041. Future studies are needed to investigate the Chr 11 locus to determine if it is 
Cyfip2 or something regulating (i.e. gene expression) or physically linked to Cyfip2, and how 
that gene is interacting with the loci on Chr 7 and 14. Additionally, studies are needed to narrow 
the identified QTL regions to reduce the number of potential candidate genes and/or validate the 
potential candidate genes that we prioritized. 
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Table 4.1: Number of mice phenotyped in COC mapping populations 
Population Generation Cross # F # M Total 
Cocaine low 
response 
F0 CC041/TauUnc (CC041) 12 12 24 
 C57BL/6NJ (B6N)* 11 13 24 
F1 B6NxCC041 13 13 26 
 CC041xB6N 11 12 23 
    49 
F2 B6NxCC041 X B6NxCC041 58 62 120 
 CC041xB6N X CC041xB6N 59 53 112 
 CC041xB6N X B6NxCC041 66 63 129 
 B6NxCC041 X CC041xB6N 37 50 87 




F0 CC004/TauUnc (CC004) 11 14 25 
 C57BL/6NJ (B6N)* 11 13 24 
F1 B6NxCC004 9 8 17 
 CC004xB6N 9 10 19 
    36 
F2 B6NxCC004 X B6NxCC004 38 39 77 
 CC004xB6N X B6NxCC004 38 39 77 
 CC004xB6N X CC004xB6N 38 40 78 
 B6NxCC004 X CC004xB6N 39 38 77 






Table 4.2. QTL regions identified in the 3-day open field test   
  Chr Position (cM) 
Position 













6 44.9 97.01 backupUNC060149691 6.39 0.001 51.5-111.7 60.2 CC041 CC 
11 21.2 35.74 UNC111423133 4.03 0.033 18.0-70.8 52.8 B6N DD/HH 
14 43.5 84.63 JAX00385742 6.66 0.001 73.3-94.6 21.3 CC041 FF 
             
Day 2 
Distance 
6 15.9 37.09 backupUNC060073738 5.45 0.001 21.9-111.7 89.8 CC041 CC 
7 16.9 28.90 UNC070790469 3.79 0.061 4.0-41.5 37.5 CC041 DD/EE/DD 
11 21.2 35.74 UNC111423133 5.12 0.002 21.7-51.5 29.8 B6N DD/HH 
             
Day 3 
Distance 
2 75.3 152.70 UNC020230950 3.71 0.075 141.5-180.8 39.3 CC041 HH/CC/EE 
7 17.2 29.74 UNC070628845 6.28 0.001 27.5-37.9 10.4 CC041 DD/EE 
11 18.2 30.88 backupJAX00025840 9.31 0.000 18.0-38.5 20.5 B6N DD/HH 
14 42.7 79.67 backupUNC140618860 4.34 0.015 12.6-97.1 84.5 CC041 DD/CC/FF 
             
D3-D2 
Distance 
7 17.2 29.74 UNC070628845 4.21 0.023 27.5-40.3 12.8 CC041 DD/EE 
11 14.3 20.98 UNC111412965 6.54 0.001 12.6-37.7 25.1 B6N DDHH 
14 42.7 79.67 backupUNC140618860 3.88 0.051 9.1-97.4 88.3 CC041 DD/CC/FF 
All QTL regions above the suggestive genome-wide threshold (p=0.01) using 1000 permutation for phenotypes in the 3-day open field 
test in the low-cocaine responding F2 population. Decreasing allele indicates the genotype associated with the lowest phenotype 
(CC041 = CC041/TauUnc; B6N = C57BL/6NJ). Collaborative Cross (CC) parental strain haplotype in QTL region is indicated by CC 
(129S1/SvlmJ), DD (NOD/ShiLtJ), EE (NZO/HlLtJ), FF (CAST/EiJ), HH (WSB/EiJ). Chr = chromosome; cM = centimorgan; Mb = 




Table 4.3: Correlation of locomotor behavior in the 3-day open field test for the low COC 
response F2 population 
Phenotypes r p 
Day 1 Day 2 0.764 7.2x10-87 
Day 1 Day 3 0.424 5.1x10-21 
Day 2 Day 3 0.518 4.0x10-32 
Day 1 Day 3-Day 2 0.311 1.7x10-11 
Day 2 Day 3-Day 2 0.366 1.2x10-15 





Table 4.4. Two scan QTL results for the low COC response population 
    
Full Model  
(allows for interaction)   
Additive Model 
(no interaction allowed) 








2 (Mb) LODav1 
  Threshold     6.0 4.0     3.0 
Day 1 
Distance 
Chr6:Chr11 71.06 31.50 6.4 2.8 97.01 35.74 3.6 
Chr6:Chr14 71.06 84.63+ 8.0 1.6 85.82 84.63+ 6.4 
Chr11:Chr14 36.50+ 84.63+ 4.8 0.8 36.50+ 84.63+ 4.0 
             
Day 2 
Distance 
Chr6:Chr7 105.06 39.67 4.3 0.6 37.09 28.90 3.7 
Chr6:Chr11 37.09+ 35.74+ 6.4 1.6 37.09+ 35.74+ 4.8 
Chr7:Chr11 28.90+ 35.74+ 4.7 0.4 28.90+ 35.74+ 4.2 
             
Day 3 
Distance 
Chr2:Chr7 164.19 29.74+ 5.5 1.2 152.70 29.74+ 4.2 
Chr2:Chr11 171.55 29.64 6.0 1.7 152.70 30.88 4.3 
Chr2:Chr14 152.70 78.22 4.7 0.3 163.21 79.67 4.3 
Chr7:Chr11 29.74+ 20.98 7.9 1.0 29.74+ 35.73 6.9 
Chr7:Chr14 29.74+ 79.67+ 5.5 0.4 29.74+ 79.67+ 5.1 
Chr11:Chr14 29.64 81.00 6.6 2.0 20.98 78.22 4.6 




Chr7:Chr11 29.74+ 20.98+ 6.1 1.8 29.74+ 20.98+ 4.3 
Chr7:Chr14 36.76 26.48 4.7 0.3 29.74 79.67 4.4 
Chr11:Chr14 20.98+ 72.60 5.8 1.7 20.98+ 79.67 4.0 
Gray shading indicates LOD scores that passed a lenient significance threshold. LODfv1 = 
comparing full model with QTL on the two chromosomes (ChrPos1:Pos2) to the single-QTL 
model, indicates evidence for a second QTL, allowing for the possibility of epistasis; LODav1 = 
comparing additive model with QTL on the two chromosomes (ChrPos1:Pos2) to the single-QTL 
model, indicates evidence for a second QTL, assuming no epistasis. LODi = improvement in fit 
of full model over additive model (LODfv1 - LODav1), indicates evidence for interaction; 




Figure 4.1. Low initial locomotor response to cocaine in CC041 
	
	
(a) RIX 41/51 is a F1 hybrid of CC041 and CC051, which are RI strains containing the genome 
of six inbred strains (color blocks). (b) Both CC parental strains and RIX 41/51 were phenotyped 
for initial locomotor response to cocaine (20 mg/kg), measured at the area under the curve 
(AUC) or total distance moved in the 3 hrs post-injection in a 6-hr open field test. There was a 
significant effect of strain (p=2.5x10-9) with post hoc showing CC041 < RIX41/51 < CC051 
(*p<0.05, **p<0.01, ***p<0.001). (c) To map low COC initial locomotor response, a reciprocal 
cross of CC041 to C57BL/6NJ (B6N) was made. F1s were then crossed in all combinations to 
generate an F2 population. (d) CC041, B6N, F1s and F2s (Ns=24, 24, 49, 448) were phenotyped 
in a 3-day open field test to assess initial cocaine response, measured as Day 3 (20 mg/kg 






























































Figure 4.2. High initial locomotor response to cocaine in CC004 
	
(a) RIX 04/17 is a F1 hybrid of CC004 and CC017, which are RI strains containing the genome 
of eight inbred strains (color blocks). (b) Both CC parental strains and RIX 04/17 were 
phenotyped for initial locomotor response to cocaine (20 mg/kg), measured at the area under the 
curve (AUC) or total distance moved in the 3 hrs post-injection in a 6-hr open field test. There 
was a significant effect of strain (p=0.001) with post hoc showing RIX 04/17 = CC004 > CC017 
(**p<0.01, ***p<0.001). (c) To map low COC initial locomotor response, a reciprocal cross of 
CC004 to C57BL/6NJ (B6N) was made. F1s were then crossed in all combinations to generate 
an F2 population. (d) CC004, B6N, F1s and F2s (Ns=25, 24, 36, 309) were phenotyped in a 3-
day open field test to assess initial cocaine response, measured as Day 3 (20 mg/kg cocaine) 
































































Figure 4.3. Significant QTLs on Chr 7, 11 and 14 for for Day 3- Day 2 distance moved in the 
low COC responding F2 population 
	
(a) Single scan QTL for initial COC response measured as Day 3 (20 mg/kg cocaine) minus Day 
2 (saline). Genome-wide significant LOD thresholds based on 1000 permutations for p=0.001 
(red line), p=0.01 (green line), p=0.05 (blue line), and suggestive at p=0.1 (black line). (b) Chr 7 
had a peak at 29.74Mb (LOD=4.21; p=0.023; LOD interval=27.5-40.3 Mb) with both the 
CC041/CC041 and HET genotypes driving low COC response. (c) Chr 11 had a peak at 
20.98Mb (LOD=6.54; p=0.001; LOD interval=12.6-37.7Mb) with B6N/B6N genotype driving 
low COC response. (d) Chr 14 had a peak at 79.67Mb (LOD=3.88; p=0.051; LOD interval=9.1-






















































































































Figure 4.4. Significant QTLs for Day 1, 2 and 3 distance moved in the low COC responding F2 
population 
	
Single scan QTL for Day 1 (saline; black line), Day 2 (saline; blue line) and Day 3 (20 mg/kg 
cocaine; red line) distance moved. Genome-wide significant LOD thresholds based on 1000 
permutations for p=0.001 (red line), p=0.01 (green line), p=0.05 (blue line), and suggestive at 
p=0.1 (black line). A peak on Chr 11 was present for all three days. A QTL peak on Chr 7 was 
identified for Day 2 and Day 3 and a peak on Chr 14 was present for Day 1 and Day 3. QTLs on 
Chr 6 were specific to non-COC exposures days (Day 1 and 2) and a QTL on Chr 2 was unique 











Figure 4.5. Paired loci at QTLs on Chr 7, 11, and 14 for Day 3– Day 2 locomotion 
	
(a) Evidence for a pair of QTL on Chr 7 at 29.74 Mb and Chr 11 at 20.98 Mb in both full or 
additive (Add) model (LODfv1= 6.1, LODav1=4.3); B6N/B6N genotype on Chr 11 shows low 
response independent of genotype on Chr 7. (b) Evidence for a pair of QTL on Chr 7 at 29.74 
Mb and Chr 14 at 79.67 Mb only in the additive model (LODav1=4.4). (c) Evidence for a pair of 
QTL on Chr 11 at 20.98 Mb and Chr 14 at 79.67 Mb only in the additive model (LODav1=4.0); 































































































































Figure 4.6. Strategy for identifying potential candidate genes within QTL regions 
	
For Chr 11 and Chr 7 QTL regions we used the following strategy to identity potential candidate 
genes. Using the BioMart tool, we identified a list of protein-coding genes, lncRNA, and 
miRNAs. From this list, we eliminated any that were in a region of IBD between B6J and the CC 
parental strain using the Mouse Phylogeny Viewer. We then eliminated any genes not expressed 
in the brain. We then prioritized genes that had a nonsynonymous SNP between B6J and the CC 
parental strain, specifically targeting SNPs in coding sequence, splice regions, stop regions, 
regulatory regions, frameshift and missense using the Sanger Institute SNP Viewer tool. From 
this list, we then prioritized genes that met all three of the following criteria: previously 
identified with a phenotype of interest (i.e. brain structure/function or behavioral); expression 
differentially regulated by COC (using www.GeneWeaver.org); region that overlapped with 
previous QTL studies for initial COC-induced locomotion. 
	
1.5 Interval of QTL Region(s) 
Protein-coding gene/transcripts, miRNA or 
lncRNA within interval 
Eliminate regions of IBD between CC 
parental strain & B6J 
Eliminate genes not expressed in 
the brain 
Genes with deleterious SNP 
• Genes in a GWAS for 
psychiatric disorder or 
phenotypes of interest 
(behavior, brain 
function/ structure)	
• Genes w/ differential 
gene expression after 
acute/repeated COC	
• Genes in COC-
locomotor QTL regions 
from other studies	
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CHAPTER 5: GENERAL DISCUSSION 
 
Conclusions of my Thesis Research 
The work presented in this thesis utilized a relatively new recombinant mouse population, the 
Collaborative Cross (CC), to study complex behaviors. In Chapter 2, I studied the effects of 
genetic background, parent-of-origin (PO) and perinatal nutrition, as well as interactions among 
the three on stress response and anxiety- and depressive-like behaviors in adult F1 hybrids of CC 
strains (Recombinant Inbred Intercross, RIX). We found that perinatal diet exposure interacted 
with genetic background to affect anxiety-like behavior and stress response. We also found PO 
effects on multiple phenotypes that were dependent on genetic background. In Chapter 3, I 
characterized addiction-related behaviors to cocaine (COC) in two of these RIX lines (RIX 04/17 
and 41/51) that I identified as phenotypic outliers for novelty-induced locomotion. RIX 04/17 
and 41/51 exhibited divergent initial COC locomotor response and this phenotypic difference 
was not due to COC metabolism, hypothalamic-pituitary-adrenal (HPA) axis dysregulation or 
dopamine (DA) dynamics in the nucleus accumbens (NAc). In Chapter 4, I performed genetic 
mapping of initial COC response and determined that low initial sensitivity to COC present in 
RIX 41/51 was driven by the CC041/TauUnc parent strain and has a dominant mode of 
inheritance. I identified three significant quantitative trait loci (QTL) on Chr 7, 11 and 14 and 
used a bioinformatics approach to identify potential candidate genes for follow-up studies.   
Below, I discuss my views on the following topics in the field of behavioral genetics: the 
utility of the CC population to study complex behaviors; the necessity to consider genetic 
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background when selecting rat or mouse models for behavior or physiological experiments; the 
challenges and need for improvement in identification and validation of genetic variants 
controlling complex behaviors; and a systems-level approach to the way we study addiction-
related behaviors based on the notion that there are multiple pathways to development of a SUD. 
 
Utility of the Collaborative Cross Population for Studying Complex Behaviors 
The CC was designed to enable a system genetics approach to study complex traits as a panel 
of recombinant inbred (RI) strains with increased allelic diversity and low levels of linkage 
disequilibrium (Churchill et al, 2004; Collaborative Cross, 2012; Threadgill et al, 2012). The 
ability to perform system genetics is directly related to the number of CC strains available and 
the range of observed phenotypes. The original design of the CC population described 
production of 1000 strains, yet only 75 strains are currently available for distribution at an inbred 
status (csbio.unc.edu/CCstatus/index.py). During the construction of the CC, breeding and 
logistical issues arose resulting in high levels of extinction in pre-CC lines (Chesler et al, 2008; 
Iraqi et al, 2008; Welsh et al, 2012) A recent study of ~350 extinct CC strains showed that male 
infertility played a major role in extinction and is thought to be due to incompatibilities of 
crossing inbred strains from the different Mus musculus subspecies (Shorter et al, 2017). Despite 
these breeding difficulties, I believe the 75 available strains will still provide significant genetic 
and phenotypic expansion to existing inbred mouse strains based on the results from the studies 
described below.  
Studies using the eight CC founder strains, pre-CC lines, CC strains, and various F1s have 
proven to provide increased phenotypic range for a variety of complex traits including: 
symptoms and susceptibility for viral and bacterial infections (Ferris et al, 2013; Gralinski et al, 
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2015; Rasmussen et al, 2014; Vered et al, 2014), bone microarchitecture (Levy et al, 2015), 
chemical metabolism (Mosedale et al, 2017; Venkatratnam et al, 2017); immune system 
(Phillippi et al, 2014), and susceptibility to melanoma (Ferguson et al, 2015). Additionally, the 
increase in diversity has provided new insights among previously established correlations of 
phenotypes. Furthermore, they have provided novel mouse models for disease states seen in 
humans that are not present in traditional mouse lines such as Ebola hemorrhagic fever 
symptoms and spontaneous colitis (Rasmussen et al, 2014; Rogala et al, 2014).  
QTL analyses were performed in several of the studies mentioned above and relatively small 
regions containing a feasible numbers of candidate genes were identified (Ferris et al, 2013; 
Gralinski et al, 2015; Levy et al, 2015; Philip et al, 2011; Vered et al, 2014). Of note, most of 
these studies were conducted on large panels of pre-CC lines or F1s of these lines and the ability 
to successful map small QTL intervals exclusively in the 75 currently available strains is less 
documented as all of these strains reaching inbred status is relatively new.  
The CC population offer several other advantages including publicly available dense 
genotyping for mapping, eliminating the need to perform genotyping in a mapping study using 
CC strains. DNA sequences and tools for genetic analysis including SNPs analysis and haplotype 
reconstructions are also available (Morgan et al, 2015; Srivastava et al, 2017). Additional data 
being generated, such as gene expression levels in brain tissue will also add in the ability to map 
eQTLs or investigate candidate genes in mapping studies using CC strains. Therefore, I believe 
the CC are a valuable resource to further our knowledge of complex traits such as addiction-
related behaviors allowing for elucidation of the genetic relationship among phenotypes and 
identification of candidate genes. The data presented in Chapter 3 and 4 are the first to 
characterize CC strains and RIX of CC strains for addiction-related behaviors. To date, 
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behavioral analysis of CC strains has been published for rotarod performance (Mao et al, 2015), 
locomotor activity in the OF, and sleep behavior (Philip et al, 2011). More studies are needed to 
further characterize the currently available CC strains for neurobehavioral phenotypes.  
 
Consideration of Genetic Background in Studies of Complex Behaviors  
Studies comparing multiple inbred strains of mice have clearly shown a role of genetics to 
influence anxiety- and depressive-like behavior (O’Leary et al, 2013; Schoenrock et al, 2016; 
Can et al 2011; Liu et al 2001; Bothe et al 2005; Miller et al 2010), stress response (Trullas et al 
1993), and addiction-related behaviors (Wiltshire et al, 2015; Thomsen et al, 2011; Eisener-
Dorman et al 2011). Additionally, studies have shown that the relationship between behaviors 
differs across genetic background (Thomsen et al, 2011). These studies in combination with the 
data presented Chapter 2 and 3 further support the consideration of genetic background when 
selecting a mouse line for behavioral or physiological experiments. This is not to say that some 
underlying mechanisms of these behaviors are not shared among all genetic backgrounds. 
However, if we limit ourselves to behavioral research in only one genetic background, we might 
come to the wrong conclusions about relationships between behaviors (i.e. initial COC 
locomotor response and COC CPP; see Fig 3.3b) or the mechanisms underlying a specific 
phenotype (i.e. DA release in the NAc and COC locomotion; see Fig 3.4).  
Phenotyping numerous strains is a costly endeavor both in time and money. However, due to 
the stable genetic background of inbred mouse strains, a specific strain only needs to be 
phenotyped once (although, validation across multiple laboratories is ideal). The Mouse 
Phenome Database (MPD; https://phenome.jax.org), curated by The Jackson Laboratory, is a 
resource that contains thousands of datasets for a wide range of phenotypes in various 
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populations (i.e., RIs, classical inbred strains, CC, F1 of strains, etc). Resources like the MPD 
allow for comparison across studies to obtain a more complete picture of the phenotypes 
associated for a given strain, so that researchers can select the appropriate strain(s) for addressing 
their specific research question. 
One current limitation in the field is the small number of genetic backgrounds used for 
generation of transgenic mice (i.e., reporter lines, cre-lines, etc) that have proven valuable for 
furthering our knowledge of complex behaviors. Most of the commonly used transgenic lines in 
behavioral neuroscience are in substrains of C57BL/6, 129, and FVB (see www.jax.org/jax-
mice-and-services). Depending on the phenotype of interest, this may not be problematic, 
however, there is an overall need for more genetic diversity in commonly used transgenic lines 
for mechanistic studies (i.e. circuitry and electrophysiology in vivo and slice preparations). I 
believe that generating common transgenic lines (i.e., targeting 5-HT, GABA, Glutamate, DA 
neuronal types) in a variety of genetically divergent inbred strains, including the inbred strains 
used to generate the CC (A/J, NOD, NZO, PWK, CAST, WSB) would greatly enhance our 
ability to consider genetic background in experimental designs and would increase the 
attractiveness and feasibility of using the CC and its companion population, the Diversity 
Outbred (DO), to study neuroscience-related phenotypes. 
 
Future Directions for the Field of Behavioral Genetics for Gene Identification 
The field of behavioral genetics has used various approaches to identifying genes that are 
associated with complex behaviors. In humans and rodents, GWAS and QTL experiments are 
commonly used approaches designed to allow for unbiased identification of causative genes. 
While reviewing the QTL literature for COC-related behaviors, it was striking to find that while 
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there are have been numerous QTL regions identified over the past 20 years, very few studies 
have led to the identification of causative variants and even fewer have validated candidate 
variants. Instead, like the QTL data I presented in Chapter 4, a list of possible candidate genes is 
proposed based on pre-existing knowledge of the systems involved for the mapped phenotype. 
This approach eliminates the possibility of identifying novel genes or pathways. The question 
then becomes how to we overcome these barriers to identifying causative genetic variants? 
The first issue to address is identification of smaller QTL regions, which has been mainly 
hindered due to the limited recombination in common mapping populations (i.e. F2 intercross or 
backcross). One approach is to increase the number of generations of intercrossing thereby 
increasing recombination events. A study by Parker et al (2012) compared an F2 and F8 
intercross population of B6J and DBA and showed a 65% decrease of the QTL region in the F8 
line compared to the F2 intercross for initial METH locomotor response. Although this approach 
substantially reduced the QTL region, it also drastically increased the time and cost associated 
with breeding multiple generations.  
An alternative approach is to increase the number of unique genetic backgrounds– either 
individual animals in an F2 or backcross or number of strains in an RI panel. The most 
commonly used RI strains, the BXD, have proven even more valuable as the availability of 
strains has increased, especially with the inclusion of lines derived from advanced intercross F9 
and F14 generations. A study by Dickson et al (2016) using 44 BXD strains identified three QTL 
regions <1-4 Mb in size that control COC IVSA behavior and identified candidate genes within 
these regions, one of which, Fam53b, was previously identified in a human GWAS for COC 
dependence (Gelernter et al, 2014). The BXD will continue to be a useful mapping population as 
new strains are being produced and there is an extensive resource of phenotypic, genetic and 
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molecular data publically available (www.genenetwork.org). However, the usefulness of this 
population is limited to identification of genetic variants that differ between the two parental 
strains.  
A third approach is the use of a relatively new mouse resource, the Diversity Outbred (DO) 
population, which was generated from the same initial intercrossing of the eight founders in the 
CC and has high levels of recombination that are increasing with each generation (Churchill et 
al, 2012). QTL analysis using the DO has identified significantly smaller QTL regions for 
several complex traits and behaviors (Gatti et al, 2014; Logan et al, 2013; Recla et al, 2014; 
Smallwood et al, 2014; Svenson et al, 2012). Allelic effects of the eight founders have been used 
to further narrow QTL regions and candidate genes have been identified for acute thermal pain 
sensitivity (Recla et al, 2014) and atherosclerosis (Smallwood et al, 2014). Due to the outbred 
nature and high level of recombination of the DO, dense genotyping is required for every 
individual which can be expensive and QTL analysis is more complicated, although a genotyping 
platform (GigaMUGA) and statistical programs have been developed to help overcome these 
obstacles (Gatti et al, 2014; Morgan, 2015; Morgan et al, 2015).  
The second issue to address is identification and validation of candidate genes within smaller 
QTL regions. One common fine-mapping approach is to use gene expression data to perform 
eQTL analysis and identify regions that overlap with behavioral QTL (Dickson et al, 2016; 
Palmer et al, 2005; Parker et al, 2012; Parker et al, 2016). This method can be expensive, 
requiring genome-wide gene expression via RNA sequencing or microarrays for either whole 
brain or targeted regions implicated in the behavior (i.e. striatum). For mapping populations 
using inbred strains such as RIs, gene expression data only needs to be generated once. However, 
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for populations in which each individual is unique (F2 intercross, backcross, DO), gene 
expression would have to be generated for each animal. 
Another approach is to generate congenic lines containing subsections of the QTL region. 
Yazdani et al (2015) employed this technique to narrow a QTL region for acute METH 
locomotor response on Chr 11 to two genes and used various approaches including sequencing, 
gene expression and targeted-gene editing to validate a novel gene, Hnrnph1, as the causative 
gene. Disadvantages of this approach include the time and costs necessary to generate the lines 
and the possibility of losing the phenotype due to multiple QTL and interactions with loci on 
other chromosomes.  
Once a candidate genetic variant is identified, it has to be validated and the mechanism of 
action determined. Successful examples include a variant in Cyfip2 that influences initial COC 
locomotor response (Kumar et al, 2013) and Rgs2 that influences anxiety-like behavior (Yalcin 
et al, 2004). Few other genetic variants have been reported thus far. The inability to move from 
QTL to QT gene to specific variant is due in part to difficulties in identifying causative variant as 
many are thought to be in intronic or regulatory regions. Gene knockouts are among the most 
frequently used tools for validation, but are limited to genetic background on which the KO was 
made. Additionally, knocking out a gene is not always useful if your genetic variant results in 
something other than complete loss of protein or protein function. One technology that may aide 
in validation of causative genetic variants in the CRISPR/Cas9 system which is becoming more 
feasible to induce specific changes on a variety of genetic backgrounds. Additional approaches 
that may aid in the process of linking genes with phenotypes are the integration of more system-
level analyses (Chesler, 2014). Above I mentioned the use of gene expression; other emerging 
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methods are the inclusion of metabolite analysis, epigenetic regulation (i.e., DNA and histone 
methylation), and ribosomal profiles (reviewed in Moreno-Moral and Petretto (2016)). 
 
Multiple Paths to the Development of Addiction 
Development of a SUD is a multi-step process with three key transitions: initiation of first 
use; first use to subsequent use; and repeated use to development of a SUD. Numerous studies in 
humans and animal models have identified factors that increase likelihood at each of these 
transitions. However, what is becoming clearer is that there are individual differences in the 
progression to development of an SUD (Egervari et al, 2017). How should this knowledge shape 
the way we study SUDs?  
I believe we need to integrate multiple levels including genes, molecules, cells, circuits and 
physiology for specific behaviors associated in each phase of the multi-step process; similar to 
the Research Domain Criteria (RDoC) Initiative set forth by NIMH (Insel et al, 2010). One way 
to do this is establishing animal models that represent different pathways to the development of 
an addiction. Comparing these models across a thorough screen for the five levels mentioned 
above will help uncover what leads to the divergent paths. This is a similar goal behind the work 
being performed across four institutions as part of The Center for Systems Neurogenetics of 
Addiction (CSNA). Preliminary data shows a similar novelty-induced locomotion, initial COC 
locomotor response and behavioral sensitization behavior in CC004 and CC041 relative to RIX 
04/17 and RIX 41/51, confirming our findings in Chapter 4 that these parents are driving the 
response seen in the RIX lines. Additionally, preliminarily IVSA shows that CC004 rapidly 
acquires IVSA at 1 mg/kg while CC041 mice do not acquire at this dose even after 24 daily 
sessions. This data in combination with the characterization of RIX 04/17 and 41/51 in Chapter 2 
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and 3 could establish these two strains as examples of diverging paths beginning with differences 
in predictive traits (response to novelty), initial drug response, and acquisition of self-
administration, but similarities in the rewarding effects of a drug upon non-contingent 
administration. These strains are of particular interest to me for follow-up analyses as our work 
shows that locomotor differences at baseline and after acute COC are not due to underlying 
differences in the DA system, but may involve the NE or 5-HT systems. 
 
In conclusion, I believe my PhD research adds to the existing knowledge in the field of 
behavioral genetics in the following ways: providing additional support for the key role that 
genetic background plays in mediating complex behaviors; offering new insights into the role of 
PO effects on complex behaviors that had not been previously reported; establishing initial data 
for the study of environmental and genetic factors mediating complex behavior in the emerging 
mouse population, the CC; identification of two novel CC mouse lines that can be used to study 
addiction-related behaviors and the underlying mechanisms including the identification of novel 





Supplemental Material for Chapter 2 
 
Supplemental Table 1. CC strains used to generate RIX lines and Ns of F1 females phenotyped 
RIX Name CC Strain Abbreviated CC Name 
Reciprocal 
Name 
# F1 Females Phenotyped Total  
RIX Ns PD ME Std VDD 
01/11 
CC001/Unc 01 CC(01x11)F1 19 13 11 20 
117 
CC011/Unc 11 CC(11x01)F1 12 14 17 11 
41/51 
CC041/TauUnc 41 CC(41x51)F1 12 24 11 20 
122 
CC051/TauUnc 51 CC(51x41)F1 13 12 16 14 
04/17 
CC004/TauUnc 04 CC(04x17)F1 12 6 12 14 
83 
CC017/Unc 17 CC(17x04)F1 9 2 15 13 
23/47 
CC023/GeniUnc 23 CC(23x47)F1 10 9 4 8 
50 
CC047/Unc 47 CC(47x23)F1 6 4 3 6 
28/38 
CC028/GeniUnc 28 CC(28x38)F1 Eliminated from study due to no viable 
CC(38x28)F1 offspring CC038/GeniUnc 38 CC(38x28)F1 
06/26 
CC006/TauUnc 06 CC(06x26)F1 6 5 10 9 
66 
CC026/GeniUnc 26 CC(26x06)F1 6 5 11 14 
03/14 
CC003/Unc 03 CC(03x14)F1 4 3 13 9 
48 
CC014/Unc* 14 CC(14x03)F1 1 4 8 6 
35/62 
CC035/Unc 35 CC(35x62)F1 1 2 5 5 
34 
CC062/Unc 62 CC(62x35)F1 4 7 4 6 
32/42 
CC032/GeniUnc 32 CC(32x42)F1 7 19 21 19 
96 
CC042/GeniUnc 42 CC(42x32)F1 6 9 9 6 
05/40 
CC005/TauUnc 05 CC(05x40)F1 14 24 NA NA 
69 
CC040/TauUnc 40 CC(40x05)F1 16 15 NA NA 
    Total Diet Ns 158 177 170 180  
*CC014/Unc is now extinct; CC = Collaborative Cross; Geni = Geniad, Australia; ME = methyl 
enriched; NA = Not-attempted; PD = protein deficient; RIX = Recombinant Inbred Intercross or 
F1 hybrid females; Std = Standard; Tau = Tel Aviv University, Israel; Unc = University of North 




Supplemental Table 2. Nutritional content of experimental diets 








Ingredient g/kg kcal/kg g/kg kcal/kg g/kg kcal/kg g/kg kcal/kg 
Casein 200 716 75 269 200* 716 - - 
L-Cystine 3 12 0.9 3.6 3 12 - - 
Sucrose 100 400 100 400 100 400 382.19 1528.76 
Cornstarch 397.486 1430.9496 481.196 1732.3056 397.486 1430.9496 100 360 
Dyetrose 132 501.6 160 608 132 501.6 100+ 363 
Soybean Oil 70 630 70 630 70 630 50++ 450 
t-Butyl 
hydroquinone 0.014 0 0.014 0 0.014 0 - - 
Cellulose 50 0 50 0 50 0 50 0 
Choline Bitartrate 2.5 0 2.5 0 2.5 0 14.48 0 
Mineral Mix 
#210025 35 30.8 
35@ 
(#213266) 30.8 35 30.8 - - 
Vitamin Mix           
# 310025 10 38.7 10 38.7 
10** 




Dibasic - - 10.97 0 - - - - 
Calcium Carbonate - - 4.42 0 - - - - 
Primex - - - - - - 100 900 
Salt Mix #215001 
(no Fe Added) - - - - - - 35 16.45 
Sodium 
Bicarbonate - - - - - - 4.3 0 
Ferric Citrate, 
U.S.P. - - - - - - 0.33 0 
Succinyl 
Sulfathiazole - - - - - - 10 0 
L-AA - - - - - - 143.7 574.8 
The PD and VDD diets were nutritionally matched to the Std diet. ME was matched to a methyl 
donor deficient diet that was used in pilot studies and eliminated from these experiments due to 
the inability of dams to produce viable offspring when exposed to the diet. Red indicates the 
main nutritional component that was changed in each diet (pelleted). The product number 
associated with each diet, vitamin mix, and mineral mix are provided (Dyets, Inc; Bethlehem, 
PA). @Ca and P free, @@Vitamin K1/Dextrose mix free w/ addition of menadione sodium 





Supplemental Table 3. Breeding statistics  
RIX 





















PD 9 19 89 92 5.41 61 0.53 
ME  7 17 71 66 5.50 44 0.83 
Std 6 11 82 63 7.00 82 0.62 
VDD 4 8 100 49 6.13 88 0.49 
CC011/Unc 
PD 9 20 65 64 4.92 82 0.43 
ME 7 19 47 65 7.22 95 0.54 
Std 6 12 67 60 7.50 95 0.50 
VDD 4 8 63 32 6.40 100 0.43 
41/51 
CC041/TauUnc 
PD 4 7 100 52 7.43 75 0.50 
ME 7 17 71 98 8.17 92 0.46 
Std 6 12 67 55 6.88 98 0.51 
VDD 4 8 88 46 6.57 100 0.50 
CC051/TauUnc 
PD 4 8 75 41 6.83 86 0.54 
ME  7 18 61 54 4.91 70 0.58 
Std 6 11 73 40 5.00 75 0.59 
VDD 4 8 75 33 5.50 100 0.53 
04/17 
CC004/TauUnc 
PD 6 14 64 48 5.33 88 0.53 
ME 8 15 80 79 6.58 94 0.57 
Std 3 6 100 41 6.83 94 0.55 
VDD 6 10 100 61 6.10 97 0.54 
CC017/Unc 
PD 6 16 75 51 4.25 88 0.57 
ME  8 19 53 36 3.60 41 0.45 
Std 3 6 100 34 5.67 88 0.66 
VDD 6 13 54 33 4.71 95 0.60 
23/47 
CC023/GeniUnc 
PD 4 12 83 35 3.50 92 0.56 
ME 4 8 75 21 3.50 100 0.55 
Std 3 7 100 26 3.71 97 0.42 
VDD 4 9 89 26 3.25 88 0.69 
CC047/Unc 
PD 4 8 88 33 4.71 57 0.55 
ME  4 10 100 31 3.10 43 0.43 
Std 3 6 83 23 4.60 48 0.56 




Supplemental Table 3 continued 
RIX 





















PD 3 4 100 22 5.50 42 0.35 
ME 2 4 50 10 5.00 100 0.42 
Std 2 2 100 7 3.50 50 0.50 
VDD 3 4 100 18 4.50 25 0.50 
CC038/GeniUnc 
PD 3 4 25 1 1.00 0 NA 
ME  2 4 50 3 1.50 0 NA 
Std 2 2 50 1 1.00 0 NA 
VDD 3 4 25 2 2.00 0 NA 
06/26 
CC006/TauUnc 
PD 6 12 50 23 3.8 92 0.82 
ME  6 15 47 35 5.0 57 0.44 
Std 3 6 67 20 5.0 75 0.78 
VDD 5 11 73 26 3.3 69 0.52 
CC026/GeniUnc 
PD 6 13 69 46 5.1 61 0.48 
ME 6 13 85 53 4.8 76 0.48 
Std 3 6 100 29 4.8 97 0.52 
VDD 5 9 89 43 5.4 78 0.56 
03/14 
CC003/Unc 
PD 4 7 57 22 5.5 75 0.49 
ME 3 6 67 20 5.0 96 0.65 
Std 5 10 90 43 4.8 92 0.44 
VDD 3 6 83 34 6.8 97 0.49 
CC014/Unc 
PD 4 8 63 13 2.6 73 0.33 
ME  3 6 67 11 2.8 75 0.59 
Std 5 10 60 23 3.8 83 0.64 
VDD 3 6 83 17 3.4 76 0.52 
35/62 
CC035/Unc 
PD 5 8 25 11 5.5 50 0.25 
ME 7 11 36 21 5.3 63 0.37 
Std 3 3 67 17 8.5 90 0.41 
VDD 3 5 80 24 6.0 100 0.59 
CC062/Unc 
PD 5 7 86 27 4.5 90 0.66 
ME  7 14 100 80 5.7 76 0.51 
Std 3 4 100 23 5.8 100 0.51 




Supplemental Table 3 continued 
RIX 





















PD 6 11 100 73 6.6 76 0.49 
ME 5 9 78 52 7.4 100 0.47 
Std 4 8 100 78 9.8 75 0.48 
VDD 7 12 100 96 8.0 83 0.56 
CC042/GeniUnc 
PD 6 21 62 34 2.6 23 0.62 
ME  5 16 56 43 4.8 85 0.31 
Std 4 12 92 31 2.8 82 0.43 
VDD 7 18 56 34 3.4 71 0.74 
05/40 
CC005/TauUnc 
PD 8 29 79 102 4.4 62 0.46 
ME 5 16 94 79 5.3 87 0.55 
Std Not Attempted 
VDD Not Attempted 
CC040/TauUnc 
PD 8 27 59 50 3.1 97 0.55 
ME  5 16 75 43 3.5 83 0.64 
Std Not Attempted 
VDD Not Attempted 
  PD 27 255 71 840 3.3±2.8 72±38 .52±.28 
 Overall Diet  ME 27 253 68 900 3.6±3.1 75±39 .53±.27 
 Means Std 18 134 82 614 4.8±3.2 84±32 .53±.24 
  VDD 23 152 78 625 4.1±3.0 82±36 .57±.22 
Grey shading indicates RIX 28/38 was removed from study due to inability to produce viable 
CC(38x28)F1 females at weaning on all diets. Twenty-eight separate breeding batches were set 
up over a two-year period to produce all the female offspring needed. Within each batch at least 
two diets and RIX were included, the number of times a RIX/diet combination was attempted is 
indicated as # Batches (of 28). % productive matings = ((# litters born/# dams mated) x 100); % 
survival weaning = ((# pups at weaning/# pups born) x 100); sex ratio = (# F pups weaning/total 




Supplemental Table 4. Statistical analysis on breeding of RIX lines  













PO 0.005 0.242 0.002 0.015 
Diet 0.229 0.003 0.750 0.029 
Diet-by-PO 0.895 0.215 0.231 0.503 
41/51 
PO 0.316 0.002 0.202 0.283 
Diet 0.387 0.404 0.168 0.973 
Diet-by-PO 0.770 0.238 0.179 0.941 
04/17 
PO 0.096 0.001 0.024 0.773 
Diet 0.122 0.221 0.006 0.853 
Diet-by-PO 0.088 0.372 0.004 0.751 
23/47 
PO 0.452 0.063 7.0E-06 0.853 
Diet 0.836 0.359 0.849 0.644 
Diet-by-PO 0.339 0.368 0.847 0.826 
28/38 
PO 0.010 0.034 0.070 NA 
Diet 0.827 0.940 0.734 NA 
Diet-by-PO 0.318 0.940 0.734 NA 
06/26 
PO 0.012 0.179 0.660 0.100 
Diet 0.294 0.811 0.690 0.220 
Diet-by-PO 0.815 0.354 0.295 0.147 
03/14 
PO 0.624 0.004 0.196 0.988 
Diet 0.592 0.692 0.756 0.496 
Diet-by-PO 0.668 0.611 0.884 0.499 
35/62 
PO 0.009 0.400 0.183 0.093 
Diet 0.488 0.279 0.118 0.392 
Diet-by-PO 0.014 0.406 0.694 0.817 
32/42 
PO 0.001 1.9E-17 0.036 0.702 
Diet 0.143 0.016 0.005 0.014 
Diet-by-PO 0.411 0.007 0.081 0.178 
05/40 
PO 0.043 0.001 0.054 0.219 
Diet 0.113 0.143 0.446 0.236 
Diet-by-PO 0.945 0.669 0.016 0.976 
Overall 
RIX 8.8E-7 3.7E-39 3.0E-12 0.542 
Diet 0.010, *ME<Std 0.139 0.069 0.504 
Diet-by-RIX 0.498 0.103 0.110 0.601 
Data are p values for effect of PO, diet and diet-by-PO within each RIX line and an overall effect 
of RIX, diet and diet-by-RIX across all 20 CC strains used. Significant values are shaded grey 
and bolded. % productive matings = ((# litters born/# dams mated) x 100); % survival weaning = 
((# pups at weaning/# pups born) x 100); sex ratio = (# F pups weaning/total pups at weaning); 




Supplemental Table 5. Tukey’s post-hoc analyses of overall diet effects 
Phenotype p-value q-value Tukey’s Post-hoc 
WeightPND21 2.2E-16 2.2E-15 ME & PD < all (p<1.0x10-7) 
WeightPND60 2.2E-16 2.2E-15 ME & PD < VDD & Std (p<1.0x10-7) 
OF TotalDist 0.772 0.881   
OF % Center 0.807 0.881   
OF VertCount 0.998 0.998   
OF Boli 0.192 0.350   
LD TotalDist 0.228 0.381   
LD DistDark 0.023 0.058 none 
LD DistLight 0.805 0.881   
LD Transition 0.837 0.881   
LD % Light 0.048 0.096 ME < VDD (p=0.024) 
LD Boli 0.352 0.502   
SIH-T1 2.0E-04 0.001 ME < PD (p=1.3x10-4) 
SIH-T2 1.9E-04 0.001 PD > ME (p=6.1x10
-6); PD > VDD 
(p=0.047); PD > Std (p=0.018) 
deltaSIH 0.342 0.502   
FST % Imb 0.377 0.502   
FST Boli 0.023 0.058 Std > VDD (p=0.018) 
BasalCORT 0.038 0.085 none 
StressCORT 0.003 0.010 PD > ME (p=0.001); PD > VDD (p=0.003) 
deltaCORT 2.1E-05 1.4E-04 PD > ME (p=7.2x10
-5); PD > VDD 
(p=1.2x10-5) 
For each phenotype that had a significant effect of diet (shaded grey and bold) at the p value 
level, a Tukey’s post-hoc was performed. CORT = corticosterone; deltaCORT = (Stress CORT – 
Basal CORT); Dist = distance; Imb = Immobile; LD = light/dark; OF = open field; ME = methyl 
enriched; PND = postnatal day; PD = protein deficient; SIH-T1 = basal temperature; SIH-T2 = 





Supplemental Table 6. Perinatal diet effects on behavior within each RIX line 
  RIX 01/11 RIX 41/51 RIX 04/17 
Phenotype p q Tukey’s posthoc p q Tukey’s posthoc p q Tukey’s posthoc 
WeightPND21 2E-04 4E-03 PD<all (p≤0.001) 1E-12 2E-11 PD&ME<all (p≤0.001) 8E-09 2E-07 PD<all (p≤0.001) 
WeightPND60 0.03 0.10 PD<Std & VDD (p≤0.001) 5E-06 5E-05 
PD&ME<all (p≤0.02) 4E-06 3E-05 PD<Std (p≤0.001); VDD>all (p≤0.04) 
OF TotalDist 0.47 0.74   0.08 0.13  0.29 0.64   
OF %Center 0.74 0.82   0.02 0.09 PD>VDD (p<0.02) 0.90 0.96   
OF VertCount 0.65 0.82   0.07 0.13  0.49 0.87   
OF Boli 0.03 0.10 none 0.80 0.80  0.61 0.87   
LD TotalDist 0.68 0.82   0.09 0.13   0.59 0.87   
LD DistDark 0.48 0.74   0.09 0.13  0.36 0.72   
LD DistLight 0.74 0.82   0.14 0.18  0.72 0.87   
LD Transition 0.97 0.97   0.08 0.13  0.95 0.96   
LD %Light 0.33 0.60   0.06 0.13  0.72 0.87   
LD Boli 4E-03 0.03 Std<ME (p<0.008) 0.03 0.11 none 0.74 0.87   
SIH-T1 2E-03 0.02 PD&VDD>ME&Std (p≤0.02) 0.27 0.32 
 0.17 0.48   
SIH-T2 0.05 0.15   0.05 0.13 Std>VDD (p<0.02) 0.01 0.04 ME<all (p≤0.007) 
deltaSIH 0.01 0.07 PD<ME&Std (p≤0.03) 0.09 0.13  0.20 0.50   
FST %Imb 0.56 0.80   0.36 0.40   0.53 0.87   
FST Boli 0.28 0.56   0.76 0.80   0.96 0.96   
BasalCORT 0.13 0.32   0.25 0.31  2E-04 8E-04 Std>all (p≤0.04) 
StressCORT 0.95 0.97   5E-04 3E-03 Std&PD>ME&VDD (p≤0.001) 5E-06 3E-05 
Std>all (p≤0.05) 






Supplemental Table 6 continued  
  RIX 23/47 RIX 06/26 RIX 03/14 
Phenotype p q Tukey’s posthoc p q Tukey’s posthoc p q Tukey’s posthoc 
WeightPND21 8E-05 2E-03 PD<all (p≤0.01) 7E-07 7E-06 PD&ME<all (p≤0.001) 0.05 0.13 PD<VDD (p≤0.01) 
WeightPND60 6E-04 6E-03 VDD>all (p≤0.005) 4E-07 7E-06 PD&ME<Std&VDD (p≤0.04) 0.01 0.10 
ME<Std (p≤0.02) 
OF TotalDist 0.13 0.21  0.25 0.50   0.65 0.72   
OF %Center 0.16 0.22  0.64 0.80   0.26 0.33   
OF VertCount 0.04 0.10 VDD>PD (p<0.04) 0.46 0.61   0.01 0.10 PD<VDD (p<0.02) 
OF Boli 0.08 0.16  0.13 0.38   0.03 0.13 ME&PD<VDD&Std (p≤0.04) 
LD TotalDist 0.30 0.34   0.45 0.61   0.17 0.27   
LD DistDark 0.43 0.45  0.33 0.51   0.04 0.13 ME>VDD (p<0.04) 
LD DistLight 3E-03 0.01 Std>all (p≤0.04) 0.83 0.94   0.32 0.37   
LD Transition 0.18 0.22  0.31 0.51   0.93 0.98   
LD %Light 0.03 0.07 Std>VDD (p<0.04) 0.90 0.95   0.16 0.27   
LD Boli 0.01 0.04 Std<ME&VDD (p≤0.04) 0.18 0.39   0.04 0.13 none 
SIH-T1 0.23 0.27  3E-03 0.01 ME<Std (p<0.01) 0.02 0.10 none 
SIH-T2 0.11 0.19  0.15 0.39   0.24 0.32   
deltaSIH 0.16 0.22  7E-03 0.02 Std<PD (p<0.009) 0.14 0.27   
FST %Imb 0.01 0.04 ME<PD&VDD (p≤0.02) 0.99 0.99   0.15 0.27   
FST Boli 0.09 0.16   2E-03 0.01 Std>ME&PD (p≤0.05) 0.17 0.27   
BasalCORT 0.56 0.56  0.29 0.51   0.13 0.27   
StressCORT 2E-03 0.01 PD>ME>VDD (p≤0.01) 4E-04 3E-03 ME&PD>Std&VDD (p≤0.03) 0.21 0.29 
  





Supplemental Table 6 continued  
  RIX 35/62 RIX 32/42 RIX 05/40 
Phenotype p q Tukey’s posthoc p q Tukey’s posthoc p q Tukey’s posthoc 
WeightPND21 0.80 0.89   1E-04 6E-04 PD&ME<Std (p≤0.03) 0.16 0.28   
WeightPND60 5E-03 0.03 none 0.22 0.40   0.31 0.39   
OF TotalDist 0.27 0.44   0.99 1.00  0.10 0.19   
OF %Center 2E-05 4E-04 VDD<all (p≤0.02) 1.00 1.00  0.09 0.19   
OF VertCount 0.22 0.43   0.94 1.00  0.29 0.39   
OF Boli 0.17 0.38   0.53 0.66  0.25 0.37   
LD TotalDist 8E-03 0.04 VDD<ME (p<0.04) 0.28 0.47   8E-03 0.05 ME>PD 
LD DistDark 0.01 0.04 ME>VDD (p<0.01) 0.14 0.31  0.04 0.11 ME>PD 
LD DistLight 9E-03 0.04 PD>VDD (p<0.04) 0.51 0.66  0.04 0.11 ME>PD 
LD Transition 0.24 0.43   0.47 0.66  0.01 0.05 ME>PD 
LD %Light 0.03 0.08 none 0.90 1.00  0.17 0.28   
LD Boli 0.73 0.89   0.16 0.31   0.49 0.54   
SIH-T1 0.06 0.16   3E-04 1E-03 VDD<all (p≤0.03) 0.83 0.83   
SIH-T2 0.96 0.96   0.05 0.15  0.02 0.05 ME<PD 
deltaSIH 0.32 0.46   0.13 0.31  0.02 0.05 ME<PD 
FST %Imb 0.78 0.89   0.36 0.56   0.26 0.37   
FST Boli 4E-03 0.03 ME>Std&VDD (p≤0.05) 0.04 0.13 none 0.40 0.47   
BasalCORT 0.29 0.44   0.04 0.13 none 5E-03 0.05 ME>PD 
StressCORT 0.89 0.93   1E-07 3E-06 VDD>all (p≤0.005) 0.81 0.83   
deltaCORT 0.36 0.48   4E-05 4E-04 VDD>all (p≤0.001) 9E-03 0.05 ME<PD 
Grey shading indicates phenotypes that had an overall significant diet-by-RIX effect and gold shading are phenotypes that did not have an overall 
effect but do have an effect of diet exposure within that particular RIX line. Tukey’s posthoc analysis was performed to determine which diet 
group was causing the effect. CORT = corticosterone; deltaCORT = (Stress CORT – Basal CORT); deltaSIH = (T2-T1); FST = forced swim test; 
Imb = immobile; LD = light/dark; OF = open field; ME = methyl enriched; PND = postnatal day; PD = protein deficient; SIH = stress-induced 




Supplemental Table 7. Percent variance explained by PO, diet, and diet-by-PO 
  RIX 01/11 RIX 41/51 RIX 04/17 RIX 23/47 RIX 06/26 
Phenotype PO Diet DxP R PO Diet DxP R PO Diet DxP R PO Diet DxP R PO Diet DxP R 
WeightPND21 0 76 9 15 6 81 7 6 22 64 10 4 59 37 2 2 7 71 14 8 
WeightPND60 16 26 12 45 5 54 3 37 13 44 2 41 49 33 6 12 4 41 10 45 
OF TotalDist 1 7 3 89 0 8 6 86 2 13 10 75 0 11 5 84 14 5 1 80 
OF %Center 0 1 1 97 0 7 6 87 2 1 9 89 3 11 3 84 4 2 7 86 
OF VertCount 13 4 3 81 6 13 1 79 10 6 10 74 12 24 4 59 19 4 2 75 
OF Boli 0 7 4 88 1 2 1 95 7 4 4 86 0 14 19 67 1 8 4 87 
LD TotalDist 3 3 6 89 1 7 2 90 0 6 3 90 0 11 3 86 2 4 4 90 
LD DistDark 2 5 6 88 0 7 1 92 1 12 1 86 2 13 3 82 1 5 3 91 
LD DistLight 3 1 5 90 4 8 3 85 0 3 9 88 0 24 4 72 3 1 7 88 
LD Transition 1 1 5 94 0 7 7 86 2 1 4 93 1 9 3 87 1 5 4 91 
LD %Light 0 3 2 96 1 8 2 89 2 3 6 88 2 15 7 76 3 1 4 92 
LD Boli 0 10 7 83 0 7 0 93 0 2 8 89 1 19 14 67 1 7 3 90 
SIH-T1 0 23 2 75 2 6 5 87 21 24 1 54 0 31 4 65 0 17 12 70 
SIH-T2 0 14 4 82 4 9 12 74 5 23 2 70 6 16 2 76 0 16 4 80 
deltaSIH 0 13 1 85 0 11 3 85 13 15 3 69 1 26 3 69 0 14 13 73 
FST %Imb 5 2 3 90 0 3 1 96 2 5 9 84 17 22 1 61 1 0 3 95 
FST Boli 4 5 2 89 1 2 5 92 0 1 0 99 2 17 8 72 5 17 8 70 
BasalCORT 0 5 1 94 0 9 2 89 4 53 1 42 0 3 3 94 13 20 1 67 
StressCORT 3 0 3 94 0 29 7 63 16 24 2 58 3 64 1 32 8 28 9 54 





Supplemental Table 7 continued 
  RIX 03/14 RIX 35/62 RIX 32/42 RIX 05/40 
Phenotype PO Diet DxP R PO Diet DxP R PO Diet DxP R PO Diet DxP R 
WeightPND21 1 33 38 27 22 35 12 30 4 67 15 14 47 9 24 20 
WeightPND60 0 32 7 61 1 29 6 64 2 14 4 80 58 2 0 40 
OF TotalDist 9 3 0 88 7 27 2 64 0 0 5 95 7 4 0 89 
OF %Center 8 7 2 83 3 52 10 35 1 0 3 96 5 9 0 87 
OF VertCount 3 18 9 69 1 12 9 77 0 0 5 95 2 2 1 95 
OF Boli 1 47 6 46 1 12 18 69 0 3 2 95 4 2 0 94 
LD TotalDist 6 11 2 81 8 24 9 59 0 5 3 92 18 10 0 71 
LD DistDark 0 16 2 82 1 33 15 50 2 6 2 90 19 5 0 76 
LD DistLight 15 7 1 77 9 26 9 56 0 2 2 95 5 6 0 89 
LD Transition 11 1 2 87 12 10 1 76 1 3 4 92 10 8 0 82 
LD %Light 18 9 8 66 10 20 11 59 0 1 1 98 0 3 1 96 
LD Boli 2 15 11 73 0 43 0 56 0 7 6 87 7 1 1 91 
SIH-T1 0 20 2 77 3 17 6 74 2 29 2 67 1 0 5 94 
SIH-T2 0 9 2 89 4 1 10 85 0 10 2 88 0 11 0 88 
deltaSIH 0 11 1 88 4 20 3 74 1 14 1 84 3 10 1 86 
FST %Imb 9 9 7 76 5 4 2 89 1 7 8 84 10 3 6 81 
FST Boli 2 14 2 82 6 28 6 60 3 10 3 85 2 1 4 93 
BasalCORT 0 48 1 51 0 28 1 71 0 15 3 82 3 18 1 78 
StressCORT 2 7 5 87 23 0 5 72 1 41 2 55 0 0 4 96 
deltaCORT 2 0 10 88 15 3 2 79 1 36 4 59 0 19 2 79 
Percent variance explained by either parent-of-origin (PO), diet, diet-by-PO, or the residuals of the lmer models (R; i.e. random 
effects, noise of the phenotype) are shown. Phenotypes that had a significant effect at the p value level are shaded grey and bolded. 
CORT = corticosterone; deltaCORT = (Stress CORT – Basal CORT); Dist = distance; Imb = Immobile; LD = light/dark; OF = open 
field; PND = postnatal day; SIH-T1 = basal temperature; SIH-T2 = post-stress temperature; deltaSIH = (T2-T1); Vert = vertical 
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Supplemental Figure 1. Correlation of behaviors 
 
Spearman correlation of 20 phenotypes. Color and direction of the ellipse indicate direction of 
the correlation. Intensity of color and size of ellipse indicate strength of correlation. The p value 















































































































































Supplemental Figure 2. Body weight is influenced by diet-by-RIX interactions 
	
Data points are means of diet exposure groups. Error bars are SEM. There was a significant diet-
by-RIX effect on (a) body weight at weaning (p=1.5x10-7, q=7.4x10-7) and (c) in adulthood 
(p=0.002, q=0.004). There was a significant overall effect of perinatal diet on (b) weight at 
weaning (p=2.2x10-16, q<2.2=10-15) and (d) in adulthood (p=2.2x10-16, q=2.2x10-15). Posthoc 
analyses revealed that females exposed to PD (N=158) and ME (N=177) weighed significantly 
less compared to Std (N=170) and VDD (N=180) at both time points (***p<0.001). 
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Supplemental Figure 3. Parent-of-origin affects locomotion, exploratory behavior and stress 
response in RIX 06/26 females 
	
Data points are individual animals with bars indicating means. Error bars are SEM. 
CC(06x26)F1 females (N=30) showed (a) increased total distance (***p=0.001, q=0.01) and (b) 
vertical counts in the OF (***p=0.0002, q=0.004) compared to CC(26x06)F1 females (N=36). 
(c) CC(06x26)F1 females (N=29) had increased basal (**p=0.004, q=0.02) and (d) stress-
induced CORT levels following restraint stress (**p=0.003, q=0.02), (e) but no difference in 
change in CORT (p>0.05). Data shown in d is also shown in Figure 6a. 
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Supplemental Figure 4. Parent-of-origin affects locomotor behavior in the OF and LD in RIX 
05/40 females  
 
Data points are individual animals with bars indicating means. Error bars are SEM. 
CC(05x40)F1 females (N=38) exhibited increased locomotion compared to CC(40x05)F1 
females (N=31) in (a) distance in the OF test (*p=0.04, q=0.14), and the LD test as measured by 
(b) total distance (***p=0.0002, q=0.003), (c) total transitions (**p=0.006, q=0.03), (d) distance 










































































































































Supplemental Figure 5. RIX significantly affects locomotor behavior in the OF and LD assays 
	
Data from individual females along with RIX mean (black bar) are shown with the RIX lines 
arranged from lowest to highest distance traveled in the OF and LD tests. There was a significant 
effect of RIX on (a) total distance in the OF test (p=2.0x10-16, q=3.4x10-16; Ns= 119, 46, 96, 110, 
66, 69, 48, 34, 83) and (b) total distance in the LD test (p=2.0x10-16, q=3.4x10-16; Ns= 122, 50, 
116, 69, 96, 48, 66, 34, 79). ***posthoc revealed that RIX 41/51 and RIX 04/17 were 





Supplemental Material for Chapter 3 
SUPPLEMENTAL METHODS 
Fast Scan Cyclic Voltammetry 
Carbon-fiber microelectrodes were prepared on the day of FSCV recordings for each animal. 
Glass-encased electrodes had 70-120 µm of the fiber exposed, and electrodes were calibrated 
post-experiment as previously described (Robinson et al, 2009) to obtain current measurements 
for known concentrations of dopamine.  
On the experiment day, animals were anesthetized with urethane (50% w/w in saline, 1.8 
g/kg i.p.) and placed in a stereotaxic frame atop a heated pad. Holes were drilled in the skull 
above the ventral tegmental area (VTA; AP -3.8, ML -0.2), nucleus accumbens (NAc; AP 
+1.2, ML -1.2), and, contralaterally, two holes were drilled for a reference electrode and screw. 
The Ag/AgCl reference electrode was lowered and fixed using a screw and dental cement. The 
stimulating electrode (bipolar, parallel, stainless-steel, 0.2mm in diameter per tip; Plastics One, 
Roanoke, VA) was lowered -4.0mm from the skull surface into the VTA. Next, the animal and 
stereotaxic frame were placed in a Faraday chamber and the carbon fiber microelectrode was 
lowered into the NAc -4.0mm from the dura mater. A triangle waveform potential ramping from 
-0.4 V to +1.3 V and back at 400 V/s was applied to the carbon-fiber electrode at 60 Hz for 20 
minutes to allow the fiber to condition to the tissue environment, then applied at 10Hz for the 
remainder of the experiment. Thereafter, the evoked dopamine signal was optimized by moving 
the stimulator and/or carbon-fiber electrode in 100 µM increments, as previously described 
(Shnitko et al, 2016). 
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Once optimal signal was achieved (signal-to-noise ratio higher than 20), the stimulating and 
recording electrodes were left in place and measurements of evoked dopamine release were 
collected using electrical stimulation (24 biphasic, square-wave pulses, 2 ms/phase, 125–185 µA, 
60 Hz). All evoked dopamine signals were collected five minutes apart with a duration of 20 s 
per recording. After stable evoked release was achieved (less than 20% variability), a saline 
injection was given and three dopamine signal recordings were collected – this constituted the 
baseline measurement. Next, animals received 20 mg/kg, (IP) or an equivalent volume of saline 
and evoked dopamine as collected every five minutes for one hour. 
 
FSCV Data Analysis 
Electrochemical signals measured upon electrical stimulation were analyzed from the color 
plots (TarHeel CV 6.0, Department of Chemistry, UNC Chapel Hill) as previously described 
(Shnitko et al, 2016). Color plots were created by plotting current as a function of applied 
potential (y-axis) over time (x-axis). Background-subtracted cyclic voltammograms were 
obtained by subtracting voltammograms collected during baseline recording (typically the 12 
scans 1.2 s immediately preceding stimulation) from those collected during and after stimulation 
(Shnitko and Robinson, 2014). An increase in current at approximately 0.65 V versus the 
Ag/AgCl reference electrode was considered to be due to oxidation of dopamine. This was 
confirmed by analyzing the background-subtracted cyclic voltammogram averaged over 500 ms 
around the peak of the oxidation current. Dopamine oxidation current was converted to 
dopamine concentration, or [DA] in µM, using in vitro calibration factors obtained following 




Dopamine Release and Clearance Parameters 
For each animal, traces for baseline dopamine release were created by averaging the 
concentration-versus-time trace from the three recordings following saline vehicle injection. For 
animals receiving cocaine injection, the recording with maximal dopamine release was 
determined and this concentration-versus-time trace was used to assess dopamine release and 
clearance dynamics following cocaine injection. Kinetics of dopamine release were assessed 
using metrics adapted from previous studies (Saddoris, 2016; Yorgason et al, 2011). In the file 
with the identified peak cocaine effect, Tmax was the time (post cocaine) that file was collected 
and [DA]max was the maximal dopamine concentration observed following electrical stimulation. 
We also measured the latency from the end of the stimulation to the [DA]max and the full width at 
half height (FWHH), or the width of the dopamine signal at 50% of [DA]max. Values for T80 and 
T30 were then determined as the time at which the [DA] decayed to 80% or 30% of [DA]max, 
respectively. Lastly, slope was determined by calculating the slope of the line between the T80 




Supplemental Table 1: Brain concentrations of cocaine and metabolites 
  
RIX 41/51                          
(n=15) 
RIX 04/17                         
(n=15) 
[ng/g] Affect Behavior Mean StDev Mean StDev 
Cocaine (COC) Active 5549.96 2319.64 6358.86 2611.19 
Metabolites      
Benzoyl Ecgonine (BZE) Active 63.69 65.75 62.19 27.28 
Norcocaine (NOR) Inactive 661.58 357.98 647.45 372.67 
Affect behavior refers to whether or not the drug or metabolite has been shown to have an effect 






Supplemental Table 2. Monoamine tissue content in dorsal striatum and nucleus accumbens 
DORSAL STRIATUM 
  RIX 41/51 RIX 04/17 
  Basal Cocaine-Induced Basal Cocaine-Induced 
[ng/mg] F (n=2) M (n=4) Both (n=6) F (n=4) M (n=5) Both (n=9) F (n=4) M (n=4) Both (n=8) F (n=3) M (n=4) Both (n=7) 
Dopamine (DA) 43.8±0.8 50.9±32 48.6±25.1 50.4±18 107.0±41 81.8±43 53.2±4.6 45.0±41 49.1±27 69.8±41 51.5±6 59.4±26 
DOPAC (D) 50.5±0.2 42.6±31 45.2±24.7 33.0±7.9 24.4±17 28.2±14 49.5±3.4 31.0±22 40.3±17 18.9±6.1 29.9±10 25.2±10 
HVA 17.4±1.6 18.5±11 18.1±8.8 21.6±3.2 21.8±4.9 21.7±4** 16.5±1.0 10.7±6.6 13.6±5.3 15.1±2.0 14.6±3.7 14.8±3** 
3-MT 7.1±0.6 6.6±5.1 6.8±3.9+ 9.2±2.4 12.2±2.0 10.8±2.6+ 8.5±1.1 5.4±6.4 7.0±4.5 9.8±9.2 10.1±1.4 10.0±5.4 
(D+HVA+3MT)/DA 1.7±.03 1.6±0.7 1.6±0.6 1.4±0.4 0.68±0.6 0.98±0.6 1.4±0.2 1.4±0.8 1.4±0.5 0.84±0.6 1.1±0.4 0.97±0.4 
Serotonin (5-HT) 3.4±0.4 3.8±1.1 3.7±0.9* 1.9±0.5 4.5±2.7 3.4±2.4 2.5±0.8 1.8±1.2 2.1±1* 4.3±2.2 2.5±0.5 3.3±1.6 
5-HIAA 9.7±1.8 9.5±2.3 9.6±2**,+++ 6.4±0.8 6.1±1.3 6.2±1+++ 7.3±1.2 5.5±1.6 6.4±1.6** 4.3±3.8 6.2±1.2 5.4±2.5 
5-HIAA/5-HT 2.9±0.9 2.6±0.7 2.7±0.7 3.4±0.7 1.0±0.1 2.2±1.4 3.0±0.6 2.0±0.2 2.6±0.7 0.79±0.7 2.6±0.9 1.8±1.2 
Norepinephrine 0.58±0.8 0.46±0.9 0.50±0.8 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.54±0.7 0.27±0.5 0.0±0.0 0.28±0.3 0.16±0.3 
NUCLEUS ACCUMBENS 
  RIX 41/51 RIX 04/17 
  Basal Cocaine-Induced Basal Cocaine-Induced 
[ng/mg] F (n=2) M (n=3) Both (n=5) F (n=4) M (n=5) Both (n=9) F (n=4) M (n=3) Both (n=7) F (n=2) M (n=4) Both (n=6) 
Dopamine (DA) 20.6±0.8 29.7±24 26.1±17.4 42.1±28 48.9±20.8 45.9±23 24.0±9.1 15.5±21 20.4±14 30.2±23 19.0±14 22.7±16.2 
DOPAC (D) 44.6±3.2 35.1±27 38.9±19.7+ 28.4±3.4 10.2±6.1 18.3±11+ 44.8±21 9.0±5.3 29.5±25 26.5±18 27.8±7.8 27.4±10.2 
HVA 15.1±0.4 12.2±8.8 13.4±6.4 16.0±3.2 9.3±3.0 12.3±4.5 14.3±6.6 4.7±0.5 10.2±6.9 10.6±3.1 10.5±4.5 10.5±3.8 
3-MT 4.2±0.3 5.2±4.6 4.8±3.3 8.0±4.0 6.9±3.1 7.4±3.3 4.4±1.5 1.2±2.1 3.0±2.3 5.7±8.1 5.3±5.4 5.4±5.5 
(D+HVA+3MT)/DA 3.1±.004 1.9±0.3 2.4±0.7 2.2±2.2 0.54±0.1 1.3±1.6 2.6±0.4 2.3±1.8 2.5±1.1 2.3±2.2 2.8±2.2 2.6±1.4 
Serotonin (5-HT) 3.0±0.1 4.6±1.9 4.0±1.6 2.6±1### 8.4±1.9### 5.8±3.4** 3.2±0.6 3.5±2.4 3.3±1.4 2.5±3.5 1.9±1.2 2.1±1.9** 
5-HIAA 9.6±1.6 8.6±1.3 9.0±1.3 8.7±2.8 5.8±2.1 7.1±2.7 10.7±2.3 9.5±3.8 10.2±2.8 6.7±1.2 8.9±3.1 8.1±2.7 
5-HIAA/5-HT 3.1±0.4 2.0±0.6 2.5±0.8 4.5±3.5 0.69±0.2 2.4±2.9 3.4±0.4 4.0±2.8 3.7±1.7 1.2±na 5.5±2.4 4.7±2.9 
Norepinephrine 0.26±0.4 0.54±0.5 0.43±0.4** 1.1±2.3 2.5±4.4 1.9±3.5 2.1±2.1# 7.6±2.5# 4.5±3.6** 0.0±0.0 3.0±2.1 2.0±2.2 




Supplemental Figure 1. Cocaine enhanced electrically-evoked dopamine release in the nucleus 
accumbens of RIX 41/51 and RIX 04/17 anesthetized mice 
 
(a) Data shown in Figure 4b, plotted in 5-min increments. Cocaine (Coc) increased evoked DA 
release in both strains. Dashed arrow indicates Coc or saline (SAL) injection. (b) Individual 
recordings illustrating the effects of 20 mg/kg Coc IP on electrically-evoked DA release in the 
nucleus accumbens by electrical stimulation of the ventral tegmental area, 10 minutes after 
vehicle (left panels) and 20 minutes after Coc (right panels), in urethane anesthetized RIX 41/51 
(top) and RIX 04/17 (bottom) mice.  DA was monitored using fast-scan cyclic voltammetry at 
carbon-fiber microelectrodes. The color plots show current (color) at applied potential (y-axis) 
over time (x-axis). Overlaid are the concentration-versus time traces for the current at the 
oxidation potential of DA, as well as the background-subtracted cyclic voltammograms that 




































Supplemental Figure 2. Kinetic factors of dopamine release after 20 mg/kg cocaine in RIX 
41/51 and RIX 04/17 anesthetized mice 
 
The recording with the peak effect of cocaine (Coc) on [DA]max was identified and characterized, 
as described in the supplemental methods, by the following parameters: (a) [DA]max at the peak 
Coc response, (b) the time of the peak Coc response (Tmax), (c) the latency from the end of the 
stimulation to the [DA]max, (d) full width at half height (FWHH), and (e) the slope of DA 
clearance after evoked release.  None of these parameters significantly differed between strains. 
Arrows in (e) indicate the average time of T80 and T30 for each strain. Data are expressed mean 
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